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Chapter 1 describes an introduction to the area of organocatalysis and delineates previous 
work within the Smith group on the use of isothioureas in asymmetric catalysis. 
Chapter 2 showcases a one-pot isothiourea-catalysed Michael addition-lactamisation using 
cheap and readily available starting materials (carboxylic acids) and easily prepared 
α,β-unsaturated ketimines via an ammonium enolate intermediate to give dihydropyridinones 
with high diastereo- and enantioselectivity (typically >90:10 dr, up to 99% ee). The resultant 
dihydropyridinones can be successfully derivatised into multiple products without erosion of 
stereointegrity. 
In chapter 3 the same concept has also been applied to the synthesis of planar molecules by 
using (phenylthio)acetic acid as a suiTable ammonium enolate precursor. Generation of an 
ammonium enolate using an achiral isothiourea (DHPB) and reaction with α,β-unsaturated 
trifluoromethyl ketones allows an isothiourea-mediated Michael addition / lactonisation / 
thiophenol elimination cascade reaction for the formation of 4,6-disubstituted and 
3,4,6-trisubstituted 2-pyrones in good to excellent yields (61-99%). Notably this method 
allows low catalyst loadings of 1% to be used. The methodology has successfully been 
applied to the synthesis of a COX-2 inhibitor and a wide range of derivatisations has been 
performed, giving valuable aromatic and heteroaromatic products containing the 
trifluoromethyl motif.  
In chapter 4 a novel N- to C-sulfonyl migration of dihydropyridinones via photoisomerisation 
is investigated. The scope and limitations of this process is investigated and the process is 
shown to proceed without compromising the diastereo- or enantiomeric purity of the starting 
material, giving 5-sulfonyl products in good to excellent yields (67-95%). Mechanistic 
crossover has indicated that this migration includes an intermolecular step, while EPR studies 
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Chapter 1. Organocatalysis 
1.1. Introduction 
Asymmetric catalysis has received ever increasing attention in the last few decades. One of 
the important reasons for this interest is the necessity to prepare enantiomerically pure chiral 
compounds which are a huge area of study in the pharmaceutical industry.
1
 Chiral compounds 
exist in biological systems; common examples such as enzymes, DNA and amino acids are 
familiar to all.
2
 Natural amino acids exist as single enantiomers, and enzymes in biological 
systems have chiral binding sites which are activated by specific chiral species. Enantiomers, 
as two structures which have the same at connectivity but are non-superimposable mirror 
images of each other, are often recognized as two different compounds in biological systems.
1
  
Due to this fact, chiral drugs play in a crucial role in medicine, with a selection of chiral, 










In many pharmaceutical cases, only one enantiomer of a drug produces the desired 
physiological effect in the body of a living being.  The other enantiomer may not produce 
any effect, be less active or in some cases, it may even have undesired side effects to live 
beings such as toxicity.
10,11
 A racemic compound that contains two enantiomers (ratio 50:50) 
therefore could result in 50% efficiency with respect to the biological target system.
1
 From the 
view of economic benefits, it is wasteful of both time and resource to test and produce drugs 
that only offer 50% effectiveness.  To achieve the goal for providing enantiomerically pure 
compounds, asymmetric organocatalysis, which uses small chiral organic catalysts to promote 
asymmetric reactions, is potentially one of the solutions.  The major target for asymmetric 
organocatalysis is to develop new reactions which can selectively produce compounds in high 
enantiomeric excess from cheap, readily available or easily prepared starting materials with 
chiral catalysts.  
 
1.2. Organocatalysis 
Organocatalysis can be defined the uses of an organic molecule as a catalyst to enhance the 
rate of a reaction.
12
 Compared with organometallic catalysts and enzyme macromolecular 
catalysts which have traditionally dominated asymmetric catalysis, small molecular 











 Advantages Disadvantages 
Enzyme catalysis -quick and specific reaction 
-providing pure enantiomer 
-limited substrate scope 
Organometallic 
catalysis 
-benefit from low catalyst loading -water and air sensitive  
-can be difficult to remove 
 trace heavy metals 
Organocatalysis -sTable in water and air 
-inexpensive and easy to prepare 
-simple to use 
-environmental friendly 
 




These include their general air/water stablility, low cost and easy preparation, as well as 
potentially low toxicity and benefits in green chemistry.
12
 These advantages make 
organocatalysts advantageous for medicinal chemistry as it does not have problem of 
removing metal impurities. Many types of organocatalysts have been developed, with a 





Figure 1.2 A selection of typical organocatalysts. 
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Before organocatalysis was widely recognised as a synthetic strategy, many individual 







reported asymmetric organocatalytic reactions from 1912 to 1960.
13
 However, at the time, 
these scientists only took these processes as individual transformations and the power of 
organocatalysis as a general method was not understood and its value as a methodology was 
underdeveloped. In the 1970s, one of most famous asymmetric organocatalysis aldol 





Scheme 1.1 The Hajos –Parrish- Sauer- Eder- Wiechert symmetric aldol reaction 
 
The Hajos-Parrish-Sauer-Eder-Wiechert reaction is an asymmetric aldol process in which an 
achiral triketone 1 is treated with the natural chiral compound, L-proline 2, giving the 
Wieland-Miescher ketone product 3, an important intermediate in steroid synthesis, in 93% ee. 
(Scheme 1.1) However, general application of this reaction was not fully understood until 30 
years later through studies by the Barbas group.
19
 They proposed the aldolase antibody 
catalysts operating in the aldol reaction, inspired from the 
Hajos-Parrish-Sauer-Eder-Wiecherft reaction, in which an enamine intermediate was 
prepared.
19
 Thus work is especially significant as it extended the Hajos–Parrish-Sauer-Eder- 
Wiechert reaction, and allowed it be applied to transformations that have broader applicability, 
specifically the development of the intermolecular aldol reaction.
20
 This publication and 






1-2-1. Organocatalytic asymmetric reactions 
Over last decade, a variety of organocatalytic strategies have been developed, that all rely 
upon interaction between catalyst and substrate. The nature of this interaction can be 
classified into two types, either covalent or non-covalent interaction pathways (Figure 1.3).
13
 
“Non-covalent” interactions between catalysts and substrates involve hydrogen bonding and 
phase-transfer catalysis. Other processes that involve the formation of covalent 
catalyst-substrate adducts are defined as “covalent catalysis”. For example the formation of 






Figure 1.3 Organocatalysis with two classes of interactions 
 
1-2-1-1. Covalent interaction cycloadditions 
Enamine catalysis 
In asymmetric organocatalysis, enamine catalysis is perhaps the most widely developed 
method. Enamine catalysis involves the in situ formation of a catalytically active enamine and 
its subsequent reaction with an electrophile.
22
 A typical enamine catalytic cycle starts from a 
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chiral amine catalyst 4 that activates the starting material aldehyde 5 through the formation of 
an iminium ion 6. This raises the acidity of the adjacent α proton, with deprotonation leading 
to an active nucleophilic enamine intermediate 7. The subsequent reaction with an 
electrophile reforms the iminium ion 8, with hydrolysis releasing the chiral catalyst and a 
desired α- functionalized aldehyde product 9 in high ee (Scheme 1.2).  
 
 
Scheme 1.2 General enamine catalytic circle with amine 
 
An early example of this approach (Scheme 1.1), the Hajos-Parrish-Sauer-Eder-Wiechert 
reaction, proceeds via an enamine intermediate through a hydrogen bonded transition state 10 







Scheme 1.3. The proposed transition state of  
the Hajos-Parrish-Sauer-Eder-Wiechert reaction 
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In 2003, Jørgensen reported a new one-pot procedure for the formal [4+2] cycloaddition of 
aldehydes 11 and enones 12 via enamine catalysis.
23
 Aldehydes and chiral proline catalyst 13 
were used to generate the intermediate enamine 15 which subsequently reacted with enones 
giving the anti-dihydropyranone products 14 in good diasteroselectivity (>20:1 dr) and high 
enantiocontrol (84-94% ee) (Scheme 1.4). 
 
 
Scheme 1.4 The asymmetric organocatalytic [4+2] cycloaddition by Jørgensen et al 
 
Iminium catalysis 
Iminium catalysis has been well developed in various reactions such as Diels-Alder reactions, 
cycloadditions and conjugate additions. In such a reaction, an α,β-unsaturated ketone or 
aldehyde 16 condenses with a chiral secondary amine catalyst 17 to form an active iminium 
ion 18.
22
 The nucleophile 19 then attacks the β-carbon atom of the conjugated iminium ion 
intermediate 18 to form the β-functionalized enamine 20. Finally, the catalyst and the product 





Scheme 1.5 General iminium catalysis cycle 
 
As an example of this approach, the first asymmetric iminium-catalyzed Diels-Alder reaction 
was reported by MacMillan in 2000.
21
 The chiral imidazolidinone 23 was used to generate the 
iminium ion 24 and catalyse the reaction between α,β-unsaturated aldehydes 25 and various 
dienes 26, obtaining cyclic products 27 with good enantioselectivity (83-96% ee).
21
  
MacMillan suggested an (E)-iminium ion 28 is the more favoured configuration in the 
reaction, as it avoids the interaction between the α-position hydrogen and methyl group on 
catalyst. The diene prefers to approach from the si face avoiding the bulky benzyl group 
catalyst resulting in the endo product being favoured (Scheme 1.6). 
 
Scheme 1.6. The first asymmetric iminium-catalyzed Diels-Alder reaction by MacMillan 
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N-Heterocyclic carbene (NHC) catalysis 
In chemistry, a carbene is a molecule that contains a neutral carbon atom with a pair of 
valence electrons.  The carbene species used in organocatalytic reactions is a “persistent 
carbene” which is sTable at room temperature.
24
 The most common carbene species which 
have been applied in organocatalytic reaction processes are thioazol- (A), triazol- (B), 





Figure 1.4 Common carbene species 
 
The Smith group developed a reaction procedure in which treatment of ketenes 29 with NHC 
catalyst 31 forms an active enolate intermediate 33, which subsequently reacted with imines 
30 in a formal [2+2] cycloaddition to form the asymmetric β-lactam products 32 with 55-75% 











Ammonium enolate catalysis 
In organic chemistry, the enolate is a powerful species in the C-C bond formation which can 





Scheme 1.8 Examples of enolate applications 
 
While enamine catalytic processes transform aldehydes and ketones directly into 
α-functionalised compounds, ammonium enolates can promote functionalised 
enantioselective transformations of various other carbonyl containing molecules,
28
 for 
example, ester, amide and other electron-withdrawing groups can all be prepared that cannot 
be achieved by enamine catalysis. Therefore, the development of chiral ammonium enolate 
catalysis has become an alternative solution for other catalytic reaction processes. 
There are three common types of ammonium enolates that can be generated (Type I-III, 
Scheme 1.9), know as C1-, C2- and C3- ammonium enolates, in which the numbering refers 
to the number of atoms from enolate to ammonium. C1-ammonium enolates 38 typically 
result from the reaction of tertiary amine catalysts (R3N) 39 and ketenes 40. C2-ammonium 
enolates 41 can be produced through reacting tertiary amine catalysts (R3N) with 
α-bromocarbonyl compounds 42 and a base. Lastly C3-ammonium enolates 43 result from 







Schemes 1.9 Three pathways to generate ammonium enolate 
 
C1-ammonium enolates have been the most developed in various reactions. For example, 
Nelson and co-workers reported the treatment of catalytic asymmetric [4+2] cycloaddition of 
ketene with N-thioacyl imines and treated with a cinchona catalyst 45.
30
 Generation of ketenes 
in situ from an acid chloride 46 then forms an ammonium enolate intermediate 47. 
Subsequently, the ammonium enolate 47 attacks the imine 48 generated in situ from α-amido 
sulfone 49 to afford the [4+2] cycloaddition product 50 with excellent diastereo- and 
enantiocontrol ( >95:5 dr, 95-98% ee) (Scheme 1.10). 
 
 
Scheme 1.10 The catalytic asymmetric [4+2] cycloaddition by Nelson et al 
 
An example of enantioselective [4+2] cycloaddition reaction has been developed by Lectka et 
al.
31
 Generation of a ketene in situ from an acid chloride 51, followed by activation with a 
cinchona alkaloid derived catalyst 52 gave the active ammonium enolate intermediate 53. The 
active enolate intermediate then underwent a [4+2] cycloaddition reaction with a range of 
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ortho-quinones, ortho-quinone diimides and ortho-quinone imides 54. The catalyst was then 
regenerated and the product 57 was obtained. This approach gave good yield (58-91%) with 
excellent ee (90-99%) (Scheme 1.11).  
 
 
Scheme 1.11 The proposed mechanism of Lectka’s approach 
 
1-2-1-2. Non-covalent interaction reactions 
Non-covalent interactions in organocatalysis mimic the interactions from natural enzymes. 
Compared with covalent interactions, non-covalent interactions are weaker, less directional 
and less distance dependent. However, this strategy can provide high level of 
enantioselectivity through cooperative effects.
32
 Three major concepts have been reported for 
organocatalytic processes involving non-covalent interactions. These are H-bonding catalysis, 
phase transfer and “ion pair” catalysis. An example of each concept will be introduced in this 





The development of H-bond donor molecules as catalysts in organic reaction has grown 
remarkably in the past few years. This concept uses catalysts, such as thioureas and 
bifunctional cinchona alkaloid derivatives, that can form hydrogen bonds with substrates to 
enhance the activity of organic reactions.
33
 As an example, a thiourea can provide dual 
H-bonding in catalysis, and has gained increasing attention. For example, in Diels-Alder 
reactions, these H-bond donor molecules act like weak Lewis acid catalysts and enhance the 
rate of the reaction.
13
 In 2008, Ricci and co-workers reported a new method for the 
organocatalytic asymmetric Diels-Alder of 3-vinylindoles (Scheme 1.12).
34
 This asymmetric 
Diels-Alder reaction was catalysed by quinine thiourea derivative 58 with a bifunctional 
acid-base functionality, allowing the formation of H-bonds to both diene 59 and dienophile 60 
resulting in excellent enantioselectivity of the product 61 (up to 98% ee). In the proposed 
transition state 62 for the reaction, H-bonding between the catalyst and the dienophile lowers 








 have reported the treatment of anthrones and maleimide in the 
presence of Takemoto’s bifunctional thiourea catalyst 63. This catalyst offers both Brønsted 
acid (secondary amine) and base (tertiary amine on thiourea moiety) active sites, to promote 
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the asymmetric Diels-Alder reaction in high yield (average 90% yield) and enantioselectivity 
(up to 96% ee). In this reaction, anthrone 64 is proposed to form H-bonds with the chiral 
secondary amine 63 generated anthrone enolate 65. Subsequent association to the maleimide 
66, which is also activated by forming dual H-bonding of 67 with the thiourea moiety of the 
catalyst, followed by a [4+2] cycloaddition reaction leads to formation of the product 68 in 
high enantioselectivity (83- 96% ee) (Scheme 1.13).  
 
Schemes 1.13 The approach of H-bonding catalysis via bifunctional thiourea 
 
Phase-transfer catalysis 
A simple explanation of a reaction system employing phase-transfer catalysis is based upon a 
biphasic system involving an organic phase and an aqueous phase. Recently, Smith and 
co-workers have proposed a catalytic 6π-electrocyclisation phase-transfer reaction catalysed 
by cinchona alkaloid derivatives 69.
36
 The reaction was carried out by treatment of 
benzaldimine 70 with 10% catalyst 69 in a biphasic system of aqueous potassium carbonate in 
toluene to give the bicyclic product 71 with high yield (81-99%) and enantioselectivity (84- 




Scheme 1.14 The proposed asymmetric electrocyclisation via phase-transfer catalysis 
 
The stereocontrol in this process may be rationalised by the tight-ion pair model which has 
been proposed for phase transfer asymmetric alkylation by Corey and co-workers.
37
 The 
oxygen enolate anion of the substrate forms an ionic pair interaction 72 with the quaternary 
ammonium cation of the cinchona catalyst; one π-face of the delocalized anionic component 
will be blocked by the bulky catalyst. Subsequently the electrocyclisation then occurs away 
from the bulky catalyst via orbital overlap 72 which has only one face to access (Scheme 1.14). 
 
Counterion catalysis 
As an example of counterion catalysis, chiral thiourea catalysts form strong complexes with 
halide ions to generate a transient ion pair that can act as a chiral counterion making 
nucleophiles approach to a single face only.
12
 Jacobsen and co-workers reported the 
transformation of asymmetric thiourea-catalyzed addition to cyclic oxocarbenium ions.
38
 The 
principle in this reaction involves the H-bonding thiourea catalyst 73 intercepting chloride 
ions from chloroisochromans 75 to generate an ion pair 76. Tetrasubstituted silyl ketene 
acetals 77 act as nucleophiles, and following addition to oxocarbenium ions 76, results 





Scheme 1.15 The Counterion catalytic approach by Jacobsen et al 
 
1-3. Previous work in the Smith Group 
Previous research in the Smith group has successfully applied NHC catalysts to the synthesis 
of δ-lactones via an azolium enolate intermediate.
39
 The method relies upon the generation of 
the active enolate intermediate 79 from ketenes 80 and the NHC catalyst 81, before reaction 
with the α,β-unsaturated ketoester 82. Cycloaddition, followed by regeneration of the catalyst, 
gave the syn-dihydropyranone 83 in modest dr, but good ee (up to 95%) and excellent yield 




Scheme 1.16 The synthesis of syn-dihydropyranone in the Smith group 
 
Although useful, the ketene involved in this process has to be purified by distillation before 
being used in the reaction and cannot be stored for indefinite periods. These characteristics of 
ketenes give them limited synthetic utility. Recently, the Smith group has reported a new 
pathway for catalytic asymmetric intermolecular [4+2] intermediate cycloadditions via the 
generation of an active ammonium enolate from simple, cheap and commercial available 
arylacetic acids 84 through reaction with a chiral isothiourea catalyst 85 (Scheme 1.17).
40
 This 
formal [4+2] cycloaddition reaction gives anti-dihydropyranone 86, through the proposed 
transition state 93, with high dr (up to 98:2) and ee (up to 99%).  
 
  





The proposed mechanism of this process relies upon the reaction of the arylacetic acid 84 
with pivaloyl chloride to form the mixed anhydride 87. N-Acylation of the chiral isothiourea 
85 with this anhydride forms the acyl ammonium adducts 88. Deprotonation generates the 
active ammonium enolate intermediate 89, that undergoes Michael addition with ketoester 
acceptor 90. Cyclisation and catalyst regeneration gives the asymmetric [4+2] cycloaddition 
products, anti-dihydropyranone 86, and catalyst 85 (Scheme 1.18). 
 
 









1-4. The aim of this work 
Building upon this previous work, the main aim of this project is to probe the reactivity of 
ammonium enolate intermediates via Lewis base catalysis, generated in situ from a carboxylic 
acid 91, with a range different Michael acceptors such as ketoenones and α,β-unsaturated 
ketimines 92 in formal [4+2] cycloaddition reaction to synthesise a diverse range of either 
stereodefined heterocyclic products or planar heterocycles. To generate the planar 
heterocycles, it was envisaged that a suiTable leaving group (R
1
) within the carboxylic acid 
would have to be identified, with the introduction of a heteroatom investigated for this 
purpose (Scheme 1.19).  
 
 
Scheme 1.19 The aim of the project  
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Chapter 2. Asymmetric Organocatalytic Michael 
Addition-Lactamisation; Access to Dihydropyridinones  
 
2-1. Introduction 
The dihydropyridinone motif is an important heterocyclic class containing a six-membered 
ring cyclic amide with a double bond. Compared with other six-membered heterocyclic 
scaffolds containing a nitrogen atom, such as pyridines, piperidines and indolizidine alkaloids, 
the dihydropyridinone structure has not been much explored, despite the motif being found in 
many natural products. For instance, homoclausenamide is a Clausena alkolid isolated from 
the leaf extract of Rutaceae Clausena lansium Skeels;
41
 widely used in Chinese medicine for 




       
Clausena lansium 
 
The dihydropyridinone motif is also an important subunit in pharmaceuticals,
43,44,45
 moreover, 
it can be used as a synthon toward the synthesis of other heterocycles.
46
 For example, the 
polysubstituted dihydropyridinone, finasteride 93 is applied in the treatment of male frontal 
pattern hair loss.
47
 A simple spiro-dihydropyridinone 94 has been reported by Wang et al 
48
 
who also disclosed its activity as an antiproliferation of leukemia cell . Dihydropyridinone 95 
has also been found as a subunit in a α1a adrenergic receptor anatagonist.
49




Figure 2.1 A selection of dihydropyridinone containing compounds 
 
A range of studies on the synthesis of dihydropyridinone have been reported, including: 
Horner-Wadsworth-Emmons/cyclocondensation;
50,51
 diene-transmissive hetero-Diels-Alder 
reactions;
46
 radical [3+2] annulations;
52
 the Nazarov intermediate cyclisation via Schmidt 
rearrangement;
53
 and 6-endo-enamide-epoxide cyclisation.
42
 Some selected examples of 
dihydropyridinone synthesis are shown below.  
 
2-1-1. Previous studies of dihydropyridinone synthesis 
2-1-1-1. Diene-transmissive hetero-Diels-Alder reaction 
The diene-transmissive hetero-Diels-Alder reaction (DTHDA) allows the synthesis of 
dihydropyridinones via two sequential cycloadditions. Compared with the diene-transmissive 
Diels-Alder reaction (DTDA), the DTHDA reaction contains more than one heteroatom 
within either a triene/polyene or a dienophile. Kobayashi and co-workers have reported the 
synthesis of dihydropyridinones via the diene-transmissive hetero-Diels-Alder reaction
46
 to 
form hexahydroquinolinones 96. The reaction starts with the formation of azatriene 97 from 
the condensation of the corresponding ketone 98 and a primary amine using TiCl4 and Et3N at 
0 ˚C for 1 h. The azatriene 97 is isolated and reacted directly without any purification with 
ketene 98 to produce the [2+2]-cycloadduct β-lactam 99 in good yield. This undergoes a 
[1,3]-sigmatropic rearrangement after refluxing in toluene for 1 h to give more 





Scheme 2.1 Diene-transmissive hetero-Diels-Alder Reaction 
 
These dihydropyridinones 100 react onwards in a second cycloaddition at room temperature 
with tetracyanoethylene (TCNE), giving 96 with complete diastereoselectivity in excellent 
yield (94-99% yield) (Scheme 2.2).  
 
 
Scheme 2.2 Second cycloaddition with TCNE 
 
2-1-1-2. Amide cyclisation  
As the dihydropyridinone structure contains a carbonyl motif, double bond, and nitrogen atom, 
one strategy for dihydropyridinone synthesis is therefore to cyclise the amide chain. For 
example, Wang and co-workers have reported using a Brønsted acid mediated stereospecific 
intramolecular enaminic reaction to synthesize the natural product-homoclausenamide, 
neoclausenamide and derivatives thereof.
42,54
 Depending upon the reagent used (TFA or 
refluxing water) the enamide 101 will give either 6-endo-cyclisation to form six-membered 
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dihydropyridinone (homoclausenamide) 102 or 5-endo-cyclisation to form 
γ-dihydropyridinone (neoclausenamide) 103 (Scheme 2.3).  
 
 
Scheme 2.3 A Brønsted acid mediated stereospecific intramolecular enaminic reaction 
 
The proposed mechanism of this intramolecular enaminic reaction is shown in Scheme 2.4 In 
the present of TFA, the oxirane-containing amide 104 may be protonated and ring-opened to 
form carbonium intermediate 105, which can proceed 6-exo-enamide-epoxide cyclisation via 
β-carbon (enaminic carbon) attack to the carbonium then form the iminium 106. Following 
deprotonation gives homoclausenamides 102. Alternatively, boiling the amide 101 in water 
leads to the α-carbon acting as the nucleophilic site to attack the epoxide ring. It suggests that 
the lone pair electron on nitrogen does not conjugate with the carbon-carbon double bond; the 
amino plane might be perpendicular to the carbon-carbon double bond resulting in inhibition 
of the delocalisation of the lone pair electron on nitrogen. This facilitates a 5-exo-cyclisation 




Scheme2.4. Plausible mechanism for 6-endo- and 5-endo-enamide-epoxide cyclisation of 101 
 
Recently, LaPorte et al. have developed a radical [3+2]-annulation of divinylcyclopropanes 
for the synthesis of analogues of the natural product meloscine.
52
 The proposed formation of 
this dihydropyridinone 109 begins with the addition of tributyltin radical to the vinyl group of 
amide 110, allowing the fragmentation of the cyclopropane ring to give the radical 
intermediate 111, which triggers the 6-endo-trig-cyclisation to form the tricyclic intermediate 
112. Finally, a 5-endo-trig-cyclisation to form the second ring structure then β-elimination to 
remove the tin radical gives the polycyclic dihydropyridinone 109 (Scheme 2.5). 
 
Scheme 2.5 The radical [3+2] annulation of divinylcyclopropanes 
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2-1-1-3. Domino electrocyclisation/azide-capture/Schmidt rearrangement of dienones  
The Nazarov cyclisation is one of the most well known methodologies to form 
cyclopentenones via a Lewis acid catalysed cationic 4π-electrocyclic ring closure. This 
reaction contains a conrotatory 4π-electrocyclisation, according to the Woodward-Hoffmann 
rules. West et al
53
 has developed a dihydropyridinone synthesis using dienones 113 to form 
the Nazarov intermediate in situ that reacts with organic azide 114, which is well known to act 
as a 1,3-dipole and as a nucleophile in the presence of electron-deficient species such as 
carbocations. This leads to highly functional trans-dihydropyridinone 115 in moderate to high 
yields and good to excellent diastereoselectivity (Scheme 2.6). 
 
 
Scheme 2.6 Intramolecular azide trapping dihydropyridinone formation 
 
This reaction process starts with the Nazarov cyclisation to form the Nazarov intermediate 
116 in situ with a carbocation facilitating the addition of azide 114 and subsequent 
Schmidt-type rearrangement. Proton transfer leads to give the major trans-dihydropyridinone 





Scheme 2.7 The proposed mechanism dihydropyridinone formation 
 
Traditionally, chiral enantiopure dihydropyridinones have been prepared from original 
starting materials such as chiral amino acids; in the other words, they have to use the 
enantiopure starting materials to obtain the compounds in single enantiomeric form. The 
enantiopure material normally comes from nature, the chiral pool, or is prepared via difficult 
biotransformations. Besides, lots of the examples are stoichiometric rather than catalytic 
reactions, generating large amounts of chemical waste. Since the importance of asymmetric 
organic compounds has been recognised in many areas, for instance in the pharmaceutical 
industry and also natural product synthesis, the development of an efficient, asymmetric and 
catalytic dihydropyridinone synthesis with excellent stereoselectivity under mild reaction 
conditions is a worthwhile endeavour. To reach this target, one of the methodologies is 
organocatalysis; the reaction is mediated by an organocatalyst, with racemic or prochiral 
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starting materials to produce products in high stereoselectivity. Among many cyclisation 
methods, this project is particularly interested in using the formal [4+2]-aza-Diels-Alder 
reaction, for the synthesis of dihydropyridinone.  
 
2-1-2. Organocatalytic enantioselective formal [4+2]-cycloaddition, 
formal aza-Diels-Alder reaction 
The Diels-Alder reaction is classified as a [4+2]-cycloaddition and has been well recognised 
as a powerful tool in synthetic chemistry for the formation of six-membered rings. 
Traditionally, the reaction favours the interaction between electron-rich dienes and 
electron-poor dienophiles, although inverse electron-demand systems are known. The 
mechanism of Diels-Alder is believed to occur in a single concerted transformation. To 
distinguish the difference from the Diels-Alder reaction, stepwise [4+2]-cycloadditions 
containing two steps, for instance, Mannich-Michael reaction, Mannich-Friedel-Crafts and 
Michael-lactamisation, have been termed the formal [4+2]-cycloadditions or the formal 
Diels-Alder reaction. Alongside the original Diels-Alder reaction with only carbon containing 
dienes and dienophiles, there are hetero-Diels-Alder reactions
55,56
 such as the aza-Diels-Alder 
reaction
56
 containing a nitrogen atom in either the diene or dienophile. Aza-Diels-Alder 
reactions can be classified into two classes, the normal-electron demand aza-Diels-Alder 
(NED-aza-Diels-Alder) and the inverse-electron demand aza-Diels-Alder 
(IED-aza-Diels-Alder). Due to the increasing attention on the synthesis of enantiopure 
bioactive aza-heterocycles and their potential as valuable intermediates for natural product 
synthesis, catalytic aza-heterocycle synthesis in an atom-economic manner are highly 
sought-after. However, the development of catalytic enantioselective aza-Diels-Alder 
reactions has been problematic as stoichiometric amount of Lewis acid catalysts are 
traditionally required for the reaction. This is mainly due to the nature of the basic nitrogen 
atom in the diene, dienophile, the aza intermediate or even the aza-heterocyclic product 
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involved in the reaction that can strongly coordinate with the Lewis acid catalyst, resulting in 
either the slowing or even shut down of the catalytic cycle. To conceal this issue, two 
successful strategies have been widely applied from the literature, the first using the 
combination of compatible Lewis acid with chiral ligands, the second is the use of 
organocatalysis.  
 
2-1-2-1. The Normal-Electron Demand Aza-Diels-Alder (NED-aza-Diels-Alder) 
Based on the knowledge of frontier molecular orbital (FMO) theory, the 
NED-aza-Diels-Alder reaction occurs between the lowest unoccupied molecular orbital 
(LUMO) of dienophile and the highest occupied molecular orbital (HOMO) of diene. Hence, 
the reaction favours to have electron rich diene 121, which has higher HOMO energy, with 
electron poor dienophile 122, which has lower energy of LUMO (Figure 2.2).  
 
 
Figure 2.2 Typical NED-aza-Diels-Alder reaction 
 
To encourage the NED-aza-Diels-Alder interaction between diene and dienophile, this 
interaction can be strengthened by either raising the HOMO energy of diene via 
aminocatalysis 124 or lowering the LUMO energy of dienophile through Lewis acid 125 or 





Figure 2.3 Activation modes of NED-aza-Diels-Alder reaction 
 
LUMO-Lowering via chiral Lewis acid catalysis 
Kobayashi et al. have presented the first example of a catalytic enantioselective reaction by 
using chiral Lewis acid complex, (R)-BINOL-Ytterbium(III), to form tetrahydroquinoline 





Scheme 2.8 The synthesis of tetrahydroquinoline catalysed by (R)-BINOL-Ytterbium(III) 
 
The proposed transition state model suggested by Kobayashi for the reaction is that the chiral 
complex prepared from Yb(OTf)3, (R)-BINOL and DBU provides bidentate coordination to 
the imine and the axial chirality of (R)-BINOL is transfered via hydrogen bonding to amine 
components. The additive, DTBP, interacts with the phenolic hydrogen of the imine 128, 
which is fixed by bidentate coordination to the metal. Due the steric hinderance of the Si face, 






Figure 2.4 The proposed transition state by Kobayashi 
 
However, to achieve the best results, different additives were required for different substrates. 
This was explained due to changes in the asymmetric environment created by 
(R)-BINOL-Ytterbium(III) with different substrates. Hence, the product scope is limited.  
 
HOMO-Raising via aminocatalysis 
In 2003, the first direct asymmetric organocatalytic NED-aza-Diels-Alder via activating the 
diene 130 by L-proline 131 was reported by Ohsawa and co-workers.
58
 They successfully 
applied this approach using cyclic imines 130 and α,β-unsaturated ketone 132 catalysed by 
L-proline to form a precursor of natural indole alkaloids 133 in good yield with excellent 
enantioselectivity (Scheme 2.9). However, high level of catalyst loading (50 mol %), 
super-stoichiometric ketone (30 eq) and also long reaction time (7 days) detract from the 
utility of this methodology.  
 
 
Scheme 2.9 The direct proline-catalysed asymmetric aza-Diels-Alder addition 
The reaction is believed to start from reacting proline 131 and ketone 132 to form the active 
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enamine 134, which will react with the cyclic (Z)-imine 130 as a dienophile in a Mannich 
type reaction to give the iminium ion intermediate 135. Subsequent intramolecular Michael 
addition is used to cyclise the ring (Scheme 2.10). Later in 2006, Ohsawa also applied this 





Scheme 2.10 The proposed mechanism of proline-catalysed asymmetric addition 
 
2-1-2-2. The Inverse-Electron Demand Aza-Diels-Alder (IED-aza-Diels-Alder).  
Compared with the NED-aza-Diels-Alder reaction, the inverse-electron demand 
aza-Diels-Alder employs the reverse concept, in that the reaction occurs between the LUMO 
of the diene and the HOMO of the dienophile. 1- and 2-azadienes (136 and 137) are suiTable 
reagents for this type of reaction as they act as electron deficient, having the LUMO with 
lower energy that will be able to react with electron rich dienophile 138 and 139 to form the 





Figure 2.5 Typical IED-aza-Diels-Alder reaction 
 
There are two classes of activation mode to promote the IED-aza-Diels-Alder reaction; the 
first one is lowering the LUMO energy of the diene generally via Lewis acid 142 or Brønsted 
acid catalysis 143, the other raisies the HOMO energy of dienophile through organocatalysis, 
such as aminocatalysis 144
60





Figure 2.6 Activation modes of IED-aza-Diels-alder Reaction 
 
Recently many studies of the dihydropyridinone functional motif synthesis have been 
reported using asymmetric organocatalytic formal IED-aza-Diels-Alder reaction via 









LUMO-Lowering via Chiral Lewis Acid 
Carretero et al
61,62
 have reported the first chiral Lewis acid promoted IED-aza-Diels-Alder 
reaction with 1-azadiene (ketimine 147). The chiral Lewis acid combination of Ni(ClO4)H2O 
and DBFOX-Ph 148 enabled ketimine 147 and vinyl ethers 140 to undergo cycloaddition to 
form piperidine derivatives 150 in high endo-selectivity (up to 98:2) and moderate to 
excellent enantioselectivity (Scheme 2.11). However, this method requires long reaction times 
and excess of the enol-ether component (5 eq).  
 
Scheme 2.11 The piperidine formation via chiral Lewis acid catalysis 
 
Ni(ClO4)H2O and DBFOX-Ph 148 form the chiral Lewis acid complex A. The reactive 
model complex B containing the pro S oxygen in ketimine 147 coordinated with Ni and the 
E-configuration of ketimine force the reaction from the Re face of ketimine and endo 





Scheme 2.12 Stereochemical model for the cycloaddition 
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HOMO-Raising via aminocatalysis 
In 2003, Jorgensen and co-workers
23
 disclosed that L-proline derived catalysts 150 and 
aliphatic aldehydes 151 can generate enamine species in situ and can act as HOMO-raised 
dienophiles in IED-hetero-Diels-Alder reactions to form lactols 153. Subsequent oxidation 
with PCC led to highly stereoselective formation of δ-lactones 154 (Scheme 2.13).  
 
 
Scheme 2.13 Jorgensen’s HOMO-raised active model  
 
Inspired by Jorgensen’s work, Chen et al
63,64
 applied aminocatalysis via enamine 








The proposed mechanism begins from the condensation of proline derived catalyst 158 with 
aldehyde 156 generate the HOMO-raised dienophile enamine 159. This enamine will then 
undergo [4+2]-cycloaddition with electron-deficient ketimine 157 to form the complex 160, 
with hydrolysis to release the catalyst and hemiaminal product 155 (Scheme 2.15). The key to 
success in this work is the MeCN/H2O solvent mixture; this aids the hydrolysis process and 
regenerates the catalyst.  
 
 
Scheme 2.15 The proposed proline catalytic cycle 
 
The hemiaminal 155 can be oxidised with PCC into dihydropyridinone 161 with moderate 
yield without compromising the enantiopurity. Using different oxidation reagents, the parent 




Scheme 2.16 Derivertisations of hemiaminal 
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2-1-3. Organocatalytic dihydropyridinone formations 
2-1-3-1. Via NHC catalysis 




 groups have applied NHC catalysis to form an 
active enolate intermediate for dihydropyridinone synthesis. Carbene catalysis has been 
applied to various reactions such as the benzoin condensation
67
 and the Stetter reaction.
25
 In 
2006, Bode and co-workers successfully generated azolium enolate intermediates 163 from 
enones 164 and used them in the first NHC catalyzed [4+2]-hetero-Diels-Alder reaction.
65
 In 
this reaction, enone was treated with N-protected α,β-unsaturated imines 165 in the presence 
of NHC 166 to give the syn-dihydropyranone product 167 with high diastereo- and 
enantiocontrol (>20:1 dr and up to 99% ee) (Scheme 2.17). 
 
Scheme 2.17 The NHC catalyzed [4+2] cycloaddition reaction by Bode et al. 
 
The proposed mechanism for this process starts from the NHC precursor 166 activated by 
(
i
Pr)2NEt, generating a homoenolate 168 with enone 164, which subsequently forms active 
enolate 169. Cycloaddition with the N-protected α,β-unsaturated imine 165 generates the 





Scheme 2.18 The proposed mechanism of NHC catalyzed [4+2] cycloaddition reaction 
 
Ye and co-workers also have developed a δ-dihydropyridinone synthesis using a NHC catalyst 
171 by reacting ketenes 172 with tosyl ketimine 173 (Scheme 2.19).
66
 The initial 
diastereoselectivity of the reaction was low (4:1 dr; anti:syn). However, stirring the crude 
product in DME at rt for 24 hours after the catalysis reaction was complete improved the 
diastereoselectivity (up to >20:1). DME played a crucial role as Cs2CO3 dissolves more 
readily in DME then benzene, allowing epimerisation of C(4) position of the 
syn-dihydropyridinone to the anti-dihydropyridinone over time. 
 
 
Scheme 2.19 Ye’s approach to the synthesis of highly enantioselective δ-dihydropyridinone 
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The proposed mechanism begins by generating the NHC 175 from its precursor followed by 
nucleophilic addition into the ketene 172 to form the enolate intermediate 176. This 
undergoes an inverse-electron-demand Diels-Alder reaction to give adduct 177. The adduct 
then collapses to give the dihydropyridinone product 174 and regenerate the NHC catalyst 
175 (Scheme 2.20). 
 
 
Scheme 2.20 The Proposed mechanism of Ye’s approach 
 
Both these methods have shown the utility of enolate chemistry via NHC catalysis, in 
providing the dihydropyridinone products with high diastereo- and enantioselectivies. 
However, ketenes are not easy to handle and are a very reactive species, which can cause 
other undesired side reactions and in many cases they have dimerisation problems.
25
 
Moreover, both methods have long reaction times, and the reaction scale was small. Hence, it 
is required to develop new and efficient methods which could use cheap, easy to handle 







2-1-3-2. Isothiourea catalysis 
The first example of organocatalytic dihydropyridinone synthesis mediated by isothiourea 
catalysts has been reported by the Smith group.
68
 The methodology uses cheap, commercially 
available and easy to handle arylacetic acids 178 as ammonium enolate precursors and 
ketimine 179 to generate highly functionalised trans-dihydropyridinone 181 (Scheme 2.21).  
 
 
Scheme 2.21 Smith’s approach 
 
2-2. The aim of this work 
Previous work from the Smith group has developed an efficient asymmetric one-pot 
intermolecular Michael addition-lactonization process from carboxylic acids and 
α,β-unsaturated carbonyl compounds that proceeds via an ammonium enolate intermediate.
40 
Smith and co-workers have also applied this active ammonium enolate species successfully 
into the asymmetric dihydropyridinone formation as shown above (Scheme 2.21). This 
previous work has shown only examples where arylacetic acids and tosyl substituted 
ketimines were used. Building upon this, the aim of this project was to probe the reactivity of 
these ammonium enolate intermediates with a range of α,β-unsaturated γ-ketoester ketimine 
acceptors, substituted with various sulfonyl groups, to form highly functionalised 





Scheme 2.22 This Work 
 
2-3. Ketimine synthesis 
To explore the limitation of reactivity of the ammonium enolate species, we decided to 
examine Michael acceptors made up of α,β-unsaturated ketimines substituted with ester 
groups, 173. These have shown good reactivity in the NHC catalysed ammonium enolate 
chemistry by Ye and co-workers.
66
 Besides, this type of ketimine can be easily synthesised by 
treating the commercially available α,β-unsaturated ketone with sulfonylamide, TiCl4 and 
NEt3. Regarding imine synthesis from the literature, the majority of methodologies treat 
carbonyl substrates and sulfonylamide with Lewis acids, such as TiCl4 or BF3OEt2, with NEt3, 
then purifying via flash column chromatography (Scheme 2.23).  
 
 
Scheme 2.23 General Scheme of ketime synthesis from literature 
 
However, these ketimines that were interesting to this project were found to be problematic by 
following the standard procedure reported by Ye et al.
66
 The issue is the pure ketimines were 
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unable to be isolated from flash column chromatography in our hands, in contrast to what Ye 
et al. have stated in their procedure. This type of ketimine were first developed and reported 
by Ye
66,69
 and then also used by Chen and co-workers,
70,71
 however, the procedure was not 
clear and those reported ketimines have not been fully characterised.  
 
Following the procedure from the literature, the synthesis did work as expected; the ketimine 
product was present in the crude 
1
H NMR spectrum. However, the major problem in this type 
of ketimine preparation was the purification; the ketimines were very sensitive, as they could 
easily hydrolyse in acidic and also basic column conditions. In our hands they did not survive 
silica gel column chromatography as reported in the literature. Basified silica or neutral 
alumina were both unsuccessful in purifying the ketimine from the crude reaction mixture and 
the ketimine was found to decompose on the column. This hydrolysis could be easily 
observed via 2D TLC. Kugel-Rohr distillation was attempted, resulting in decomposition into 
the starting enone and sulfonamide. Moreover, literature preparations removed impurities 
such as titanium salts by adding water into the reaction crude that could possibly accelerate 
the hydrolysis. 
 
At this stage, it was clear that the flash column chromatography was not an option for 
obtaining the ketimine products cleanly. To avoid hydrolysis, it was necessary to develop 
either a new procedure avoiding using Lewis acids, which could stop forming the unwanted 








2-3-1. Aza-Wittig Reaction 
To achieve these goals, an Aza-Wittig reaction was applied for the preparation of ketimine 
acceptors 189, ketone 187 was reacted with N-tosyl triphenylphosphane Wittig reagent 188. 
(Table 2.1) However, the results show that the yields of this reaction are very low and 
changing the solvent, temperature, increasing the reaction time, or performing the reaction in 
a sealed microwave tube did not improve the yields. In most cases, the starting material was 
the only recovered material. Surprisingly, even adding a Lewis acid, TiCl4, up to one 
equivalent, did not improve the conversion and the reaction mixture looks significantly 
messier from the 
1
H NMR spectra.  
 
Table 2.1 Aza-Wittig reaction optimisation 
 
Entry t (day) TiCl4 (%) Temp. (
o
C) Solvent Heating method Ketimine
a 
1 1 - 85 THF Reflux 2% 
 2 - 160 toluene Reflux 6% 
 3 - 160 toluene Sealed tube 13% 
2 1 10 85 THF reflux - 
3 1 100 85 THF Sealed tube - 
 2 100 160 THF Sealed tube - 
4 7 100 160 toluene Sealed tube 7% 







2-3-2. New purification procedure 
An alternative that has been tried is to find a new purification which could limit hydrolysis 
from the reaction procedure (Scheme 2.23). Instead of quenching the reaction mixture with 
water, diethyl ether was used to precipitate impurities. The organic solvent was then removed 
and more diethyl ether added again, this step was repeated until there was no further 
precipitate was observed. This crude material was then triturated with diethyl ether at －20˚C 
in a ice/salt/acetone bath. During the trituration, it was important to make sure all the crude 
was fully triturated into a crystalline solid, as the gummy impurities accelerate ketimine 
decomposition. Moreover, it was also found that the concentration of reaction solvent cannot 
be lower than 0.3 м, otherwise clean solid ketimine cannot be made. Also, using freshly 
re-purified enone starting materials in the ketimine synthesis improved the purification of the 
ketimine. Following the optimised purification, six ketimines with various sulfonyl groups 
including electron withdrawing (nitro) 194 and donating (alkyl, methoxy) 191-193 aryl 
substituents and also non-aryl (mesyl) 195, were prepared in good yield (Scheme 2.23). 
Trifluoromethanesulfonamide (H2NSO2CF3) was also applied into the ketimine preparation 
but there was no reaction at all, only the starting material enone returned. 
 
 





Modified aryl substituted ketimines were also prepared, with the precursor enone synthesised 
through Xiao’s procedure
72
 from the oxidation of diethyl tartrate 196 to form aldehyde 
intermediate in situ. This undergoes highly stereoselective Wittig reaction with the 
corresponding 2-(triphenylphosphoranylidene)acetophenone 197, resulting in the 
corresponding α,β-unsaturated enones 198-203, only (E)-isomer was observed by 
1
H NMR 
spectroscopy (Scheme 2.24).  
 
 
Scheme 2.24 The preparation of α,β-unsaturated enones 
 
The enone 204 with the reversed substituents can be prepared from the previous work of 
Smith et el, by reacting pyruvic acid 205 with aryl aldehyde 206 and potassium hydroxide to 
obtain potassium enoate 207, which reacts with the corresponding alcohol resulting the 
reversed enone 204 (Scheme 2.25).  
 
 
Scheme 2.25 The preparation of enone 204 with reversed substituents 
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However, the substrates with methyl, aryl p-trifluoromethyl and aryl p-nitro substituted 
ketimines were difficult to prepare as the reaction only had maximum 50% conversion. The 
aryl p-nitro enone did not even react with benzensulfonamide by 
1
H NMR spectroscopy. 
Besides, those ketimines were not sTable and decomposed easily on attempting trituration. 
Also, they were hydrolysed back immediately to starting material once applied to flash 
column chromatography. The reactions of aryl p-methyl, p-chloro and p-methoxyl enones 
with benzenesulfonamide were working fine but the crude materials were all gums even at －
20˚C, and could not be triturated to solid forms in our hands. Aryl p-methyl, p-chloro 
substituted enones have also repeated with tosyl amides which have been prepared by Ye and 
Chen’s group, however, none of them could be obtained in solid form. Despite these issues, 
the reversed enone 204 and aryl p-methoxyl enone 202 worked with tosyl amide and those 
two ketimines, 208 (43% yield) and 209 (37% yield), could be purified by flash column 
chromatography (Scheme 2.26). 
 
 
Scheme 2.26 The modified ketimines 
 
2-4. Background reactions 
Initial studies, reacting phenylacetic acid 210 with a ketimine 190 catalysed by an isothiourea 
211, formed dihydropyridinone 212 with excellent diastereo- and enantioselectivity (>95:5 dr 
and 84% ee) (Scheme 2.27). The original process dissolved both phenylacetic acid and the 
ketimine in CH2Cl2 before adding pivaloyl chloride and (
i
Pr)2NEt for 30 minutes then adding 
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Scheme 2.27 Initial studies with acceptor added before the catalyst 
 
However, during the ketimine synthesis, this type of ketimine was shown to easily decompose 
under either acidic or basic reaction conditions. Hence, before starting the optimisation 
process, background reactions were examined to find out if the starting material ketimine 191 
can tolerate the reaction conditions. The results showed the ketimines easily hydrolyse back 
into enone 213, by stirring with pivaloyl chloride and (
i
Pr)2NEt individually for one hour 
(Scheme 2.28).  
 
  
Scheme 2.28 Background reactions with (
i
Pr)2NEt and pivaloyl chloride 
 
Due to this fact, the pivaloyl chloride and also (
i
Pr)2NEt have to be distilled first before 
applied into the reactions. Moreover, the initial reaction conditions for dihydropyridinone 
synthesis has started from the minimum amount of agents used, with 1 eq of pivaloyl chloride 
and 1 eq of (
i
Pr)2NEt used to form a mixed anhydride. After 30 minutes the mixed anhydride 
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is formed in situ, followed by adding the catalyst, ketimine and a further 1 eq of base. The 
new procedure avoids decomposition of the ketimine before the desired catalysis and also 
minimises the possible racemic background reaction which has been suggested by previous 
dihydropyridinone projects. Hence, this results in the increases of enantioselectivity from 
84% ee to 97% ee and also improving the yield from 40% to 46%. (Scheme 2.29) 
 
 
Scheme 2.29 New procedure with acceptors added after catalyst 
 
2-5. Initial Catalyst Studies 
The model reaction employed phenylacetic acid with a ketimine catalysed by achiral 
isothiourea DHPB 214, affording the dihydropyridinone in promising 65% yield and with 
excellent diastereocontrol (anti: syn, 88:12) (Table 2.2, Entry 1). Various chiral isothioureas, 
including HBTM 2.1 215, benzotetramisole (BTM) 216 and (－)-tetramisoleHCl 211, were 
tested in this process. Chiral isothiourea HBTM 2.1 was the most “active” catalyst, with 
complete reaction in one hour, but it gave the poor diastereocontrol (75:25 dr) (Entry 2). BTM 
also gave equally good enantioselectivity, however, the yield was much lower and reaction 
was not complete after double the amount of time (Entry 3). Commercially available 
(－)-tetramisoleHCl gave not only the best yield (46%) but also high diastereo- and 
enantioselectivity (>95:5 dr and 97% ee) (Entry 4). Hence, (－)-tetramisoleHCl was chosen 
as the chiral catalyst for this project.  
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Table 2.2 Initial studies with various isothiourea catalysts 
 







1 DHPB THF 1 65% >99:1 88:12 - 
2 HBTM 2.1 CH2Cl2 1 33% >99:1 75:25 95 
3 BTM CH2Cl2 6 28% 71:29 >95:5 98 
4 (－)-TetramisoleHCl CH2Cl2 3 46% >99:1 97:3 98 




The initial study showed this methodology had extraordinary diastereo- and enantiocontrol 
when catalysed by tetramisoleHCl. However, product yield was low and the crude residues 
contained many unidentified species. There were a few options to improve product yield, for 










2-6-1. Activating Agent Screen 
Several activating agents were tested to see which resulted in highest product yield (Table 
2.3). Benzoyl chloride 218 (Entry 2) and 4-nitrobenzoyl chloride 219 (Entry 3) provided both 
good diastereocontrol (91:9 dr and 83:17 dr); however, compared with pivaloyl chloride, the 
reaction was much slower and was not complete in three hours. 4-Methoxybenzoyl chloride 
220 (Entry 4) gave the same enantioselectivity as with pivaloyl chloride, however the reaction 
was not only much slower but also it was difficult to separate the δ-dihydropyridinone 
product from the mixed anhydride, formed from phenylacetic acid and 4-methoxybenzoyl 
chloride, hence, the isolated yield was much lower. 
 
Table 2.3 Activating agent screen 
 











1 Pivaloyl Chloride 3 46% >99:1 97:3 98 
2 Benzoyl Chloride 3 32% 71:29 91:9 94 
3 4-Nitrobenzoyl Chloride 3 29% 61:39 83:17 92 
4 4-Methoxybenzoyl Chloride 16 16% >99:1 90:10 98 
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2-6-2. Equivalents of base screen 
During the preparation of the ketimine starting material, it was found to be very sensitive and 
easy to be hydrolyzed under both acid and base conditions, even in water. Hence, the use of 
excess (
i
Pr)2NEt should be minimised. However, the catalyst, (－)-tetramisole is used as its 
HCl salt and activated by base. To investigate the role of base, various amount of (
i
Pr)2NEt 
were examined in the model reaction. Consequently, extra base added in second step of the 
reaction did not affect stereoselectivity but also did not improve the yield (Entry 5-7, Table 
2.4). The addition of 1 eq each in first and second steps (Entry 1 and 2) gave the consistent 
result on different reaction scales (0.2 mmol and 1.0 mmol). Therefore, we chose to maintain 
these base equivalents. 
 
Table 2.4 Base Equivalent Optimisation 
 









1 (－)-TetramisoleHCl 1 46%  96:4 97 
2 (－)-TetramisoleHCl 1  48% 98:2 98 
3 Free base (－)-Tetra 1 62%  93:7 98 
4 Free base (－)-Tetra 1  45% - 98 
5 (－)-TetramisoleHCl 1.2 31%  98:2 98 
6 (－)-TetramisoleHCl 1.2  40% 98:2 98 
7 (－)-TetramisoleHCl 1.5 37%  - 97 
a 0.2 mmol scale; b 1.0 mmol scale; - overlap with impurities, dr cannot be measured through 1H NMR spectroscopic analysis; c 




2-6-3. Catalyst loading screen 
One of the important aims in the development of catalytic methodology is to use as little 
catalyst as possible. Reducing the catalyst loading to 10 mol% did not affect the 
enantioselectivity (98% ee), but slightly increased the diastereocontrol from 93:7 to 97:3 dr. 
(Table 2.5, Entry 2). However, 10 mol% catalyst loading was insufficient to complete the 
reaction overnight and yield was low. On the other hand, increased catalyst loading to 40 
mol% gave better yield (75% yield) (Entry 3). It is worth pointing out, using 1 eq of catalyst 
resulted in even better diastereo- and enantioselectivities (95:5 dr, 99% ee) but it did not help 
with yield (67% yield) (Entry 4). 
 
Table 2.5 Catalyst loading Screen 
 







1 20 3 46% 1:0 97:3 98 
2 10 16 38% 1:0.3 97:3 98 
3 40 3 75% 1:0 93:7 98 
4 100 1 67% 1:0 95:5 99 








2-6-4. Equivalents of acids screen 
Next, the equivalents of phenylacetic acid used were investigated to try and improve the yield. 
Doubling the equivalents of carboxylic acid, pivaloyl chloride and (
i
Pr)2NEt gave a higher 
yield of product (from 49% to 62%) and shorter the reaction time (from three hours to one 
hour) without compromising the stereocontrol (Entry 2, Table 2.6). Moreover, this reaction 
could be repeated under open flask conditions with bench solvent and the results remained the 
same with excellent diastereo- and enantiocontrol (Entry 3). However, using two equivalents 
of acid but using the catalyst loading of 10 mol% gave the same yield, diastereo- and 
enantiocontrol (Entry 4) as the conditions with one equivalent of acid and 20 mol% catalyst 
(Entry 1). Using 5 mol% catalyst loading did not complete the reaction overnight and gave 
more side-products by 
1
H NMR spectroscopic analysis (Entry 5).  
 
Table 2.6 Equivalents of Acids Screen 
 
Entry Acid (eq) Cat (%) (CH3)3CCOCl (eq) i) (
i





1 1 20 1 1 3 49% 98:2 97 
2 2 20 2 2 1 62% 93:7 98 
3* 2 20 2 2 1 65% 92:8 98 
4 2 10 2 2 3 45% 97:3 95 
5 2 5 2 2 16 - - - 






2-6-5. Pre-formed anhydride screen 
The use of pre-formed homo-anhydrides was also applied to this methodology to simplify the 
procedure and to try and avoided undesired by-products. Using phenylacetic anhydride 221 
improves the purification from flash column chromatography, however, the 
diastereoselectivity decreased from 97:3 to 84:16 (Table 2.7, Entry 1). HBTM 2.1 was also 
tested as a catalyst with pre-formed anhydride at 5 mol% catalyst loading, but the 
diastereoselectivity dramatically decreased to 60:40, although the enantiocontrol remained 
high (>99% for major, 93% for minor) (Entry 2). Using one equivalent of anhydride with 5 
mol% HBTM 2.1 loading gave even lower yield and diastereoselectivity (Entry 3). 
 
Table 2.7 Pre-formed Anhydride Screen 
 
Exp Cat Catalyst loading Yield dr ee (%) 
1 (－)-TetramisoleHCl 20% 62% 84:16 95 
2 HBTM 2.1 5% 56% 60:40 >99 (ent), 93 
3
a HBTM 2.1 5% 28% 52:48 - 
a experiment was carried with only 1 eq anhydride 
 
In conclusion, the best condition for this dihydropyridinone was with two equivalents each of 
acetic acid, pivaloyl chloride and (
i
Pr)2NEt to generate excess mixed anhydride, followed by  








2-7. Product Scope 
2-7-1. Variation of the Acid 
Some selected phenylacetic acids were next applied in this methodology using both one and 
two equivalents of acid. Using two equivalents of acetic acid generally resulted in improved 
enantiocontrol; however, the diastereoselectivity was slightly lower when more acid was used 
in most cases. Ye et al (Scheme 2.19) improved diastereoselectivity by stirring the crude in 
DME for 24 hours with Cs2CO3 to facilitate the epimerisation of syn-dihydropyridinone to 
trans-dihydropyridinone
66
. However, treating this dihydropyridinone product under reaction 
condition again with DHPB and (
i
Pr)2NEt did not improve the diastereoselectivity. Overall, 
using two equivalents of acid mainly improved the yield. For example, p-bromophenyl acetic 
acid and 3-thiophene acetic acid gave incomplete reactions overnight with one equivalent of 
acid and were difficult to purify by flash column chromatography. However, these reactions 
with two equivalents of acid worked well in one hour and the yields of product increased 
remarkably (Scheme 2.30, 234, 19% to 60%; 236, 10% to 64%). 
 
Other aryl acetic acids were also successfully demonstrated in this method. For example, p-, 
o- and m-tolyl acetic acids (224-226) did not affect the reaction resulting in excellent yield, 
diastereo- and enantiocontrol. Increasing the size of the aromatic ring by applying 1-, 
2-naphthalene and 4-biphenylacetic acid (227-229) also gave product with high diastereo- and 
enantiocontrol. The electron-donating substituted aryl, p-methoxy 230, 3,4-dimethoxy 231, 
and p-dimethylamino 232 worked best in this methodology. Moreover, this methodology was 
highly tolerant of a range of substituents such as p-chloro 235, p-bromo 234, and heterocyclic 
3-thiophene 236. Notably, alkenylacetic acid 237 substituents also worked well, only the 
diastereocontrol was slightly lower compared with other aryl substituents and the 




Scheme 2.30 Reaction scope: variation of acid 
Red: reaction condition with 2 eq of acid, Black: reaction condition with 1 eq of acid. 
 
However, the scope was limited to mono-substituted acetic acid. Di-substituted acetic acids 






2-7-2. Ketimines Scope 
Various ketimines were also successfully applied to the reaction using two equivalents of acid. 
The ketimines with various N-sulfonyl groups have been examined in this reaction, which has 
shown sulfonyl groups such as mesyl 244, p-methoxy 245, and p-nitro 246, did not 
compromise the stereocontrol. Moreover, the p-nitro sulfonyl group gave even better yield 
and excellent stereocontrol. The ketimine bearing with tri-isopropyl group 247 also gives 
good stereocontrol; however, the yield is much lower than others. This reduced yield is due to 
the product requiring purification via recrystallisation; it could not be easily purified by flash 
column chromatography. The ketimines with a p-methoxy substituted aromatic ring were also 
successful applied to the reaction resulting in moderate yield (241 and 242). The ketimine 
with reversed ester and phenyl substituents 243 can be tolerated in this reaction, the yield was 
high (89%) but the diastereoselectivity was very low (58:42). Due to the separation issue in 
chiral HPLC, the enantioselectivity of the reversed dihydropyridinone is still under 
investigation (Scheme 2.31).  
 
Scheme2.31 Variation of ketimine 
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2-8. Evidence of the absolute configuration 
The initial assignment of the anti relative configuration within the parent dihydropyridinone 
212 is consistent with the observed preferential anti-selectivity in the related reaction of 
chalcone-derived ketimines promoted by isothioureas
68
. The comparison of the 
1
H coupling 
constants of related N-tosyl dihydropyridinone 213 (J ≈ 10 Hz, relative configuration 
confirmed by X-ray crystallography) and the parent dihydropyridinone 212 (J ≈ 10 Hz) giving 
the similar coupling constants (Figure 2.7). 
 
 
Figure 2.7 The 
1
H coupling constants comparison of dihydropyridinones 
 
To unambiguously identify both the relative and absolute configuration of the major 
diastereomer of dihydropyridinone, enantiopure dihydropyridinones 230 has been examined 
via X-ray crystallography analysis (Figure 2.8). This confirmed the absolute and relative as 
anti-(3S, 4S).  
 
 
    
 
 





2-9. Proposed Mechanism 
The proposed mechanism starts with activation of the acetic acid with pivaloyl chloride to 
form a mixed anhydride 248. N-acylation of the chiral isothiourea 211 with this anhydride 
forms an acyl ammonium adduct 249. Deprotonation generates the active (Z)-ammonium 
enolate intermediate 250, which subsequently undergoes Michael addition with the 
α,β-unsaturated acceptors 238. Then, intramolecular cyclisation and catalyst regeneration 
gives the dihydropyridinone product 239 (Scheme 2.32). 
 
 
Scheme 2.32 The proposed mechanism 
 
From the scope of this investigation, the results have shown high diastereo- and 
enantiocontrol. The results may be proposed due to several factors which have been involved 
in the transition state. The (Z)-ammonium enolate form allows for a favourable nonbonding 
interaction (no -> σ* C-S) between the oxygen of the enolate and the sulfur
73,74
 on the 
isothiourea catalyst as been suggested by Birman
75
 and also Romo
76
 et al. This nonbonding 
interaction not only influences the flat ammonium enolate conformation but also stabilises the 
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transition state by locking the isothiourea catalyst in position. Therefore, the phenyl group of 
the isothiourea catalyst would sit in the pseudo-axial orientation which blocks the Re face, 
subsequently forcing the Michael acceptor to approach from the Si face (Figure 2.9). Hence, 




Figure 2.9 The Michael addition transition state 
 
2-10. Derivatisation 
As having prepared the dihydropyridinone successfully, we were interested in examining a 
range of derivatisations into functionalised products.  
 
2-10-1. Dehydrogenation/desulfonylation and tetra-substituted pyridine 
Dehydrogenation/desulfonylation of the model dihydropyridinone can be carried out in a 
one-pot reaction by treatment with palladium on carbon and sodium formate in DMF, 
resulting in 2-pyridone 252 in 82% yield. This pyridone could be O-tosylated, by the 
treatment with sodium hydride and tosyl chloride in DMF, to form the highly functionalised 





Scheme 2.33 Pyridone and pyridine synthesis 
 
Next, dehydrogenation was investigated as it could be a pathway transferring 
dihydropyridinone 212 directly to pyridine 253 in one step via the spontaneous N- to O-tosyl 
transfer of intermediate pyridone 254 (Scheme 2.34). However, the model dihydropyridinone 
with various dehydrogenating reagents such as 10% palladium on carbon (Pd/C), magnesium 
dioxide (MnO2), chloranil and DDQ unfortunately gave no reaction. This observation 
suggests dehydrogenation could not happen without desulfonylation first. 
 
 
Scheme 2.34 Pyridine synthesis via dehydrogenation then spontaneous N- to O-tosyl transfer 
 
This observation suggests dehydrogenation could not happen without desulfonylisation first. 
Pyridone 252 was also reacted with phosphorous oxychloride (POCl3) to form the 2-chloro 
pyridine 256, but the crude contained more than three different products which could not be 
isolated by flash column chromatography (Scheme 2.35). 
 
 
Scheme 2.35 Chlorination 
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The product of tosylation of pyridine has been assigned as the tetra-pyridine 257. However, 
formation of the isomer, N-tosyl pyridone 258, was also possible (Scheme 2.36). In order to 
determine the structure, various spectroscopic methods were used.  
 
 
Scheme 2.36 The potential product of tosylisation 
 
Comparing with the IR data with other similar structures (Table 2.8), the model 
dihydropyridinone 212 and the dehydrogenation pyridone 252 all have peaks around 
1710-1725 cm
-1
 due to the carbonyl C=O stretch. Pyridone also has a strong signal at 1629 
cm
-1
 due to the α,β-unsaturated C=O motif. Consequently, if the tosylated product is pyridone, 
there should also be a strong signal around 1629 cm
-1
 for the α,β-unsaturated C=O motif; 
however, only a signal at 1718 cm
-1
 is observed.   
 




) 1718 1722 1714 
   1629 
 
The structures were also investigated by NMR spectroscopic analysis and the structure 
predicted by NMR simulation. The computational calculations show pyridine 257 has lower 
energy ( － 84.49 Kj/mol) than pyridone 258 that make the pyridine 257 more 
thermodynamically sTable (Table 2.9). Comparing the experimental NMR data with the 
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simulation NMR data from three different databases, DET, ACD and Mnova, which have 
been listed in Table 2.9, the 
15
N NMR chemical shift orediction of pyridine from the databases 
is average 286.7 ppm, which is in close agreement to the experiment result of 286.7 ppm. On 
the other hand, pyridone is calculated around 202.5 ppm. The 
1
H NMR shift of the indicated 
C(5) proton is 7.99 ppm by experiment which is located in the aromatic region as matched to 
pyridine, with an average calculated value of 7.92 ppm. The 
13
C NMR of C(5) position of 
pyridine 257 is also closer to the experimental finding, with the calculated average of 120.0 






C NMR) the 
simulation of pyridine isomer is closer to the experimental result, which gives the confidence 
in the assignment of pyridine 257.  
 
Table 2.9 Comparison of chemical shift calculation of pyridone 258 and pyridine 257 
       
 Pyridone 258 Pyridine 257 Experimental 
Rel. E[Kj/mol] 0 -84.49  
DFT- 
15
N (ppm) 240.7 293.4 
284.7 ACD- 
15
N (ppm) 195.8 287.9 
Mnova- 
15
N (ppm) 171.8 278.7 
DFT- 
1
H, C(5)H (ppm) 5.80 7.87 
7.99 ACD- 
1
H, C(5)H (ppm) 6.78 8.51 
Mnova- 
1
H, C(5)H (ppm) 6.37 7.39 
DFT- 
13
C, C(5) (ppm) 111.9 121.4 
118.1 ACD- 
13
C, C(5) (ppm) 99.7 116.5 
Mnova- 
13
C, C(5) (ppm) 112.9 122.0 
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In the end, a suitable crystal of sulfonylation product 257 was obtained and has been 
examined via X-ray crystallography. This allowed the structure to be unambiguously 
confirmed as pyridine 257 (Figure 2.10). 
 
 
    
 
Figure 2.10 Crystal structure of pyridine 257 
 
2-10-2. Desulfonylation 
The parent dihydropyridinone can be desulfonylated via treatment with sodium/naphthalene 
at -78 ˚C to give product 259 that crystallised after flash column chromatography to give 
excellent >99% ee and a single diastereoisomer in 42% yield. Alternatively, samarium iodide 
was used to remove the triisopropylbenzensulfonyl group, giving the desulfonyl product 259 
as a single diasteromer with excellent enantioselecticity and good yield (>99% ee and 86% 
yield) (Scheme 2.37). Both desulfonylation methods provide product 259 in excellent 
diastereo- and enantiopurity .  
 
Scheme 2.37 Desulfonylation of dihydropyridinones 
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2-10-3. Desulfonylation and ring opening 
Magnesium/MeOH as a one-electron reducing agent has been applied in the literature for 





 Previous studies have shown that magnesium/MeOH can also remove 
the sulfonyl group from the nitrogen in various ring sizes (4-7 membered ring) of cyclic 
amines
79–81
 or from the nitrogen of amides.
82
 Therefore, treatment of dihydropyridinone 212 
with magnesium/MeOH resulted in formation of ketone 260 via desulfonylation and 
ring-opening, in 35% yield and 96% ee (Scheme 2.38). Pyridone 252 was also formed and 
able to isolate in 60% yield.  
 
 
Scheme 2.38 Reduction with magnesium/MeOH 
 
2-10-4. Bromination and Suzuki reaction 
Bromination can also be demonstrated with dihydropyridinone by treatment with bromine and 
(
i
Pr)2NEt to give brominated product 261 in 87% yield with 97% ee as a single 
diastereoisomer. We anticipated that brominated product could potentially being further 
modified via Suzuki coupling. Brominated dihydropyridinone 261 was treated with phenyl 
boronic acid 262 catalysed by 10 mol% Pd/C in DME and refluxed at 90 ˚C. The brominated 
dihydropyridinone was fully consumed by TLC analysis in two hours, however, the crude 
showed a complex mixture by 
1
H NMR spectroscopic analysis and there were no sign of the 
desired product. The reaction was also tried using 5% Pd(OAc)2 but again none of the desired 




Scheme 2.39 Bromination and the future Suzuki reaction 
 
2-10-5. Epoxidation 
The next idea was to treat the dihydropyridinone 212 with mCPBA then PTSA to give the 
γ-lactone 264 or 265 in a one-pot reaction as the similar example which has been 
demonstrated by Chi and co-workers.
83
 Chi showed that treatment of δ-lactone 263 with 
mCPBA then PTSA gave two separable diastereomers γ-lactone 264 and 265 without 
compromising enantioselectivity in good overall yield (Scheme 2.40).  
 
 
Scheme 2.40 γ-Lactone formation in Chi’s approach.  
 
However, the reaction with dihydropyridinone 212 did not work as planned, although it can 
be oxidised to form the epoxide 266, adding PTSA was found to decompose the epoxide 
product. The epoxide was sensitive to acidic conditions and it did not survive in CDCl3 when 
used for 
1
H NMR analysis. The epoxidation worked much slower than expected and the 
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reaction mixture had to be left at 0 ˚C for 24 hours. The epoxide 266, which has four 
contiguous stereocentres, was obtained as single diastereomer with 72% yield (Scheme 2.41). 
 
 
Scheme 2.41 Epoxidation  
 
To assign the configuration of the epoxide, 2D nOe spectroscopic analysis was applied to 






H NMR spectrum of the 
epoxide 266 has been fully assigned for H
4
 (4.02 ppm), H
5
 (3.13 ppm) and H
6
 (3.79 ppm) and 
is shown in Figure 2.11 
 










, two nOe spectra have been performed. 
The first nOe spectrum irradiated H
6







 are close in space and are on the same face of the molecule (Figure 
2.12). Correlation with H
5
 was also observed, which would be expected from protons on 
adjacent carbon atoms.  
 
Figure 2.12 nOe analysis of epoxide with aadiated the H
6 
 
For comparison, the second nOe spectrum has irradiated the H
4
 peak at 4.02 ppm. Again, the 
H
6
 peak has been observed, as well as the H
5
 peak which is adjacent to H
4










This is consistent with the epoxide ring being on the same face as the phenyl group on the C(4) 
position, and the structure has been assigned. further unambiguous evidence for this structure 
was obtained by X-ray crystallography, with the absolute configuration confirmed as 










1S, 4S, 5R, 6S 
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Due to the separation issues on chiral HPLC, the enantiomeric excess of epoxide could not be 
determined. However, the enantioselectivity of epoxide is assumed to be identical to the 
starting material dihydropyridinone 212 (98% ee). 
 
2-10-6. Reduction 
The model dihydropyridinone 212 contains both ketone and ester functional groups, which 
can be reduced by treatment with two equivalents of 2M LiAlH4 in THF solution at 0 ˚C. The 
reduction was completed in one hour by TLC analysis. The reaction mixture was quenched 
with 0.1 M HCl then extracted with diethyl ether immediately. NaBH4 can also provide the 
same result. From the crude 
1
H NMR spectra, it showed both the amide and ester functional 
groups were reduced; however, the sulfonyl group has remained on the nitrogen. The 
dihydropyridinone 212 had been ring-opened to give the acyclic enamine-diol product 267 
with the sulfonyl amine product and two hydroxyl groups. Flash column chromatography 
gave a single diastereomer of dihydroxyl N-sulfonyl amine 267 with 98% ee and 65% yield 
(Scheme 2.42). It is surprising that the N-sulfonyl enamine is retained in the molecule and can 
be isolated from the silica column without being hydrolysed. The isolated yield is good 
suggested the significant stability of molecule with this functionality  
 
 
Scheme 2.42 Reduction with LiAlH4 
 
The bicyclic ketal formation was also observed after reduction of dihydropyridinone with two 
equivalents of 2 M LiAlH4 in THF solution at 0 ˚C. The reaction was quenched with 0.1 M 
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HCl, stirred for one hour and extracted with CH2Cl2. The dihydroxyl N-sulfonyl amine 267 
was observed in the crude 
1
H NMR spectra at this stage. The crude was stirred with CHCl3 
overnight to give the bicyclic ketal 268. Following flash column chromatography gave a 
single diastereomer of bicyclic ketal in 34% yield after chromatography (Scheme 2.43).  
 
Scheme 2.43 Bicyclic ketal formation 
 
The key step for formation of this bicyclic ketal is stirring the reaction mixture with 0.1 M 
HCl for no less than an hour. Without this step, 
1
H NMR spectrum analysis shows the 
presence of the dihydroxyl product 267, which could not be cyclised through heating or 
stirring with chloroform. Hence, 0.1 M HCl is needed to promote cyclisation into the ketal. 












The proposed mechanism of bicyclic ketal contains two cyclisation, the five member ring 
closed first to eliminate the sulfonamide forming the oxonium ion that is trapped in the 
formation of a six membered ring to obtain the bicyclic ketal product (Scheme 2.44).  
 
Scheme 2.44 The proposed mechanism of bicyclic ketal formation 
 
2-11. Conclusion 
In conclusion, this project has developed a one-pot methodology using cheap and easy 
handled acetic acids via isothiourea catalysis to synthesise highly functionalised 
dihydropyridinones with excellent diastereo- and enantioselectivities. This methodology can 
tolerate not only electron withdrawing and donating substituted arylacetic acid but also the 
alkene acetic acid. Various sulfonyl substituted ketimines also give good yield without 
compromising the stereocontrol.  
 
The model dihydropyridinone 212 has been successfully derivatised in a wide range of 
transformations, such as pyridine formation, bromination, epoxide formation, in good yield 





Scheme 2.45 The summary of derivatisation 
 
2-12. Future Works 
During the optimisation of this process, the results of using different equivalents of starting 
material acetic acid affected the diastereo- and enantiocontrol noticeably. Using two 
equivalents of acid accelerated the reaction when compared with one equivalent of acid. The 
reaction time was shortened from three hours to one hour. One possibility may be the reaction 
conditions facilitated epimerisation, hence, lowering the diastereoselectivity (Scheme 2.46).  
 
 




However, re-treating the product with (－)-tetramisoleHCl and base did not change the 
diastereoselectivity; instead the product started to decompose. Hence, it could be other factors 
from in the original reaction that affect the diastereoselectivity. Therefore, more in-depth 
studies of this epimerisation are required.   
 
To date, the examples which have been demonstrated via isothiourea-mediated form a single 
N-heterocyclic molecule in one-pot reactions. However, there are known natural products and 
also synthetic products that have multi-ring structures, such as spirocyclic oxindole,
84–88
 with 





Figure 2.16. Selected natural and synthetic products with biological activities. 
 
In 2013, Chi and co-workers has reported using α-aryl ester and unsaturated imine catalysed 
by NHC (in the box) to access spirocyclic oxindoles (Scheme 2.47). However, the work 
resulted in good yield but poor stereocontrol with mainly racemic examples. Due to the steric 
nature of quaternary centre, the methodology with high diastereo- and enantioselectivities still 
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remain challenging.  
 
Scheme 2.47 Spirocyclic oxindoles formation via NHC catalysis 
 
There are other well developed ketimines in the literature (Figure 2.17). Carrying these into 
the isothiourea catalysis reaction with commercially available acetic acids, theoretically, will 
result in highly functionalised spirocyclic oxindoles or bicyclic products in an efficient 
one-pot reaction (Scheme 2.48). 
 
 
Figure 2.17 Selected potential ketimines from literatures 
 
 




Chapter 3. Isothiourea-Mediated Synthesis of Heterocycles 
 
3-1. Introduction and initial aims 
Previous work from the Smith group has developed an efficient asymmetric one-pot 
intermolecular Michael addition-lactonization process from aryl carboxylic acids 272 
exclusively and α,β-unsaturated carbonyl compounds 273 that proceeds via an ammonium 
enolate intermediate (Scheme 3.1, a).
40
 To extend this methodology, we wished to introduce 
heteroatom containing acetic acids 275 to further probe the activity of the ammonium enolate 
intermediate and lead to functional products (Scheme 3.1, b).  
 
 
Scheme 3.1 Isothiourea-mediated one-pot synthesis of heterocycles 
 
3-1-1. Initial studies 
Initial studies were carried with commercially available oxygen containing acetic acids, 
methoxyacetic acid and benzyloxyacetic acid with α,β-unsaturated ketoester 279 using the 
commercial available isothiourea catalyst, (－)-tetramisoleHCl. However, under standard 
condition, no oxygen substituted lactone 280 was observed upon using either methoxyacetic 





Scheme 3.2 The initial studies with oxygen containing acetic acids 
 
The same reaction condition has also been repeated with commercially available 
(phenylthio)acetic acid 281, the sulfur substituted dihydropyridinone 282 was not observed. 
However, the major product isolated from these reactions was 2-pyrone 283 in 31% yield, 




Scheme 3.3 The test results with (phenylthiol)acetic acid and α,β-unsaturated acceptors 
 
Next, (Phenylthio)acetic acid was further examined as an ammonium enolate precursor to 
understand and optimise the elimination process for 2-pyrone synthesis. Modification of the 
reaction conditions by varying the catalyst or using different activating agents such as benzoic 
anhydride, all lead to the same eliminated product in modest yield (26-35%, Table 3.1, Entries 
1-3). These experiments demonstrated the elimination step could not be stopped due to 




Table 3.1 The Initial Studies with Ketoeaster 279 
 
Entry  Isothiourea cat Activating agent  t (hr)  Yield (%)  
1 (－)-TetramisoleHCl  pivaloyl chloride 18  35  
2  (R)-Benzotetramisole  pivaloyl chloride 18  27  
3 (－)-TetramisoleHCl benzoic anhydride 18 26 
 
However, after initial attempts at optimisation with acceptor 279, it was unable to raise the 
yield of pyrone 283 to a promising level. Therefore, an alternative trifluoromethyl enone 284 
was tested. CF3 group was examined and provided promising results, with 72% isolated yield 
of pyrone 285 obtained after 72 hours (Scheme 3.4).  
 
 
Scheme 3.4 Pyrone synthesis with α,β-unsaturated trifluoromethyl enone 284 
 
3-1-2. Previous studies on 2-pyrone synthesis 
2-Pyrones (and commonly called 2H-pyran-2-ones, 2-pyranones, α-pyrones)
91
 contain a 
oxygen atom, a carbonyl functionality on C(2) and a diene motif, in other words, it is an 
unsaturated cyclic ester. The aromatic character of 2-pyrone allow it readily undergo 
electrophilic substitution, for example, sulfonations and halogenations. The aliphatic character 
of 2-pyrone allow it to participate in Diels-Alder reaction as a diene.
92
 Thus allows the 
2-pyrone motif to be used a pathway toward other aromatics. 2-Pyrone is also the common 
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motif found in natural products. For example, Proscilardein 288, a cardiac glycoside classified 
in Bufadienolides class contains a steroid structure and 2-pyrone motif can also be obtained 
from the plant of genus Scilla and in Dermia maritima.
93
 Compounds of the bufadienolides 
class have been employed as treatment for heart failure and cardiac arrhythmia and also in 




Figure 3.1 Selective 2-Pyrone Examples  
 
2-pyrones substituted with styryl groups, such as compound 287, isolated from ethanolic 
extracts of the seed of Alpinia bleharocalyx have demonstrated excellent activity in 
antiproliferation.
94
 Several 2-pyrones 286 with long alkane chain at C(3) have recently 




Although various 2-pyrones containing compounds have been successfully isolated from 
plant origins and animal sources
92
 and their bioactivities have been identified for important 
medical therapies, the convenient and highly functionalised synthesis of 2-pyrones is not 
much explored yet. The most common route to 2-pyrone synthesis is condensation/cyclisation 
of β-ketoester. Alternative other methods can be synthesised 2-pyrones from gold-catalysed 





3-1-2-1. Via condensation/cyclisation reaction 
In the presence of sulfuric acid, ethyl acetoacetate 289 undergoes self-condensation to form 
the adduct 291 then following by cyclisation to obtain pyrone 292 The ester group can be 
decarboxylated by treating with more sulfuric acid afford pyrone 293 (Scheme 3.5).
92,96,97
   
 
 
Scheme 3.5. The acid-catalysed condensation/cyclisation 
 
3-1-2-2. Via gold-catalysis 
Schreiber and co-workers
98
 have reported an alternative methodology to synthesise analogues 
of pyrone 295 and 296 from propiolic acid 294 via gold-catalysis. Using 5% 
[(Ph3P)AuCl]/AgSbF6 in the reaction condition gives the dimerisation product 295 in good 
yield. However, employing 5% [(Ph3P)AuCl]/AgOTf results pyrone 296 formation with low 
to excellent yield through gold-catalysed coupling reaction (Scheme 3.6). 
 
Scheme 3.6 Syntheses of 2-Pyrone via Gold-Catalysed Coupling Reaction 
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This process is presumed to proceed by initial gold(I) catalysed form an intermediate 298 by 
an intermolecular coupling. The intermediate then undergoes a 6-endo type cyclisation to 
afford oxocarbenium intermediate 299, which following deprotonation and 
proto-demetalation results in the desired product 296 (Scheme 3.7). 
 
 
Scheme 3.7 The proposed mechanism of gold-catalysed coupling reaction 
 
Alternative other catalytic methodologies have been reported for 2-pyrone synthesis, for 
example, base-catalysed Michael addition-lactonisation of 1,2-allenyl ketones by K2CO3,
99
 
rhenium-catalysed sequential addition-cyclisation of 1,3-dicarbonyl compounds via 
ReBr(CO)5 
100,101
 and palladium-coupling Stille reaction/heterocyclisation.
102
 However, to date, 
organocatalysis has not been much applied in planar molecule synthesis, particularly for 
pyrone synthesis.  
 
3-1-3. Synthesis of trifluoromethyl substituted 2-pyrones 
From the literature, few syntheses of 2-pyrones bearing the biologically interesting CF3 group 
have been developed. To prepare several CF3-containing bioactive compounds, Martin et al
103
 
applied Cu(I)-catalytic approach for trifluoromethyl substituted 2-pyrones synthesis. Reacting 
300 and dimethyl itaconate 301 at 140 ˚C generated adduct 302 and then following double 
dehydrochlorination by refluxed in NEt3 resulting in two isomers 303 and 304. These isomers 








 have also presented a synthetic route to CF3 substituted pyrone synthesis 
from in situ prepared α,β-unsaturated enone.  Diones 306 was first reacted with PCl5 then 
with sodium diethyl malonate 307 resulting in pyrone 308 in low to moderate yields. Pyrone 
underwent decarboxylation process by refluxing in aqueous acetic acid with addition of 
H2SO4. Pyrones 309 were isolated in good yields (Scheme 3.9).   
 
 
Scheme 3.9 The Synthesis of 2-Pyrone  
 
Dione 306 was firstly chlorinated by treatment of PCl5 to generate two α,β-unsaturated chloro 
ketone regioisomers 311 and 312. α,β-Unsaturated chloro ketone 311was more favoured to 
react with sodium diethyl malonate through nucleophilic addition to form intermediate 313, 
which undergoes [1,5] H-transfer to generate intermediate 314. Finally, cyclised intermediate 




Scheme 3.10 Proposed Mechanism of Pyrone Synthesis 
 
Both methods used similar strategies to synthesis 2-pyrone by synthesed α,β-Unsaturated 
intermediate in situ. However, it leads to form different regio-isomeric intermediates and 
unusually only one is favoured the other to undergo a cyclisation forming the desired pyrone 
product. Hence, in most cases, pyrones were obtained with low yield.  
 
3-2. The aim of this project 
Building on this discovery of pyrone formation and the interest within this motif, this project 
aimed to synthesise a range of planar, 2-pyrones 318, from acetic acid deriverties bearing a 




Scheme 3.11 This work 
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3-3. Starting material preparation 
3-3-1. Acetic acid preparation 
(Phenylthio)acetic acid, which has been used mainly in this project is commercially available, 
and applied into the reaction directly without further purification; same as bromoacetic acid, 
chloroacetic acid and (phenylthio)phenyl acetic acid. 2-(phenylthio)propanoic acid 320, 
2-(phenylsulfinyl)acetic acid 321 and bis(phenylthio)acetic acid 322 were prepared following 
by literature procedures.
105–107
 2-(phenylthio)propanoic acid 320 was prepared from refluxing 
2-bromopropanoic acid, sodium hydroxide and thiophenol in ethanol overnight resulting in 
excellent yield (99%) (Scheme 3.12).  
 
 
Scheme 3.12 Synthesis of 2-(phenylthio)propanoic acid 320 
 
2-(phenylsulfinyl)acetic acid 321 was obtained by oxidation of (phenylthio)acetic acid in 
Oxone®  with 85% yield, the product was pure and applied into reactions directly without any 
further purification. 2-(phenylsulfinyl)acetic acid could be transferred into 
bis(phenylthio)acetic acid 322 by refluxed in glacial acetic acid overnight. The crude was 
washed with water then purified through recrystallisation giving bis(phenylthio)acetic acid in 
63 % yield (Scheme 3.13).  
 
 
Scheme 3.13 Synthesis of 2-(phenylsulfinyl)acetic acid 321 and bis(phenythio)acetic acid 322 
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3-3-2. Trifluoromethyl enone synthesis 
Various trifluoromethyl enones 323-329 were prepared following the procedure of Zhang et 
al.
108
 LDA was formed treating diisopropylamine with 
n
butyl lithium and diisopropylamine in 
THF at −78 ˚C, subsequent addition of diethyl methylphosphonate, then nucleophilic addition 
to imidoyl chloride resulting in a phosphonate intermediate. This intermediate undergoes 
Horner-Wadsworth-Emmons reaction with different aldehydes to afford various 
trifluoromethyl enones (Scheme 3.14). Seven examples were prepared following this method 
including the parent CF3-enone 323, m- and o-bromo 324 and 325, p-methyl 326, 2-furan 327, 
2-nathphalene 328 and hexyl 329 substituted enone. p-nitro, p-bromo substituted and 
2-thiophene enones were also applied in this project and were prepared by other Smith group 
colleagues using the same method. 
 
 








3-4-1. Catalyst screen 
With the promising acceptor, trifluoromethyl enone, in hand, optimisation of the process 
began with a catalyst screen. A model reaction using (phenylthio)acetic acid 281 and phenyl 
trifluoromethyl enone 284 was investigated. Various isothiourea catalysts, such as achiral 
DHPB and commercially available racemic tetramisoleHCl, or alternative nucleophilic 
catalysts, such as DMAP, DBU and DABCO, were examined to assess their reactivity in this 
reaction. The results of this screen are shown in Table 3.2. DHPB gave the best yield (68%, 
Table 3.2, Entry 1). (－)-tetramisoleHCl resulted product in a moderates yield  (52%, Entry 
2) with remaining enone (24%). DMAP gave a lower isolated yield (34%, Entry 3), however, 
further investigations with DMAP were conducted, the enone was fully consumed after 24 hr 
by 
1
H NMR.  DBU and DABCO led to low isolated yields under the reaction conditions 
described (Entry 4 and 5).  
 
Table 3.2 Catalyst Screen 
 





1 DHPB 24 - 68 
2 (±)-TetramisoleHCl 24 24 52 
3 DMAP 27 - 34 
4 DBU 27 41 15 
5 DABCO 27 61 9 




3-4-2. Solvent screen 
Next, DHPB and DMAP were examined in a range of solvents, using the model substrates 
281 and 284. Pleasingly, employing DHPB in acetonitrile (MeCN) gave an excellent 
conversion (96%) by NMR spectroscopic analysis using 1-methyl naphthalene as an internal 
standard and 88% isolated yield through flash column chromatography (Table 3.3, Entry 3). 
The yield of the DMAP catalysed reactions was not improved by varying the solvent (Entry 
4-6). Therefore, DHPB in MeCN was identified as the optimised catalyst and solvent in this 
2-pyrone synthesis. 
 
Table 3.3. Solvent screen 
 
Entry Catalyst Solvent SM (%)
a Yield (%)a Isolated yield (%) 
1 DHPB THF 32 54  
2 DHPB Toluene 44 46  
3 DHPB MeCN - 96 88 
4 DMAP THF 52 27  
5 DMAP Toluene 40 35  
6 DMAP MeCN - 55 50 
a yield has been measured with 1-methyl naphthalene as an internal standard through 1H NMR spectroscopic analysis. 
 
3-4-3. Acid, base and activating agent equivalent screen 
So far, the reaction condition used for above screening was with the excess amount of acid (2 
eq), base (3 eq then 2.5 eq) and additives (3 eq). The possibility of reducing these reagents 
was next explored and the results displayed in Table 3.4. Using 1 eq of acid resulting in low 
yield from 37-49% with unreacted starting material enone 284 (Entry 1-3) after 24 hours. 
Employing 2 eq equivalents of the acid, base and additives of the reaction improved the yield 
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remarkably and the starting material enone was fully consumed (Entry 4-7). However, The 
optimised experiments show excess acid (2 eq), base (3 eq then further 2.5 eq) and pivaloyl 
chloride (3 eq) were necessary for obtained high yield (96% by 
1
H NMR) with 88% isolated 
yield (Entry 10). In addition, the purification through flash column chromatography is also 
much easier compared with others conditions. 
 
Table 3.4. Acid, base and additive equivalent screen 
 
Entry Acid (eq) (CH3)3CCOCl (eq) i) (
i
Pr)2NEt (eq) ii) (
i





1 1 1.5 1.5 1 16 49 
2 1 2 2 1 36 40 
3 1 2 2 2 39 37 
4
c 1.5 2 2 2 - (77) 
5 2 2 2 1 - 72 
6 2 2 2 2 - 71 
7
 2 3 2 2 - 81 
8 2 3 3 1 trace 57 
9 2 3 3 2 trace 55 
10 2 3 3 2.5 - 96 (88) 
a yield has been measured with 1-methyl naphthalene as an internal standard through 1H NMR spectroscopic analysis. b the 









3-4-4. Acetic acid screen 
A variety of acetic acids bearing a range of potential leaving groups were also examined with 
the previously optimised reaction condition. For the model pyrone 285 synthesis, both bromo- 
335 and chloroacetic acid 336 gave the product in 23% and 24% isolated yields, respectively. 
Sulfoxide substituted acid 321 gave low conversion to pyrone 285. (Thiophenyl)acetic acid is 
still the best choice for this methodology (Scheme 3.15). 
 
 
Scheme 3.15 Reaction scope: variation of acetic acids 
*yield has been measured with 1-methyl naphthalene through 1H NMR spectra. 
 
3-4-5. Catalyst loading screen 
Finally, catalyst loading in this reaction was examined. Initial studies used 20 mol% DHPB 
and gave 88% isolated yield (Entry 1, Table 3.5). Reducing the catalyst loading to 10 mol% 
gave 81% isolated yield (Entry 2). Further reduction of the catalyst loading to 5 mol% 
resulted in also good 82% yield (Entry 3). Pleasingly, even 1 mol% and 0.1 mol% catalyst 
loading gave good isolated yields of 77% and 71%, respectively (Entry 4 and 5).  
Surprisingly, without catalyst, 59% product was obtained after 24 hours (Entry 6). However, 
the purification is challenging as there was more impurities in the crude mixture. DHPB plays 





Table 3.5 Catalyst Loading Screen 
 
Entry DHPB (mol%) Isolated yield (%) 
1 20  88  
2 10  81  
3 5  82  
4 1  77  
5 0.1  71  
6 -  59  
 
3-4-6. Moisture condition and scale-up 
So far, the reactions were conducted in dry conditions, including using flame dried glassware 
and dry solvent. Carrying out the reaction in open-flask condition slightly reduced the yield, 
from 88% to 80% (Table 3.6 Entry 1). The absence of standard indicator, 1-methyl 
naphthalene, did not impact the reactivity, resulting in the excellent yield of 89% (Entry 2). 
The reaction was also scaled up to gram scale (6 mmol), resulting in an isolated yield of 90% 
(1.30 g) (Entry 3). The same scale was also applied in using less equivalents of activating 











Table 3.6 Moisture condition and scale-up 
 
Entry (CH3)3CCOCl (eq) i) (
i
Pr)2NEt (eq) ii) (
i
Pr)2NEt (eq) Isolated yield (%) 
1
a 3 3 2.5 80 
2
b 3 3 2.5 89 
3
c
 3 3 2.5 90 
4
c 2 2 2 83 
a Open-flask conditions. b without standard indicator (SI). c the reaction was in 1.0 mmol scale 
 
The optimation process has shown the best condition for 2-pyrone formation is with two 
equivalents of (phenylthio)acetic acid, three equivalents of pivaloyl chloride and 3 
equivalents of (
i
Pr)2NEt to generate excess mixed anhydride, followed by the addition of 1 or 




The reaction has also been attempted adding all the reagents at the outset of reaction, without 
activating the acetic acid with pivaloyl chloride, using 20 mol% DHPB. However, the yield 
decreased to 65%.  Hence, performing the activation process step initially, leads to higher 
isolated yield of desired product (Scheme 3.16).  
 
 






3-5. Product scope 
3-5-1. Acceptor screen 
Following optimisation of this process, various trifluoromethyl enones were next studied to 
assess the scope and limitations of the reaction. The experiments were examined using both 1 
and 20 mol% catalyst loading and results were shown in Scheme 3.17, the yield in brackets 
refers to the isolated yields from 20 mol% catalyst loading reaction. In general, the 20 mol% 
catalyst loading gave pyrone 337-346 in excellent yields (61-99% yield). This methodology 
tolerated a range of aromatic substituents in the enone, for example, pyrones with 
o/m/p-bromo substitution 337-339 were isolated in excellent yields. Other 
electron-withdrawing 340 and 343 and electron-donating substituted aryl motifs 341 and 342, 
were obtained in high yield. Additionally, heteroaromatic functionalities 344 and 145 could be 
incorporated. In comparison with other substituents, formation of p-methoxy substituted 
pyrone 342 requires extended reaction time of 72 hours using at 20 mo% catalyst loading, 
while the and 2-furyl substituted pyrone 345 was also obtained with moderate yields. Catalyst 
loading of 1 mol% leads to good isolated yields in most cases, however, generally 10-20% 
lower yield than compared to the use of 20 mol% catalyst loading. The isolated yields of 
p-nitro substituted aryl 340 and 2-thiophene 344 pyrones were also dramatically reduced at 1 
mol%, but good at 20 mol% catalyst loading. Pyrone with 2-nathphalene 346 was isolated in 




Scheme 3.17 Reaction Scope: Variation of Trifluoromethyl Enone 
*numbers in brackets refer the isolated yields from 20 mol% catalyst loading reactions 
 
(Phenylthio)acetic acid has been applied in the isothiourea catalysed synthesis of 2-pyrone 
with trifluoromethyl enones. Further investigations focused on alternative Michael acceptors 
in related processes. Reversed trifluoromethyl and phenyl enone 348, α-substituted 
trifluoromethyl enone 349 and alkanyl substituted trifluoromethyl enone 350 were submitted 
to the optimised reaction conditions but give no reaction (Scheme 3.18). Other substrates with 
various substituents have also been examined under the reaction conditions described, but 
only starting enone was returned. The α,β-unsaturated trichloroketone 353 is unreactive in this 
system. α,β-Unsaturated keto-phosphates 354 and 355 were also examined, however, the 
reactions resulted in a complex mixture, observed by crude 
1
H NMR, and only 10 % of 





Scheme 3.18 Reaction scope: variation of Michael acceptors 
 
3-5-2. The α,α-disubstituted acetic acids 
To expand the scope to include tri-substituted pyrones, α,α-disubstituted acetic acids have 
been examined in this methodology. Pleasingly, α,α-disubstituted acetic acids, which have 
been incompatible in our previous isothiourea-mediated methodologies, could also be 
tolerated in this system giving the tri-substituted pyrone product 357 from both 
2-bromopropionic acid 358 and α,α-di(phenylthio)acetic acid 320. The reaction with α-methyl 
(phenylthio)acetic acid gave better reactivity, with higher isolated yield of 39% and a much 





Scheme 3.19 Reaction scope: variation of acetic acids 
*yield has been measured with 1-methyl naphthalene through 1H NMR spectra. 
 
The yield of the reaction with α-methyl (phenylthio)acetic acid was improved by reacting the 
substrate and catalyst in a sealed tube at reflux (95 ˚C). The desired pyrone product 359 was 
isolated in 52% yield but in addition, a single diastereomer of sulfide substituted δ-lactone 
360 was also isolated from the reaction mixture in 30% yield (Scheme 3.20). 
 
Scheme 3.20 Reaction with α-methyl (phenylthio)acetic acid 
 
The relative configuration of racemic δ-lactone 360 was confirmed by X-ray crystallography 
to show the trans-δ-lactone with a syn-relationship between thiophenol substituent on C(3) 











   
 
 
Figure 3.2 X-ray Crystal Structure of δ-lactone 360 
 
3-5-2-1. Syn-periplanar elimination via sulfide oxidation 
Following the synthesis of anti-lactone 360, via isothiourea catalysis, futher 
1,2-syn-elimination to pyrone 359 was desired. To facilate the desired elimination, the 
δ-lactone was oxidised with mCPBA to form sulfoxide 361 then in situ syn-periplanar 








The oxidation with mCPBA has also been applied directly to the crude catalysis reaction 
mixture from α-methyl (phenylthio)acetic acid 320 and acceptor 284, in a cascade process 
without any work-up and direct purification, giving the desired tri-substituted pyrone 359 in 
65% yield (Scheme 3.22).  
 
 
Scheme 3.22 One-Pot Tandem Tri-substituted Pyridine Synthesis 
 
α-Phenyl (phenylthio)acetic acid 363 has also been examine in this methodology. The desired 
pyrone 364 was isolated in 46% yield alongside unexpected lactone 365 in 33% yield 
(Scheme 3.23).  
 
 Scheme 3.23 Reaction with α-phenyl (phenylthio)acetic acid 
 
3-6. Application of methodology-synthesis of COX-2 inhibitor 
To demonstrate the utility of this methodology, it was applied to the synthesis of pyrone xx, 
which was investigated by Merck & Co.,
109
 and has biological activity as a COX-2 inhibitor. 
Retrosynthesis analysis suggests the potent pyrone 366 can be formed from the reaction with 





Scheme 3.24 Retrosynthetic analysis of COX-2 inhibitor 366 
 
The reactions with 1 or 20 mol% catalyst loading were successful; however, they gave a 
separable mixture containing two products (with 20 mol%, 1:1, 366 and 343; with 1 mol%, 
31:47, 366 and 343), the target pyrone 366 and also the undesired desulfurised pyrone 343 
(Scheme 3.25).  
 
Scheme 3.25 The synthesis of COX-2 inhibitor 366  
 
Presumably, the desulfurisation occurs due to the thiophenol generated during the reaction. To 
investigate this further, control experiments were studied. Product 366 was resubmitted to the 
standard reaction conditions for 24 hours, returning only pyrone 366. Another experiment 
re-treated pyrone 366 in the same condition with the addition of 0.5 eq of thiophenol, 
resulting in both pyrone 366 and 343 in a 62:38 ratio by 
1
H NMR spectroscopic analysis of 




Scheme 3.26 The control experiments with pyrone 366 
 
Attempts to prevent the undesired desulfurisation unfortunately did not improve the isolated 
yield of product pyrone 366, such as the addition of dibenzyl disulfide. 
 
3-7. Derivatisation 
To exemplify the used of pyrones in synthesis, their derivatisation to a range of 
aromatic/heteroaromatic building blocks was investigated.  
 
3-7-1. Formation of aromatics  
via Diels-Alder /retro-Diels-Alder reaction of 2-pyrone 
The general proposed mechanism of making aromatics from a pyrone utilities as a diene in a 
Diels-Alder reaction with the various dienophile. This forms a bicyclic intermediate 369, that 
undergoes a retro-Diels-Alder reaction and loss of CO2 to give various aromatic product 370 
(Scheme 3.27).  
 
Scheme 3.27 The general proposed mechanism of aromatics formation 
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The parent pyrone 285 was treated with various dienophiles such as dimethyl 
acetylenedicarboxylate (DMAD) 371, ethyl propiolate 372 and benzyne precursor 373 to 
generate benzene 374-377 and naphthalene 375 derivatives via Diels-Alder /retro Diels-Alder 
reaction. The low polarity of naphthalene 375, resulted in challenging purification and a 
reduced isolated yield. These type of reactions were generally carried out in a sealed tube in 
refluxing xylene at 200 ˚C for 72 hours. Ethyl propiolate gave a mixture of two regioisomers 
(68:38, 377 and 376), that were separable by flash column chromatography. Further attempted 
examples used methyl phenyl propiolate 378, as well as cyclic dienophiles, such as maleimide 
380 and 2,5-dihydrofuran 379, were also examined, however, no reaction was observed in 
these cases, with only starting material returned (Scheme 3.28).  
 
 





3-7-2. Aza-heterocycle synthesis 
3-7-2-1. Pyridone 384 and pyridine 385 





 Treatment with pyrone 285 with ammonium acetate in 
refluxing in aqueous DMF generated pyridone 384 in good yield, 70%.
104
 Pyridone 384 was 






Scheme 3.29 Pyridine synthesis through 2-pyrone 
 
3-7-2-2. Synthesis of 2-amino pyridine 386 
The parent pyrone 285 was also transformed into 2-amino pyridine 386 resulted in 54% yield 





Scheme 3.30 Synthesis of 2,4,6-Subtituted Pyridine Synthesis 
 
Having utilised this methodology for the synthesis of 2-pyrone, its applicability for the 





3-8. Pyridine synthesis 
Pyridine is a six-membered aromatic ring containing a nitrogen atom. The first pyridine, 
picoline, was isolated by Anderson in 1846 from the pyrolysis of bone oil. The pyridine was 
formed from the condensation of a simple aldehyde and ketone with ammonia which is 
believed to be formed from the decomposition of glycerol and nitrogenous materials.
115
 
However, the correct structure was only reported 20 years later by Körner in 1869 and Dewar 
in 1871.
115
 The pyridine motif has raised lot of attention in the last 50 years from many 
synthetic chemists as many pyridine-containing compounds have been employed as bioactive 
agents in pharmaceutical chemistry for various medicinal treatments, such as human 








Figure 3.3 A Selection of Bioactive Molecules Containing Pyridines 
 
To form the core pyridine structure, common methods employ the condensation of amine and 
carbonyl compounds or thermal [2+2+2] cycloaddition. However, to access highly 
functionalised substituted pyridines is more challenging. There are many classic 
methodologies such as muticomponent reaction (MCR),
117





 and Chichibabin pyridine synthesis,
126–129
 
that are well known (Scheme 3.31).  
 
 

















 are quite well 
developed for pyridine synthesis, particularly in [2+2+2] cycloaddition pyridine 
synthesis.
138,139
 Recently, Yoshikai et al.
140
 have reported a copper/iminium dual-catalysis 
system. However, based on the best knowledge, the first organocatalytic pyridine synthesis 




3-8-1. The first pyridine synthesis example of organocatalysis 
The original idea was to develop short synthetic routes for natural alkaloids, such 
(＋)-sesbanine- a potential cytotoxic alkaloid, and also the other antitumor and antibiotic 
agents Sesbania drummondii.
143,144
 Initially, Boger and co-workers found that reacting 
electron-rich olefins, such as the pre-formed enamine 390, with 1,2,4-triazine 391 resulted in 
a thermal cycloaddition process via inverse electron demand aza-Diels-Alder reaction (IED 
aza-DA reaction). Intermediate 392 is initially formed, followed by a retro Diels-Alder 
reaction process eliminating nitrogen gas to obtain pyridine 393 with excellent regiocontrol 
(Scheme 3.31). This study also showed that pyrrolidine enamine have better reactivity in this 




Scheme 3.31 Thermal cycloaddition for pyridine synthesis from pre-formed enamines 
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However, to circumvent enamin preparation, Boger and co-workers successfully formed 
enamine intermediate 394 in situ using achiral pyrrolidine as catalyst (20 mol%) to form 
pyridine 393.
142
 The key to the success of this method is the addition of activated 4 Å  
molecular sieves as to catalyse and complete the enamine formation that helps to regenerate 
the pyrrolidine then complete the catalytic cycle (Scheme 3.32).  
 
 
Scheme 3.32 One-pot organocatalytic pyridine synthesis 
 
However, at the outset of this project, there were no general routes for the organocatalytic 
synthesis of functionalised pyridines.  
 
3-9. The aim of this work 
The previous isothiourea-mediated pyrone synthesis has shown that (phenylthio)acetic acid 
could be used to trigger thiophenol elimination from an in situ prepared lactone. Based on the 
same idea, this work examined the ketimines for the same reaction condition through a formal 
[4+2] cycloaddition then thiophenol elimination to result in pyridone 398. Regarding 
literature examples
145–148
, the N-sulfonyl substituted pyridines were found to spontaneously 
undergo N- to O- sulfonyl migration at room temperature or under heating. Hence, the 
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intermediate pyridone 398 was expected to undergo subsequent an N- to O- sulfonyl 
migration giving a functionalised tri-substituted pyridine 399 in a one-pot reaction (Scheme 
3.33). The 2-sulfonyl group has the potential for having further installation ofkm   H, aryl, 
heteroaryl, alkyl and amino substituents via various cross-coupling strategies or SNAr 
processes. To the best of our knowledge, this represents the first example of catalytic 
isothiourea mediated pyridine synthesis.  
 
 
Scheme 3.33 One-pot isothiourea mediated pyridine synthesis 
 
(Thiophenyl)acetic acid using in this project is commercially available and the preparation of 
the acceptor ketimines 190-192 has been discussed in chapter 3.  
 
3-10. Initial results and discussion 
Initial work aimed to assess the scope of N-sulfonyl substituent on this process. Under the 
reaction conditions described in Scheme 3.34 various size sulfonyl substituted ketimines 190, 
191 and 195 have examined. Benezensulfonyl and tosyl ketimine gave the same isolated yield 
(45%). However, the triisopropylsulfonyl substituted ketimine only gave the pyridine in 19%. 
The crude was observed by 
1
H NMR contained a mixture of pyridone intermediate and 
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pyridine product. Unfortunately, the isolation of the pyridone failed.  
 
Scheme 3.34 Various sulfonyl groups scope 
 
3-11. Confirmed constitution 
To confirm the constitution of pyridine product, various analytical techniques were applied. 
1
H NMR spectroscopic analysis showed the signal of C(5)H is 8.21 ppm, which is located in 
the aromatic region matching the result, which has been discovered from the pyridine 
analogue 257 in the dihydropyridinone project (7.99 pm), in Chapter 2. Furthermore, IR data 
only has the carbonyl C=O stretch at 1724 cm
-1
, showing the structure is not like the pyridone 
containing the α,β-unsaturated C=O motif. Unambiguous evidence to prove the constitution 
of pyridine 400 was finally identified by a suiTable crystal structure examined via X-ray 
crystallography (Figure 3.4). 
 
 
   
 
Figure 3.4 Crystal Structure of Pyridine 400 
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After these initial studies, this project formed the basis of another PhD student’ research.
149
 
The further optimised studies have shown the N- to O-sulfonyl migration can be accelerated 
via heating the reaction mixture at 70 ˚C fully converting pyridone into pyridine (Scheme 






Scheme 3.35 Isothiourea-mediated one-pot pyridine synthesis from Smith group 
 
Following the publication of this work, Chi and co-workers reported a DMAP-catalysed 






Scheme 3.36 Chi’s approach of DMAP-catalysed one-pot pyridine synthesis 
 
3-12. Conclusion 
In conclusion, (thiophenyl)acetic acid react, under Lewis base catalysis, with a range of 
electron deficient enone Michael acceptors to generate planar, pyridine and pyrone, via 
isothiourea-mediated Michael addition/cyclisation/thiophenol elimination cascade protocol in 




Scheme 3.37 One-Pot Isothiourea-Mediated Plan Molecule Synthesis 
 
This methodology has been utilised in the synthesis of COX-2 inhibitor 366 with good overall 
yield. The parent pyrone has been employed in a series of further manipulations and is readily 
derivertised into a wide range of valuable aromatics/heteroaromatics with good yields 
(Scheme 3.38).  
 
 
Scheme 3.38 The summary of pyrone derivatisation  
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Chapter 4. N- to C- Sulfonyl Migration via Photoisomerisation 
 
4-1. Introduction 
Previous work within the Smith group identified an interesting N- to C-sulfonyl migration. 
Upon storage in sealed vial expose to air and light for prolonged periods of time, N-Ts 
dihydropyridinone 406 undergoes N- to C-sulfonyl migration into product 407 without loss in 
enantioselectivity (Scheme 4.1, a). The same rearrangement could also be promoted through 
heating 408 in ethyl acetate at reflux for 72 hours. However, subjecting dihydropyridinone 
408 to UV light induced efficient photoisomerisation forming 409 in 92% yield without 





Scheme 4.1 Previous observations from the Smith group 
 
This novel N- to C-sulfonyl migration process via photoisomerisation has not been explored 
in detail and further investigation into the scope and limitation of this reaction are needed. 
Studies into the mechanism of the N- to C-sulfonyl migration would also be of interest. The 
product 5-sulfonyl dihydropyridinone are also of interest as they have the potential for further 
derivatisation.
151–153
  Previously, 5-sulfonyl dihydropyridinone were demonstrated as 





 and peptide mimic 411 which were specifically designed as a 





Scheme 4.2 Target molecules synthesised from 5-sulfonyl dihydropyridinones 
 
4-1-1. Alternative literature on the formation of 5-sulfonyl dihydropyridinones 
Stille et al. reacted BnNH2 and ketone 413 bearing an electron-withdrawing substituent 
(SO2Ph and SO2Me) with pTsOH in benzene to form enamine 414 in situ. Subsequently,  
aza-annulation with acryloyl chloride 415 results in the formation of 5-sulfonyl 
dihydropyridinones 416 and 417 in good yields (Scheme 4.3).
155
 The electron-withdrawing 
sulfonyl group is the key to the reaction as it favours the β-enamino form of the ketimine, 
encouraging the aza-annulation process.  
 
 
Scheme 4.3 Synthesis of 5-sulfonyl dihydropyridinone  
via enamine condensation/aza-annulation 
  
Tai and co-workers also developed a stepwise reaction to generate glutarimides 422.
154,156
 The 
reaction starts by treating chloroacetyl chloride 418 with a primary amine and sodium 
p-toluenesulfinate to form p-toluenesulfonyl acetamide 419. Deprotonation of 
p-toluenesulfonyl acetamide with 2 eq sodium hydride results in formation of dianion 420, 
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which then readily reacts with variety of α,β-unsaturated esters 421 to afford glutarimides  
422. The imide moiety was reduced with sodium borohydride forming δ-lactam 423. Finally, 
lactam was dehydrated with boron trifluoride in the presence of anhydrous magnesium sulfate 
resulting in dihydropyridinones 424 in good to excellent yields (up to 97%) (Scheme 4.4).  
 
 
Scheme 4.4 Synthesis of 5-sulfonyl dihydropyridinones 
 
5-sulfonyl dihydropyridinone 425 was applied in the synthesis of racemic indolizidine 
alkaloid analogue, 8a-epi-dendroprimine 410. Firstly, 425 was treated with NaI in acetone at 
reflux to form intermediate 426, which underwent intramolecular cyclisation with 
Bu3SnH/AIBN giving the indolizidine carbon skeleton of 427 that was elaborated in the 
further synthesis of 8a-epi-dendroprimine 410 (Scheme 4.5).  
 
 
Scheme 4.5. Synthesis of 8a-epi-dendroprimine 410 from 5-sulfonyl dihydropyridinone 427 
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4-1-2. The N- to C- Sulfonyl Migration 
To the best of our knowledge, N- to C sulfonyl migration has not been previously reported in 
cyclic non-aromatic ring structures. However, related reactions have been reported for both 
acyclic and and aromatic systems and have been termed 1,3-sulfonyl migration, 1,3-sulfonyl 
shift and ortho-isomerisation (Scheme 4.6). 
 
 
Scheme 4.6. General Scheme of N- to C sulfonyl migration in sulfonamides 
 
From the literature, N- to C sulfonyl migration can be promoted by either photochemical or 
thermal reactions and these approaches are discussed in the following section.  
 
4-1-2-1. Photochemistry 
The general term photochemistry is used to describe the use of light to promote chemical 
reactions by absorption of either ultraviolet (wavelength from 100-400 nm), visible light 
(400-700 nm) or infrared radiation (700-2500 nm). Compared with thermal chemical 
reactions, photochemical reactions can help to overcome large activation barriers and can also 
be used to promote reactions that are inaccessible by thermal processes, for example some 
[2+2] cycloaddition processes.  
 
N- to C-Sulfonyl Photoisomerisation Reaction 
In 1959, Stacey et al. reported a photoisomerisation under UV light at 250 nm to convert 
vinylsulfonamides 430 into 2-sulfonylvinylamines 431 (Scheme 4.7).
157
 Aryl sulfonylamides 
such as SO2Ph and tosyl gave isomerisation products in good yields (68-94%). Unfortunately, 
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alkyl sulfonylamides only result in 5-10% yields of the photoisomerisation products. 
Furthermore, the reaction could be inhibited by small amounts of Et3N, 1,2-ethanedithiol, 
thiophenol, butyraldehyde or styrene, and is not catalysed by either pyridine or 
p-toluenesulfonic acid, which all suggest that the isomerisation is not an ionic reaction but is 
radical in nature.  
 
 
Scheme 4.7 The photochemical isomerisation of sulfonamides 
 
Photo-Fries Rearrangement 
The Fries rearrangement is an ortho, para-selective isomerisation transforming a phenolic 
ester 432 into a hydroxyl aryl ketone catalysed by a Lewis acid such as AlCl3 under thermal 
conditions. The reaction involves an acyl group migration onto an aromatic ring.
158
 The 
regioselectivity can be affected by variation in the reaction conditions such as temperature 
and solvent (Scheme 4.8).  
 





Photo-Fries rearrangements are promoted by light and are thought to proceed by a radical 
mechanism. Irradiating the N-sulfonyl aniline 437 under UV light generates sulfonyl radical 
and aniline radical. These two radicals can recombine at the ortho position or para position 
resulting in two regioisomers 439 and 441 (Scheme 4.9). There are a few literature reports of 










Scheme 4.9 General proposed mechanism of photo-Fries rearrangement 
 
For example, Park and co-workers have demonstrated a photo-Fries rearrangement of 
N-tosylamides.
160
 Irradiating N-tosyl amides 442 at 254 nm in acetonitrile resulted in 
photoisomerisation into anilines 443 and 444. The regioselectivity of the method could be 
improved by blocking the para position with a substituent (Scheme 4.10). However, the 
yields were generally low in most cases.  
 
 





Photo-Fries rearrangement of carbazoles with various sulfonyl groups has been reported by 
Chakaborty et al.
162
 The carbazoles 445 were irradiated with UV light at 254 and 365 nm 
either in methanol or benzene (Scheme 4.11). The wavelength at 365 nm gave shorter reaction 
times and slightly increased yields. The aryl sulfonyl substituent favoured forming the 
para-isomer 447 (ortho: para, 3:4), whereas, the mesyl sulfonyl group more favoured the 
ortho-isomer 446 (ortho: para, 4:3).  
 
 
Scheme 4.11 Photo-Fries Rearrangement of Carbazoles with Various Sulfonyl Groups 
 
In most cases, photo-Fries rearrangement gives a mixture of two regioisomer of products with 
low yield and poor regioselectivity. Hence, this reaction procedure is not readily applied in 
large-scale synthetic procedures. 
 
4-1-2-2. Catalytic 1,3-Sulfonyl Migration 
In addition to photo-induced procedures, N- to C-sulfonyl migration can be promoted by 
organometallic chemistry.
163–165
 Recently, Chan and co-workers have developed a 








Scheme 4.12 Gold-Catalysed Cycloisomerisation of 1,7-enyne benzoates 
 
This gold-catalysed cycloisomerisation could involve the activation of 1,7-enyne benzoates 
by coordinating gold catalyst 450 with the alkyne moiety to give gold(I) intermediate 451, 
which undergoes the intramolecular aminocyclisation forming complex 452. Then, complex 
452 can undergo either dehydration following by 1,3-sulfonyl migration into product 449 
(Scheme 4.13, path a) or 1,3-sulfonyl migration then dehydration (path b).  A crossover 










A novel 1,3-sulfonyl migration has also been demonstrated using Lewis base catalysis. Zhan 
et al. employed DMAP as catalyst for synthesis of mutisubstituted pyrazoles from propargylic 
hydrazones 453 (Scheme 4.14).
166
 This method examined various sulfonyl groups and a wide 
scope providing good to excellent yields (47-95%). A crossover experiment of propargylic 
amides suggested this 1,3-sulfonyl migration is an intramolecular process. The proposed 
mechanism starts with isomerisation of the alkyne moiety of propargylic amide 453 into the 
allenic sulfonamide 454. Nucleophilic addition of DMAP to the terminal sp
2
 carbon of the 
allene 456 pushes electron density onto the sulfonylamide to afford intermediate 457, which 
undergoes 1,3-sulfonyl migration resulting in 458. Elimination of the Lewis base catalyst 
gives α,β-unsaturated imine 459, which then undergoes intramolecular Michael addition to 
generate the zwitterionic cyclic intermediate 460. Finally, proton transfer affords the observed 
pyrazole products 455.  
 





Compared with photoisomerisation, catalytic thermal methodologies not only provide more 
precise 1,3-sulfonyl migration without regioselectivity issues but also generally provide a 
wide range of scope and good yields. Hence, the photo-induced N- to C-sulfonyl migration 
discovered from Smith group is particularly interesting as it provides specific isomerisation 
products in excellent yield and it is also the first example of N- to C-sulfonyl migration of 
non-aromatic cyclic substrates containing stereocentres.  
 
4-2. The aim of this work 
Building on the discovery of the N- to C-sulfonyl migration from previous work within the 
group, this project aimed to study the limitation of this rearrangement and also to investigate 
the mechanism of the photo-induced migration process (Scheme 4.15).  
 
 
Scheme 4.15 The Proposed N- to C-sulfonyl migration 
 
We envisaged using a range of N-sulfonyl dihydropyridinones synthesised using the 
isothiourea-catalysed Michael-addition lactamisation protocol developed previously (chapter 
2) and subjecting them (R
3
= ester) to photoisomerisation conditions. Moreover, to probe the 






4-3. Starting Material Preparation 
4-3-1. Ketimines with Various R
3
 and N-Substituent 
A series of ketimine was synthesised from the reaction of chalcone 463 with sulfonamides 
using TiCl4 and Et3N in CH2Cl2 (Scheme 4.16). The ketimine product 464-466 could mostly 
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be purified by trituration in diethyl ether, giving pure products in good yield without the need 
for further purification. Only ketimine 467 bearing N-SO2NMe2 substituent needed to be 
purified through flash chromatography, which accounts for the lower isolated yield.  
 
 
Scheme 4.16 Ketimines Prepared from Chalcones. 
 
4-3-2. Aldimine Synthesis 
Aldimines 469 and 470 were also synthesised by heating cinnamoyl aldehyde 468 with 
sulfonylamides at reflux in toluene under Dean-Stark conditions. The products precipitated 
from the reaction mixture by quenching with diethyl ether allowing aldimines 469 and 470 to 
be obtained in excellent yield on a gram scale (88% and 83%) (Scheme 4.17).  
 
 






4-3-3. Dihydropyridinone Synthesis 
Dihydropyridinones with a C(4) ester substituent, were prepared following the 
isothiourea-mediated methodology from aryl and alkyl acetic acids and ketimines catalysed 
by (±)-tetramisoleHCl previously discussed.
167
 Aryl substituted dihydropyridinone 474 and 
475 were prepared under the same reaction condition, using DHPB as a catalyst. All the 
dihydropyridinones were purified through recrystallisation from diethyl ether to give the 
anti-diastereomers (>95:5 dr) form. Dihydropyridinone 237 was prepared using 
(－)-tetramisoleHCl and was purified by column chromatography to give product with 88:12 
dr (Scheme 4.18).  
 
Scheme 4.18. Dihydropyridinones Preparation 
acatalysed by (±)-tetramisoleHCl; bcatalysed by DHPB;  








4-3-3-1. Effect of C(5) Substituent 
The 5-bromo dihydropyridinone 261 was prepared by treating dihydropyridinone 212 with 
bromine and (
i
Pr)2NH in CH2Cl2, following the bromination procedure that as reported in 




Scheme 4.19 Synthesis of 5-bromo dihydropyridinone 261 
 
4-3-3-2. Dihydropyridinone with Alkyl Substituent on C(3) 
3-Methyl dihydropyridinone 478 was synthesed using an NHC-redox catalysis procedure 
previously developed within the group.
168
 α-Aroyloxyaldehyde 476 was reacted with ketimine 
464 catalysed by racemic triazolium NHC catalyst 477. The crude was purified through flash 
column chramotography giving the desired anti major product 478 in 85% yield with 74:26 dr 
(Scheme 4.20).  
 
Scheme 4.20 Dihydropyridinone Preparation via NHC-redox catalysis 
 
4-3-3-3. Dihydropyridinone with H Substituent on C(6) 
Following Bode’s NHC approach,
169
 treatment of α,β-unsaturated aldehyde 479 and aldimine 
470 catalysed by racemic triazolium NHC catalyst 480 afford anti major dihydropyridinone 




Scheme 4.21 Dihydropyridinone Preparation via Bode’s Approach 
 
4-4. Initial Studies 
The N- to C-sulfonyl migration was initially observed during the preparation of the C(4) ester 
substituted dihydropyridinones. The isomerisation occurred when product 230 was 
concentrated under reduced pressure with the bath at 40 ˚C. Moreover, p-OMe aryl substituted 
dihydropyridinones such as 241 and 242 were even more reactive as sulfonyl migration was 
observed in CDCl3 during NMR spectroscopic analysis.  
 
Ester substituted dihydropyridinone 212 was initially examined under the same 
photochemical reaction conditions as previously found.
68
 Therefore, dihydropyridinone 212 
was dissolved in CDCl3 and irradiated with a standard UV lamp for 24 hours. This promoted 
N- to C- sulfonyl migration, allowing product 482 to be isolated in 58% yield with no loss in 
diastereo and enantioselectivity (Scheme 4.22). However, the crude reaction mixture 
contained unidentified side products and therefore the yield was lower than expected.  
 
 




The standard broad spectrum UV lamp output wavelength mainly at 365 nm but also gives 
strong wavelengths at 405 nm and also 435 nm,
170
 which may cause the formation of 
undesired side products. The UV light resource was therefore replaced by a black light lamp 
that has a sharp wavelength at 365 nm only. In this case, the reaction was much cleaner giving 
the desired product in 91% yield, again with no loss in stereoselectivity.  
 
4-5. Control Experiments 
4-5-1. Acid, temperature and light screen 
The initial studies indicated that this N- to C-sulfonyl transfer can be triggered by a number of 
potential factors including mild acid (in CDCl3), thermally (refluxing), or by light (UV). In 
order to investigate factors affecting efficient product formation, several control experiments 
were carried out. Firstly, dihydropyridinone 212 was placed in an NMR tube in CDCl3 and 
was covered in foil to eliminated UV light. After 16 hour at rt. 
1
H NMR analysis indicated 
that there was 37% conversion transferred into product 482. After 40 hours, the ratio of 
dihydropyridinone 212 to product 482 increased to 51:49, but no further increase in product 
was observed after 112 hours (Table 4.1, Entry 1). Next, the reaction mixture was placed in 
bench chloroform and covered in foil eliminated UV light before being heated to 50 ˚C for 16 
hours. 
1
H NMR analysis showed a 212: 482 ratio of 50:50, that proving that the 
transformation can be accelerated thermally in chloroform (Entry 2). In comparison, the 
sulfonyl transformation could be more efficiently performed under UV irradiation with 
product 482 formed in an excellent 91% isolated yield (Entry 3). Replacing the bench NMR 
solvent with CDCl3 that was basified using solid K2CO3 completely shut down the reaction 
(Entry 4), while heating the reaction mixture to 50 ˚C led to no product being observed (Entry 
5). However, the sulfonyl transfer did occur in basified CDCl3 under UV irradiation and 
1
H 
NMR analysis showed that starting material was fully consumed, resulting in the isolation of 
482 in 90% yield (Entry 6). These results show that photo-irradiation with UV light at 365nm 
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is the most efficient way of promoting N- to C-sulfonyl migration. However the isomerisation 
also occurs under thermal conditions in the presence of bench CDCl3, which is likely to be 
mildly acidic.  
 
Table 4.1 Control Experiments- Acid, Temperature and Light  
 







 off rt 16 63 37 
 off rt 40 51 49 
 off rt 112 50 50 
2 off 50 16 47 53 
 off 50 40 47 53 




 off rt 16 100 - 
5
d
 off 50 16 100 - 
6
d
 on 30 16 4.5 90 
a conditions: reactions have been carried with racemic dihydropyridinone (>95:5 dr), in CDCl3 in a NMR tube. 
b yield measured 
with 1-methyl naphthalene as internal standard by 1H NMR spectroscopic analysis. c CDCl3 used directly from bottle. 
d CDCl3 
basified with K2CO3 before used. 
e isolated yield  
 
4-5-2. Scale-up 
An interesting observation was made upon scaling-up the photoisomerisation procedure 
during optimisation. The reactions were mostly performed in NMR tubes with fairly on small 
scale (0.1 mmol). To enable to scale up, the reaction was performed in a round bottomed flask 
(RBF). However, irradiating 212 in CDCl3 in a RBF did not give the expected product 482 but 
highly functionalised lactone 483 in 25% yield, the configuration was confirmed by X-ray 
crystallography. Hence, on scale-up reaction transfer to RBF required degassed CDCl3.  
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4-5-3. Lactone Synthesis via Photolysis 
Repeating the scaled-up photoisomerisation of dihydropyridinone 212 under an oxygen 
atmosphere allow resulted in formation of lactone 483, which was isolated in 35% yield as 
confirmed by 
1
H NMR analysis (Scheme 4.23)  
 
 
Scheme 4.23 Lactone Formation under an O2 atmosphere  
 
The formation of lactone suggests there is an oxygen source in the reaction. Compared with 
the reaction carried out in an NMR tube, the RBF has increased surface area in contacting 
with air. Dihydropyridinone was treated with methylene blue in methanol and red light 
(wavelength= 620-750 nm), which generate highly reactive singlet oxygen; however, no 
product was observed. This project was not followed further.  
 
4-6. Optimisation-Solvent Screen 
Various solvents were examined in this photoisomerisation reaction using enantiomerically 
pure dihydropyridinone 212 to determine the best solvent. Methanol gave only 9% conversion 
into product 482 after 16 hours by 
1
H NMR analysis (Table 4.2, Entry 1). Ethyl acetate gave 
slight improvement resulting in 48% isolated yield without affecting the products 
enantiopurity (98% ee) (Entry 2). THF worked well, affording product 482 in 68% isolated 
yield and 97% ee. Using either CH2Cl2 or CHCl3 gave completed conversion in 16 hours 
forming product 482 in 84% and 71% isolated yield, respectively (Entry 4 and 5 ). The yield 
was not affected by diluting the reaction in CH2Cl2 (Entry 6). The reaction was scale-up using 
racemic dihydropyridinone 212 (0.4 mmol) performing the reaction in a round-bottomed flask 
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in both CH2Cl2 and CHCl3. Pleasingly, both reactions worked well, forming product 482 in 
excellent yield in both cases, and CH2Cl2 was chosen as the optimial solvent for further 
investigations. While performing the scale-up reaction it was also observed that trace 
impurities on the reaction glassware could affect the reaction yield. Therefore, all glassware 
was thoroughly cleaned in a KOH base bath and washed with water before use.  
 
Table 4.2 Optimisation-Solvent Screen 
 






 ee (%) 
1 MeOH 1 64 9 - - 
2 EtOAc 1 18 51 48 98 
3 THF 1 11 78 68 97 
4 CH2Cl2 1 - 85 84 98 
5 CHCl3 1 - - 71 98 
6 CH2Cl2 2 - - 87 98 
 7
c,e CH2Cl2 4 - 98 95 N/A 
  8
c,d,e
 CHCl3 4 - 97 95 N/A 
a yield measured with 1-methyl naphthalene as internal standard by 1H NMR spectroscopic analysis.b isolated yield. c 0.4 mmol 
scale. d the glassware has been cleaned in a KOH bath overnight before used; eracemic 212 used 
 
4-7. Scope 
4-7-1. Variation of sulfonyl groups 
With an optimised procedure in hand, the scope of this process was tested. A range of 
N-sulfonyl dihydropyridinones was subjected to the optimised photoisomerisation conditions. 
The methodology tolerates various different sulfonyl substituents including SO2Ph and Ts, 
which give the isomerised products 482 and 484 in 95% and 88% yields, respectively. Aryl 
sulfonyl group containing both electron-donating (p-MeO) and electron-withdrawing (p-NO2) 
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substituents also worked well, giving the products 485 and 486 in high yields. The N-mesyl 
substituted dihydropyridinone gave product 487 in a reduced isolated yield of 67%, with the 
remaining material isolated as un-reacted starting material (Scheme 4.24). All products retain 
high diastereoselectivity (>95:5 dr) and there is no epimerisation was observed.  
 
 
Scheme 4.24 Variation of Sulfonyl Group 
 
4-7-2. Variation of Ring Substituents 
Dihydropyridinones with various substituent on C(3) and C(4) were investigated under the 
previously optimised conditions. Replaced the aryl group on C(3) with a 2-thiophene 
substituent, gave product 488 in a good 79% yield. An alkyl group could also be tolerated, 
giving 489 in good isolated yield (80%). Dihydropyridinones 474 and 475 with three aryl 
substituents also work well with product 490 and 491 formed in 88% and 87% yield, 




Scheme 4.25 Variation of Ring Substituents 
 
Dihydropyridinone 481 without a C(6) substituent was also examined in this 
photoisomerisation. Surprisingly, in this case, no reaction was observed and only starting 
material was returned. This suggests that an aryl C(6) substituent may be important for the N- 
to C-sulfonyl migration process (Scheme 4.26). 
 
 
Scheme 4.26 Reaction without C(5) substituent. 
 
As expected, blocking the C(5) position with a bromine substituent prevented the 





Scheme 4.27 Reaction with 5-Bromo Dihydropyridinone 261 
 
4-8. Mechanism Studies 
To investigate the mechanism of this N- to C-sulfonyl migration process a number of 
experiments were performed.  
 
4-8-1. Crossover Reaction 
Firstly, a crossover experiment was performed to probe whether the process is intra- or 
intermolecular in nature. Dihydropyridinones 474 and 212 (45:55) were irradiated at 365 nm 
in CH2Cl2 for 16 hours. Analysis of the crude 
1
H NMR showed the formation of all four 
possible C-sulfonyl products, 482, 484 and 490-491,  in approximately equal amounts, 








Irradiating a 1:1 mixture of C-sulfonyl products 490 and 482 under the standard reaction 
conditions did not lead to any further crossover, and two C-sulfonyl products 490 and 482 
were returned unchanged (Scheme 4.29). This suggests that the products are sTable to 
photolysis and do not undergo further photo-induced processes.  
 
 
Scheme 4.29 Product Crossover Reaction 
 
These two crossover experiments indicate that the N- to C- sulfonyl migration reaction is 
intermolecular, as all four possible products were obtained from a crossover experiment in an 
approximate statistical mixture.  
 
4-8-2. Proposed Mechanism 
A plausible mechanism of this photoisomerisation reaction involves the homolysis of the N-S 
bond upon UV photolysis at 365 nm. The UV/Vis spectrum of dihydropyridinone 212 showed 




Figure 4.1 The UV/Vis spectrum of dihydropyridinone 212 
 
The strong absorption at 365 nm radiation indicates that the dihydropyridinone 212 may be 
excited under the reaction conditions. A plausible radical mechanism for this 
photoisomerisation process is shown in Scheme 4.30. It is proposed that the reaction could be 
initiated by the homolysis of the N-S bond of dihydropyridinone 212 to generate sulfonyl 
radical 494 and radical 493. The radical process can be propagated by the reaction of sulfonyl 
radical 494 with dihydropyridinone 212 at C(5) position to form intermediate 496 and 
generate more sulfonyl radical 494. The reaction can be terminated by radical recombination 
of 494 and 493 at C(5) position to form intermediate 496 that can subsequently tautomerise 
into product 482. This mechanism is consistent with the crossover experiments described 
previously (Scheme 4.28) as sulfonyl radical 494 reacts is proposed to react in an 





Scheme 4.30 The Proposed Mechanism  
 
In an attempt to confirm the presence of radical intermediates, the photoisomerisation of 
dihydropyridinone 212 was repeated with the addition of one equivalent of TEMPO as a 
radical scavenger. In the case, no product formation was observed and the starting material 
was recovered unchanged (Scheme 4.31). 
 
Scheme 4.31 The Reaction with TEMPO 
 
4-8-3. EPR Experiment  
To further investigate the possibility of radical formation, a sample of dihydropyridinone 212 
was irradiated analysed by EPR spectroscopy in collaboration with Professor John Walton.  





BuPh) and radiated at 250 nm at room temperature (295 K) with sources after 1 minute and 
40 minutes giving interesting data on the species in solution. The experimental g-factor and 
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the hyperfine splitting (hft) of the initial species in spectrum (a) and the major component in 
(b) are very close to the parameters from the literature for the benzenesulfonyl radical, 
SO2Ph. (Lit
171
: g-factor = 2.0045, a(2Hm) = 1.18, a(1Hp) = 0.55, a(2Ho) = 0.35 G) (Figure 
4.2). This is positive evidence supporting the formation of benzenesulfonyl radical 494 during 
the photolysis. In addition the EPR signal is isotropic that confirms radical 494 disconnected 
from dihydropyridinone xx and is freely mobile in the solution. 
 
 
Figure 4.2 EPR Spectra During Continuous Photolysis of a Solution of  
Dihydropyridinone 212 in 
t
BuPh at 295 K. 
(a) 1 scan after 1 min UV irradiation; (b) 40 scans after ~ 15 min UV irradiation; (c) Computer simulation; (d) 70 scans after ~ 60 
min UV irradiation.; Best fit of spectrum (b) (R = 0.900) was obtained with the following parameters: Major radical: 77 %, lw = 
0.54 G, g-factor = 2.0044, a(2Hm) = 1.18, a(1Hp) = 0.55, a(2Ho) = 0.35 G; Minor radical: 23% , lw = 0.0.6 G, g-factor= 2.0090, 
a(3H) = 2.51 G  
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As photolysis was continued, a second radical was generated and dominated in the spectrum 
(d) after 60 minutes. Compared with the experimental hfs and computational hft from the 




Figure 4.3 Experimental and DFT computed hfs of radicals related to 493 
 
The g-factor of the second radical is unusually large (g= 2.0090), which is consistent with it 
not being located in carbon or nitrogen. The literature suggests that the radical is 
benzenesulfinyl radical, SOPh. (lit
172
: g-factor = 2.0091, a(2Hm) = 0.7, a(1Hp) = 2.4, a(2Ho) 
= 2.4 G). Although the small hfs from meta-H atom is resolved in spectrum (d), otherwise, the 
other correspondence are close. Spectrum (b) and simulation spectrum (c) contains both 
sulfonyl and sulfinyl radicals and are closely matched to the related radical from literature.
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The sulfinyl radical could possibly be generated from the sulfonyl radical or from either 
starting material dihydropyridinone 212 or photoisomerisation product 482. although none of 










In summary, a novel N- to C-sulfonyl migration promoted by UV light was developed and a 
range of dihydropyridinones with various sulfonyl, aryl and alkyl substituents were 
successfully isomerised. This method uses mild reaction conditions and generally gave high 
yields without loss of the diastereo- or enantioselectivity of the dihydropyridinone products 
tested. Mechanistic studies indicate that N- to C-sulfonyl migration is a radical process 
promoted by UV absorption at 365 nm and crossover studies indicate there is an 
intermolecular step in the reaction process.  
 
4-10. Future Work 
The synthetic utility of the C-sulfonyl products could be investigated. For example, literature 
precedent indicated that treating C-sulfonyl alkenyl with organometallic reagents results in 
alkyl substitution. Treatment with Bu3SnH/AIBN may lead to formation of alkenyl tin product 
499, which could be further utilised in cross-coupling reaction.
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 The alkene moiety of 
dihydropyridinone 482 can be functionalised via hydrogenation by a treatment with Pd/C/H2 








EPR analysis of photoisomerisation showed evidence of formation of benzenesulfonyl radical 






 can be used as a 
benzensulfonyl radical scavenger to form phenylsulfinic acid 502, which is sTable and water 
soluble. This could be used in combination with the optimised photoisomerisation conditions 
to form desulfonylation products 259 (Scheme 4.33).  
 
 





This thesis has demonstrated the organocatalytic ammonium enolate chemistry principally 
applied to ketimine acceptors using isothiourea catalysts. For example, the synthesis of 
dihydropyridinones resulted in excellent stereoselectivity (94-99% ee and 84:16 dr to >95:5 
dr). The dihydropyridinone product was successfully transferred into several potential 
products via bromination, dehydrogenation and reduction without compromising the 
stereoselectivity. A one-pot highly efficient planar heterocycle synthesis catalysed by 
isothioureas was developed resulting in the formation of highly functionalised pyridines and 
pyrones. This methodology was then extended to the preparation of the patent COX-2 
inhibitor 366 (see Scheme 3.25). The pyrone product was also utilised as a diene in forming 
various aromatics such as benzene and naphthalene via Diels-Alder/retro-Diels-Alder 
reactions.  
 
The intermolecular 1,3-sulfonyl migration of these asymmetric dihydropyridinones was 
performed by photoisomerisation. The scope covered with a range of sulfonyl groups and the 




To date, organocatalytic ammonium enolate chemistry has shown the potential for the 
synthesis on enantiopure heterocycle products with high stereocontrol. This project has 
demonstrated it can also apply to planar heterocycle synthesis. The next step for 
organocatalytic ammonium enolate chemistry could be to develop the synthesis for multi-ring 
structure (see Figure. 2.16), creating for quaternary carbon centre formation and subsequent 
application in natural product synthesis.  
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Chapter 5. Experimental 
5-1.General information  
Anhydrous CH2Cl2 was obtained from an Mbraun SPS-800 system. Pet. ether is defined as 
petroleum ether 40–60 °C. All other solvents and commercial reagents were used as supplied 
without further purification unless stated otherwise. Room temperature (rt) refers to 20–25 °C. 
Temperatures of 0 °C and −78 °C were obtained using ice/water and CO2(s)/ acetone baths, 
respectively. Analytical thin layer chromatography (TLC) was performed on pre-coated 
aluminium plates (Kieselgel 60 F254 silica). TLC visualisation was carried out with 
ultraviolet light (254 nm), followed by staining with a 1% aqueous KMnO4 solution and 
heating. Flash column chromatography was performed on Kieselgel 60 silica in the solvent 
system stated. Melting points were recorded on an Electrothermal 9100 apparatus. Optical 
rotations were measured on a Perkin Elmer Precisely/Model-341 polarimeter operating at the 
sodium D line with a 100 mm path cell at 20 °C. HPLC analyses were obtained on a 
Shimadzu HPLC consisting of a DGU-20A5 degasedser, LC-20AT liquid chromatography, 
SIL-20AHT autosampler, CMB-20A communications bus module, SPD-M20A diode array 
detector and a CTO-20A column oven which allowed the temperature to be set from 25–40 °C. 
Separation was achieved using a Chiralcel OD-H column or Chiralpak AD-H, and IA, 
columns. Authentic racemic samples of chiral products were synthesised using achiral DHPB 
214 or racemic tetramisole·HCl 211. Infrared spectra (νmax) were recorded on a Shimadzu 
IRAffinity-1 Fourier transform IR spectrophotometer as thin films using Pike MIRacle ATR 
accessory. Analysis was carried out using Shimadzu IR solution v1.50 and only characteristic 




C{1 H} spectra were acquired on either a Bruker Avance 300 
{δH (300 MHz), δC (75 MHz), δF (282 MHz)}, a Bruker Avance II 400 {δH (400 MHz), δC 
(101 MHz), δF (376 MHz)} or a Bruker Ultrashield 500 {δH (500 MHz), δC (126 MHz), δF 
(471 MHz)} spectrometer at ambient temperature in the deuterated solvent stated. Chemical 
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shifts, δ, are quoted in parts per million (ppm) and are referenced to the residual solvent peak. 
Coupling constants, J, are quoted in Hertz (Hz) to the nearest 0.1 Hz. The following 
abbreviations are used: s, singlet; d, doublet; t, triplet; q, quartet; sept, septet; dd, doublet of 
doublets; dq, doublet of quartets; ddd, doublet of doublet of doublets; ddt, doublet of doublet 
of triplets; td, triplet of doublets; tt, triplet of triplets; tdd, triplet of doublet of doublets; m, 
multiplet; bs., broad singlet. Mass spectrometry (m/z) data were acquired by electrospray 
ionisation (ESI), electron impact (EI), chemical ionisation (CI), atmospheric solids analysis 
probe (ASAP), atmospheric pressure chemical ionisation (APCI) or nanospray ionisation 
(NSI) at the EPSRC National Mass Spectrometry Service Centre, Swansea. 
 
5-2. Preparation of potassium salts 207 
Potassium (E)-2-oxo-4-phenylbut-3-enoate, 207 
 
Following the procedure outline by Smith et al.,
40
 to a solution of pyruvic acid (3.58 ml. 50 
mmol, 1 eq), benzaldehyde (5.09 ml, 50 mmol, 1 eq) and MeOH at 0 
o
C was added a solution 
of KOH (4.20 g, 75.0 mmol, 1.5 eq) in MeOH (15 ml). The first equvalent of the KOH 
solution was added dropwise over 30 min. the last third was added as one portion and the 
reaction stirred at 40 
o
C for 1 hr then rt overnight. The precipitate was collected by filtration, 
washed twice with cold MeOH, once with ether and dried under vacuum gave potassium salt 









H (400 MHz D2O) δH: 6.80 (1H, d, J 16.5, C(3)H), 








5-3. Preparation of α,β- unsaturated ketoesters 
(E)-ethyl 2-oxo-4-phenylbut-3-enoate, 204 
 
Following the procedure outline by Meng et al.,
176
 acetyl chloride (34.4 ml, 483 mmol, 11.5 
eq) and potassium salt 207 (9.0 g, 42 mmol) were added to the ethanol (300 ml) at 0 
o
C for 30 
minutes then warmed to rt then heating at reflux overnight. Concentration in vacuo gave a 
solid which was dissolved in water and extracted with CH2Cl2. The combined organics were 
washed with sat. aq. NaHCO3, water and brine being dried (MgSO4), filtered and 
concentrated in vacuo to give the crude reaction mixture. Purified by flash column 
chromatography gave 204 as yellow oil (4.4 g, 50%).; 
1
H NMR (300 MHz CDCl3) δH 1.41 
(3H, J 7.1, CH2CH3), 4.40 (2H, J 7.1, CH2CH3), 7.34 (1H, J 16.1, C(4)H), 7.40-7.48 (3H, m, 





5-4. Data for Phosphoranes 
General procedure A- preparation of phosphorane 197 
 
Following the procedure outline by Smith et al.,
40
 the corresponding 2-bromoethanone (1.0 eq) 
and triphenylphosphine (1.0 eq) were refluxed in dry THF for 4 hrs. Once the completion, the 
reaction mixture was allowed to cool down to rt and the phosphonium salt was filtered and 
washed with Et2O. The phosphonium salt was re-dissolved in water/CH2Cl2 and 2 м. aq. 
NaOH was added. The mixture was stirred overnight at rt and then extracted with CH2Cl2. 
The combined organic phases were washed with brine, dried over MgSO4 and concentrated in 





Following general procedure A: 2-bromo-1-(4-trifluoromethyl)phenylethanone (8.0 g, 30.0 









H NMR (300 MHz CDCl3) δH  4.45 (1H, d, J 21, C(2)H), 
7.43- 7.54 (6H, m, ArH), 7.54- 7.63 (5H, m, ArH), 7.65- 7.77 (6H, m, ArH), 8.08 (2H, d, J 8.0, 






Following general procedure A: 2-bromo-4’-chloroacetophenone (7.0 g, 30.0 mmol), 









H NMR (300 MHz CDCl3) δH 4.39 (1H, d, J 23.7, C(2)H), 
7.30 (2H, d, J 8.5, ArH), 7.42- 7.52 (6H, m, ArH), 7.54- 7.57 (3H, m, ArH), 7.64- 7.77 (6H, m, 






Following general procedure A: 2-bromo-4’-methylacetophenone (6.39 g, 30.0 mmol), 









H NMR (300 MHz CDCl3) δH 4.41 (1H, d, J 24.7, C(2)H), 
7.16 (2H, d, J 8.0, C(2)H), 7.43- 7.50 (6H, m, Ph), 7.52- 7.58 (3H, m, Ph), 7.67- 7.77 (6H, m, 







Following general procedure A: 2-bromo-4’-methoxylacetophenone (6.87 g, 30.0 mmol), 









H NMR (300 MHz CDCl3) δH 4.41 (1H, d, J 24.7, C(2)H), 7.16 
(2H, d, J 8.0, C(2)H), 7.43- 7.50 (6H, m, ArH), 7.52- 7.58 (3H, m, ArH), 7.67- 7.77 (6H, m, 






Following general procedure A: 2-bromo-4’-methoxylacetophenone (7.32 g, 30.0 mmol), 









H NMR (300 MHz CDCl3) δH 4.50 (1H, d, J 23.0, C(2)H) , 
7.50- 7.53 (6H, m, ArH), 7.58- 7.63 (3H, m, ArH), 7.68- 7.74 (6H, m, ArH), 8.08 (2H, d, J 8.6, 




5-5. Data for α,β- unsaturated ketones (198-203) 
General procedure B- preparation of α,β-unsaturated ketones 
 
Following the procedure outline by Xiao et al.,
72
 periodic acid dehydrate (10 mmol, 1 eq.) 
was added into a stirred solution of diethyl tartrate (10 mmol, 1 eq.) in dry Et2O (20 ml) at RT.  
After 3 hrs, the suspension was filtered and the solid was wash with 25 ml dry THF. 
Magnesium sulphate (3.0 g) was added to the organic phase and the reaction mixture was then 
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cooled in the ice bath for 30 mins. The corresponding 
2-(triphenylphosphoranylidene)acetophenone (15 mmol, 1.5 eq.) was add and then warmed 
up to rt. Once completion, the mixture was filtered and concentrated in vacuo. The residue 
was purified by flash chromatography (petrol: EtOAc = 15:1) to afford the desired product.  
 
(E)-ethyl 4-oxopent-2-enoate, 198 
 
Following general procedure B, the reaction of periodic acid dehydrate (2.28 g, 10 mmol) and 
diethyl tartrate (2.06 g, 1.71 mL, 10 mmol) in dry Et2O (20 ml), then added 
1-(triphenylphosphoranylidene)-2-propanone (4.78 g, 15 mmol), after purification (Et2O : 
petrol 5:95) gave 198 (1.86 g, 13.0 mmol, 87%), as yellow liquid.; 
1
H NMR (300 MHz, 
CDCl3) δH 1.26 (3H, d, J 7.1, CH3) , 2.30 (3H, s, -Me), 4.20 (2H, q, J 7.1, -CH2), 6.58 (1H, d, 




(E)-ethyl 4-oxo-4-(4-(trifluoromethyl)phenyl)but-2-enoate, 199 
 
Following general procedure B, the reaction of periodic acid dehydrate (2.28 g, 10 mmol) and 
diethyl tartrate (2.06 g, 1.71 mL, 10 mmol) in dry Et2O (20 ml), then added S1 (6.73 g, 15 
mmol), after purification (Et2O : petrol 5:95) gave 199 (3.63 g, 13.3 mmol, 89%), as as yellow 




H NMR (400 MHz, CDCl3) δH 1.35 (3H, d, J 7.1, CH3) , 4.31 (2H, q, 
J 7.1, -CH2), 6.91 (1H, d, J 15.6, -CH), 7.78 (2H, d, J 8.8, ArH), 7.89 (1H, d, J 15.6, -CH), 





(E)-ethyl 4-(4-chlorophenyl)-4-oxobut-2-enoate, 200 
 
Following general procedure B, the reaction of periodic acid dehydrate (2.28 g, 10 mmol) and 
diethyl tartrate (2.06 g, 1.71 mL, 10 mmol) in dry Et2O (20 ml), then added S2 (6.21 g, 15 
mmol), after purification (Et2O : petrol 5:95) gave 200 (3.19 g, 13.4 mmol, 89%), as yellow 








H NMR (400 MHz, CDCl3) δH 1.34 (3H, d, J 7.1, 
CH3) , 4.29 (2H, q, J 7.1, -CH2), 6.88 (1H, d, J 15.5, -CH), 7.48 (2H, d, J 8.5, ArH), 7.85 (1H, 




(E)-ethyl 4-oxo-4-(p-tolyl)but-2-enoate, 201 
 
Following general procedure B, the reaction of periodic acid dehydrate (2.28 g, 10 mmol) and 
diethyl tartrate (2.06 g, 1.71 mL, 10 mmol) in dry Et2O (20 ml), then added S3 (5.92 g, 15 
mmol), after purification (Et2O : petrol 5:95) gave 201 (2.83 g, 13.0 mmol, 86%), as yellow 
liquid; 
1
H NMR (400 MHz, CDCl3) δH 1.34 (3H, d, J 7.1, CH3) , 2.43 (3H, s, -Me), 4.29 (2H, 
q, J 7.1, -CH2), 6.86 (1H, d, J 15.6, -CH), 7.30 (2H, d, J 7.9, ArH), 7.86-7.95 (3H, m, -CH & 




(E)-ethyl 4-(4-methoxyphenyl)-4-oxobut-2-enoate, 202 
 
Following general procedure B, the reaction of periodic acid dehydrate (2.28 g, 10 mmol) and 
diethyl tartrate (2.06 g, 1.71 mL, 10 mmol) in dry Et2O (20 ml), then added S4 (6.16 g, 15 
mmol), after purification (Et2O : petrol 5:95) gave 202 (3.12 g, 13.3 mmol, 89%), as yellow 
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H NMR (300 MHz, CDCl3) δH 1.35 (3H, t, J 7.1, CH3) , 
3.90 (3H, s, -OMe), 4.30 (2H, q, J 7.1, -CH2), 6.87 (1H, d, J 15.5, -CH), 6.98 (2H, d, J 9.0, 




(E)-ethyl 4-(4-nitrophenyl)-4-oxobut-2-enoate, 203 
 
Following general procedure B, the reaction of periodic acid dehydrate (2.28 g, 10 mmol) and 
diethyl tartrate (2.06 g, 1.71 mL, 10 mmol) in dry Et2O (20 mL), then added S5 (6.38 g, 15 
mmol), after purification (Et2O : petrol 5:95) gave 203 (3.24 g, 13.0 mmol, 87%), as yellow 








H NMR (300 MHz, CDCl3) δH 1.35 (3H, t, J 7.1, 
CH3), 4.31 (2H, q, J 7.1, -CH2), 6.92 (1H, d, J 15.5, -CH), 7.86 (1H, d, J 15.6, -CH), 8.14 (2H, 




5-6. Data for ketimines 
General procedure C- preparation of ketimine 
A flame-dried flask containing a stirrer bar was charged with the requisite sulfonamide (1 eq.), 
ethyl 3-benzoylacrylate (1 eq.) and CH2Cl2 (ca. 0.2 M). The resulting solution was stirred and 
cooled to 0 °C before Et3N (2 eq.) was added followed by TiCl4 (1 eq.) dropwise. The 
reaction mixture was allowed to warm to rt, a reflux condenser fitted to the flask, and the 
reaction heated at reflux overnight. The solvent was removed in vacuo, the titanium salts 
precipitated with Et2O and the suspension filtered. The filtrate was concentrated in vacuo, the 
residue cooled in an ice/acetone/salt bath (~ −20 °C), and triturated with a small amount of 
Et2O (ca. 5 mL g
−1
) with stirring. The resultant solid was collected by filtration and washed 




(2E,4Z) Ethyl -4-phenyl-4-((phenylsulfonyl)imino)but-2-enoate , 190 
 
Following general procedure C, the reaction of (E)-ethyl 3-benzoylacrylate 13 (1.84 mL, 10 
mmol), benzenesulfonamide (1.57 g, 10.0 mmol), NEt3 (2.8 mL, 20 mmol) and TiCl4 (1.1 mL, 
10 mmol) in CH2Cl2 (30 mL) gave the title compound 190 after trituration as white crystals 
(2.04 g, 6.0 mmol, 60%). 
mp. 51-52 C {lit.
66
 mp. 52 C }; 
1
H NMR (500 MHz, CDCl3) δH 1.35 (3H, t, J 7.0, 
-CH2CH3), 4.30 (2H, q, J 6.3, -CH2CH3), 6.24 (1H, d, J 16.2, C(2)H), 7.44 (2H, t, J 7.7, ArH), 





H} NMR (126 MHz, CDCl3) C 14.3 (-CH2CH3), 61.7 (-CH2CH3), 127.5, 128.8, 





(2E,4E)-Ethyl -4-phenyl-4-(tosylimino)but-2-enoate, 191 
 
Following general procedure C, the reaction of ethyl 3-benzoylacrylate (1.84 mL, 10 mmol), 
p-toluenesulfonamide (1.68 g, 10.0 mmol), NEt3 (2.8 mL, 20 mmol) and TiCl4 (1.1 mL, 10 
mmol) in CH2Cl2 (30 mL) gave the title compound 191 after trituration 
(1.22 g, 3.4 mmol, 34%) as white crystals. 
mp. 53-54 C; νmax (ATR): 2938, 1714, 1545, 1304, 1157, 1094; 
1
H NMR (500 MHz, CDCl3) 
δH 1.35 (3H, t, J 6.8, -CH2CH3), 2.44 (3H, s, -Me), 4.30 (2H, q, J 6.6, -CH2CH3), 6.22 (1H, d, 
J 16.2, C(2)H), 7.34 (2H, d, J 7.9, ArH), 7.43 (2H, t, J 7.6, ArH), 7.56 (1H, t, J 7.4, ArH), 




H} NMR (100 
MHz, CDCl3) C 14.2 (-CH2CH3), 21.1, 61.7 (-CH2CH3), 126.6, 127.6, 128.7, 129.7, 132.7, 
133.9, 135.9, 136.5 (C-CO), 137.8 (NSO2ArC(1)), 144.7 (NSO2ArC(4)), 164.7 (C(1)), 174.4 
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The starting ketone, (E)-ethyl 2-oxo-4-phenylbut-3-enoate, was prepared according the 
procedure outlined by Smith et al.
149
 Following general procedure C, the reaction of the 
ketone 204 (2.0 g, 9.8 mmol), p-toluenesulfonamide (1.68 g, 9.8 mmol), NEt3 (2.8 mL, 19.6 
mmol) and TiCl4 (1.1 mL,9.8 mmol) in CH2Cl2 (30 mL) gave 208 after purification by 
flashchromatography (EtOAc–pet. ether, 1 : 5) as a brown oil (1.51 g, 4.2 mmol, 43%). 
1
H NMR (300 MHz, CDCl3) δH 1.48 (3H, t, J 7.1, -CH2CH3), 2.43 (3H, s, -Me), 4.55 (2H, q, 
J 7.1, -CH2CH3), 6.82 (1H, d, J 16.5, C(2)H), 7.29-7.56 (8H, m, ArH and C(3)H), 7.90 (2H, d, 




(2E,4E)-Ethyl 4-(((4-methoxyphenyl)sulfonyl)imino)-4-phenylbut-2-enoate, 193 
 
Following general procedure C, the reaction of (E)-ethyl 3-benzoylacrylate (0.92 mL, 5.0 
mmol), 4-methoxybenzenesulfonamide (0.94 g, 5.0 mmol), NEt3 (1.39 mL, 10.0 mmol) and 
TiCl4 (0.55 mL, 5.0 mmol) in CH2Cl2 (15 mL), gave the title compound 193 after trituration 
(0.95 g, 2.5 mmol, 50%) as an orange solid. 
mp. 76-78 C; νmax (ATR): 2985, 1716, 1552, 1494, 1311, 1255, 1184, 1143, 1089, 1002, 975; 
1
H NMR (500 MHz, CDCl3) δH 1.35 (1H, t, J 6.4, -CH2CH3), 3.38 (3H, s, -OCH3), 4.18-4.40 
(2H, m, -CH2CH3), 6.21 (1H, d, J 16.2, C(2)H), 7.00 (2H, d, J 8.3, C(4)ArC(3)H), 7.43 (2H, t, 
J 7.5, C(4)ArC(3)H), 7.56 (1H, t, J 7.2, C(4)ArC(4)H), 7.363-7.80 (2H, m, NSO2ArC(3)H), 




H} NMR (126 MHz, 
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CDCl3) C 14.3 (-CH2CH3), 55.8 (-OCH3), 61.7 (-CH2CH3), 114.2 (C(4)ArC(3)), 128.7 
(C(4)ArC(2)), 129.7 (NSO2ArC(2)), 130.3 (NSO2ArC(3)), 132.3 (NSO2ArC(1)), 132.9 (C(3)), 
133.4 (C(4)ArC(4)), 136.0 (C(4)ArC(1)), 136.9 (C(2)), 160.8 (NSO2ArC(4)), 163.4 (C(1)), 
170.3 (C(4)); HRMS (ESI+): C19H20NO5S [M+H]
+





Following general procedure C the reaction of (E)-ethyl 3-benzoylacrylate (0.92 mL, 5.0 
mmol), 4-nitrobenzenesulfonamide (1.01 g, 5.0 mmol), NEt3 (1.39 mL, 10.0 mmol) and TiCl4 
(0.55 mL, 5.0 mmol) in CH2Cl2 (15 mL), gave the title compound 194 after trituration as a 
yellow solid (1.32 g, 3.4 mmol, 68%). 
mp. 84-86 C; νmax (ATR): 3115, 2978, 1724, 1519, 1294, 1271, 1184, 1161, 1147, 1091, 
1029, 983; 
1
H NMR (400 MHz, CDCl3) δH 1.35 (1H, t, J 7.1, -CH2CH3), 4.18 (2H, q, J 7.1, 
-CH2CH3), 6.32 (1H, d, J 16.1, C(2)H), 7.47 (2H, d, J 7.8, C(4)ArC(3)H), 7.61 (1H, t, J 7.5, 
C(4)ArC(4)H), 7.65-7.80 (2H, m, C(4)ArC(2)H), 8.22 (3H, d, J 8.5, NSO2ArC(2)H and 




H} NMR (101 MHz, CDCl3) C 14.3 
(-CH2CH3), 61.9 (-CH2CH3), 124.4 (NSO2ArC(3)), 128.8 (NSO2ArC(2)), 129.0 (C(4)ArC(3)), 
130.4 (C(4)ArC(2)), 134.0 (C(4)ArC(4)), 134.1 (C(2)), 135.3 (C(4)ArC(1)), 146.4 
(NSO2ArC(1)), 150.4 (NSO2ArC(4)), 164.5 (C(1)), 176.6 (C(4)); HRMS (ESI+): 
C18H17N2O6S [M+H]
+









Following general procedure C, the reaction of ethyl 3-benzoylacrylate (0.92 mL, 5.0 mmol), 
methanesulfonamide (0.48 g, 5.0 mmol), NEt3 (1.39 mL, 10.0 mmol) and TiCl4 (0.55 mL, 5.0 
mmol) in CH2Cl2 (30 mL), gave the title compound 195 after trituration as an orange solid 
(0.87 g, 3.1 mmol, 62%) 
mp. 76-78 C; νmax (ATR): 2991, 1718, 1639, 1579, 1554, 1442, 1365, 1309, 1292, 1269, 
1184, 1134, 1026, 970; 
1
H NMR (500 MHz, CDCl3) δH 1.32 (3H, t, J 7.1, -CH2CH3), 3.26 
(3H, s, -SO2CH3), 4.28 (2H, q, J 7.1, -CH2CH3), 6.25 (1H, d, J 16.2, C(2)H), 7.47 (2H, t, J 7.8, 
C(4)ArC(3)H), 7.60 (1H, t, J 7.1, C(4)ArC(4)H), 7.76 (2H, d, J 7.2, C(4)ArC(2)H), 8.13 (1H, 




H} NMR (126 MHz, CDCl3) C 14.1 (-CH2CH3), 43.0 (SO2CH3), 61.6 
(-CH2CH3), 128.8 (C(4)ArC(3)), 130.1 (C(4)ArC(2)), 133.4 133.3 (C(4)ArC(4)), 133.5 (C(2)), 
135.7 (C(4)ArC(1)), 136.2 (C(3)), 164.5 (C(1)), 175.3 (C(4)); HRMS (ESI+) C13H16NO4S 
([M+H]
+




Following general procedure C, the reaction of (E)-ethyl 3-benzoylacrylate (7.3 mL, 40.0 
mmol), 2,4,6-triisopropylbenzenesulfonamide (11.34 g, 40.0 mmol), NEt3 (11.2 mL, 80.0 
mmol) and TiCl4 (4.4 mL, 5.0 mmol) in CH2Cl2 (120 mL), gave the title compound 192 after 
trituration as a white solid (14.50 g, 30.8 mmol, 77%). 
mp. 104-106 C; νmax (ATR): 2964, 1720, 1622, 1150, 939; 
1
H NMR (500 MHz, CDCl3) δH 
1.25 (18H, t, J 6.9, -CH(CH3)2), 1.31 (3H, t, J 7.1, -CH2CH3), 2.90 (1H, hept, J 6.8, 
NSO2ArC(4)CH), 4.20-4.29 (4H, m, -CH2CH3 and NSO2ArC(2)CH), 6.09 (1H, d, J 16.3, 
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C(2)H), 71.6 (2H, s, NSO2ArC(3)H), 7.42 (2H, t, J 7.1, C(4)ArC(3)H), 7.49-61 (1H, m, 





(126 MHz, CDCl3) C 14.3 (-CH2CH3), 23.8 (-CH(CH3)2), 24.8 (-CH(CH3)2), 30.2 
(SO2ArC(2)CH), 34.4 (SO2ArC(4)CH), 61.6 (-CH2CH3), 123.7 (NSO2ArC(3)), 128.8 
(C(4)ArC(3)) , 130.3 (C(4)ArC(2)), 132.4 (C(2)) 133.3 (C(4)ArC(4)), 134.2 (C(4)ArC(1)), 
136.2 (NSO2ArC(1)), 136.7 (C(3)), 150.0 (NSO2ArC(2)), 153.3 (NSO2ArC(4)), 164.6 (C(1)), 
173.8 (C(4)); HRMS (ESI+) C19H20NO4S ([M+H]
+





Following general procedure C with a modified work up, the reaction of (E)-ethyl 
4-(4-methoxyphenyl)-4-oxobut-2-enoate (0.77 g, 3.3 mmol), p-toluenesulfonamide (0.57 g, 
3.3 mmol), NEt3 (0.92 mL, 6.6 mmol) and TiCl4 (0.36 mL, 3.3 mmol) in CH2Cl2 (17 mL) was 
followed by aqueous work up. The reaction mixture was quenched with water (30 mL) and 
extracted with EtOAc (×3), dried over MgSO4, filtered, and concentrated in vacuo. The crude 
residue was purified by Biotage® Isolera™ 4 [SNAP Ultra 25 g, 75 mL min
−1
, 
hexane–EtOAc (75 : 25 2CV, 57 : 43 7CV)] to give the title compound 209 (1.08 g, 2.8 mmol, 
85%) as a thick yellow oil; 
1
H NMR (500 MHz, CDCl3) δH: 1.34 (3H, t, J 6.7, OCH2CH3), 
2.43 (3H, s, NTsCH3), 3.85 (3H, s, ArOCH3), 4.29 (2H, q, J 6.9, OCH2CH3), 6.18 (1H, d, J 
16.2, C(2)H), 6.90 (2H, d, J 8.2, NSO2ArH), 7.32 (2H, d, J 7.5, C(4) ArH), 7.75 (2H, d, J 7.0, 








5-7. Data for Dihydropyridinones 
General procedure D: one-pot isothiourea-mediated dihydropyridinone synthesis 
A flask containing a stirrer bar was charged with CH2Cl2 (to give 0.4 M acid], aryl acetic acid 
(2 eq.), (
i
Pr)2NEt (2 eq.) and cooled to 0 °C. Pivaloyl chloride (2 eq.) was added and the 
reaction stirred for 30 minutes. (−)-Tetramisole·HCl 211 (20 mol%) was added followed by 
the ketimine (1 eq.) and additional (
i
Pr)2NEt (1 eq.) in CH2Cl2 (to give 0.4 M of ketimine). 
The reaction was allowed to warm to rt and stirred until complete by TLC. The reaction was 
quenched with 0.1 M HCl (～20 mL/mmol acid), the layers separated and the aqueous layer 
extracted with CH2Cl2 (2 × eq. vol.). The combined organics were dried over MgSO4, the 
solvent removed in vacuo on a rotary evaporator (<30 °C bath temp.), and the residue purified 





Following general procedure D, the reaction of phenylacetic acid (1.36 g, 10.0 mmol), 
(
i
Pr)2NEt (1.73 mL, 10.0 mmol) and pivaloyl chloride (1.23 mL, 10.0 mmol) in CH2Cl2 (25 
mL), followed by (−)-tetramisole·HCl (0.24 g, 1.0 mmol, 20 mol%), ketimine 190 (1.72 g, 5.0 
mmol), (
i
Pr)2NEt (0.87 mL, 5.0 mmol) and CH2Cl2 (50 mL), for 1 h gave a crude residue of 
92 : 8 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 212 (1.48 g, 3.2 
mmol, 64%, 92 : 8 dr) as a white solid. 
mp. 128-129 ˚C; 
22
D][  ＋32.9 (c 0.55, CH2Cl2); Chiral HPLC, (Chiralpak IA, 20:80 IPA: 
hexane, flow rate 0.5 mL min
-1
, 254 nm, 30 ˚C) tR (3S, 4S): 13.2 min, tR (3R, 4R): 33.1 min, 
98% ee; max (ATR): 2970, 1722, 1448, 1155, 989 
1
H NMR (400 MHz, CDCl3) major 
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diastereomer δH 1.04 (3H, t, J 7.1, -CH2CH3), 3.75 (1H, dd, J 9.6, 4.8, C(4)H), 4.02 (2H, qq, J 
7.5, 3.7, -CH2CH3), 4.10 (1H, d, J 9.6, C(3)H), 5.87 (1H, d, J 4.8, C(5)H), 7.01 (2H, dd, J 6.4, 
2.4, C(3)ArC(3)H), 7.26-7.27 (3H, m, C(3)ArCH), 7.38-7.40 (5H, m, C(6)ArH), 7.50 (2H, t, J 
7.9, NSO2ArC(3)H), 7.65 (1H, t, J 7.4, NSO2ArC(4)H), 7.95 (2H, d, NSO2ArC(2)H); minor 





NMR (126 MHz, CDCl3) major diastereomer δC 13.9 (-CH2CH3), 45.1 (C(4)), 54.0 (C(3)), 
61.6 (-CH2CH3), 115.9 (C(5)), 126.1 (C(6)ArC), 128.0 (C(3)ArC), 128.5 (C(6)ArC), 128.6 
(C(3)ArC), 128.6 (C(6)ArC), 128.7 (NSO2ArC(3)), 128.8 (C(6)ArC), 129.4 (NSO2ArC(2)), 
134.0 (NSO2ArC(4)), 135.3 (C(3)ArC(1)), 136.6 (C(6)ArC(1)), 139.2 (NSO2ArC(1)), 141.3 




), found 462.1373, 





Following general procedure D, the reaction of p-tolylacetic acid (60.1 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
followed by (−)-tetramisole ·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 190 (68.7 mg, 0.2 
mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 92 : 
8 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 224 (63.2 mg, 0.13 
mmol, 66%, 94 : 6 dr) as a white solid. 
mp. 100-102 ˚C; 
22
D][  ＋31.1 (c 0.54, CH2Cl2); Chiral HPLC, (Chiralpak IA, 20:80 IPA: 
hexane, flow rate 0.5 mL min
-1
, 254 nm, 30 ˚C) tR (3S, 4S): 30.4 min, tR (3R, 4R): 55.2 min, 
98% ee; max (ATR): 2933, 1730, 1516, 1355, 1159, 929; 
1
H NMR (400 MHz, CDCl3) major 
diastereomer δH 1.06 (3H, t, J 7.1, -CH2CH3), 2.29 (3H, s, -CH3), 3.72 (1H, dd, J 9.7, 4.8, 
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C(4)H), 3.97-4.07 (3H, m, C(3)H and -CH2CH3), 5.84 (1H, d, J 4.8, C(5)H), 6.88 (2H, d, J 
8.1, C(3)ArC(2)H ), 7.07 (2H, d, J 7.9, C(3)ArC(3)H), 7.31-7.42 (5H, m, C(6)ArH), 7.49 (2H, 
t, J 7.4, NSO2ArC(3)H), 7.64 (1H, t, J 7.4, NSO2ArC(4)H), 7.94 (2H, d, NSO2ArC(2)H); 
minor diastereomer (selected) δH 1.17 (1H, t, J 7.1, -CH2CH3), 2.38 (3H, s, -CH3), 3.93 (1H, t, 





(126 MHz, CDCl3) major diastereomer δC 14.2 (-CH2CH3), 21.2 (-CH3), 45.2 (C(4)), 53.7 
(C(3)), 61.7 (-CH2CH3), 116.0 (C(5)), 126.2 (C(6)ArC), 128.5 (C(6)ArC), 128.6 (C(3)ArC(2)), 
128.7 (C(6)ArC), 128.9 (NSO2ArC(3)), 129.5 (NSO2ArC(2)), 129.6 (C(3)ArC(3)), 132.3 
(C(3)ArC(1)), 134.1 (NSO2ArC(4)), 136.7 (C(6)ArC(1)), 137.9 (C(3)ArC(4)), 139.2 










Following general procedure D, the reaction of m-tolylacetic acid (60.1 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 190 (68.7 mg, 0.2 
mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 92 : 
8 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 225 (69.6 mg, 0.15 
mmol, 72%, 93 : 7 dr) as a white solid. 
mp. 134-136 C; 
20
D][  +27.9 (c 0.64, CH2Cl2); Chiral HPLC (Chiralpak IA, 10:90 IPA : 
hexane, flow rate 1.0 mL min
-1
, 254 nm, 30 C) tR (3S, 4S): 22.7 min, tR (3R, 4R): 62.7 min, 
99% ee; max (ATR): 2922, 1726, 1516, 1359, 1155, 887; 
1
H NMR (500 MHz, CDCl3) major 
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diastereomer δH 1.05 (3H, t, J 7.1, -CH2CH3), 2.26 (3H, s, -CH3), 3.72 (1H, dd, J 9.5, 4.9, 
C(4)H), 3.98-4.07 (3H, m, C(3)H & -CH2CH3), 5.84 (1H, d, J 4.9, C(5)H), 6.79 (1H, d, J 7.8, 
C(3)ArC(6)H ), 7.05 (1H, d, J 7.6, C(3)ArC(4)H), 7.14 (1H, t, J 7.6, C(3)ArC(5)H), 7.33-7.42 
(5H, m, C(6)ArH), 7.50 (2H, t, J 7.9, NSO2ArC(3)H), 7.65 (1H, t, J 7.4, NSO2ArC(4)H), 7.94 
(2H, d, NSO2ArC(2)H); minor diastereomer (selected) δH 1.17 (1H, t, J 7.1, -CH2CH3), 2.22 





H} NMR (126 MHz, CDCl3) C 14.0 (-CH2CH3), 21.5 (-CH3), 45.2(C(4)), 53.9 
(C(3)), 61.7 (-CH2CH3), 115.8 (C(5)), 125.6 (C(3)ArC(6)), 126.1 (C(6)ArC)), 128.6 
(NSO2ArC(3)), 128.6 (C(6)ArC), 128.7 (C(3)ArC(5)), 128.9 (C(3)ArC(4)), 129.3 
(C(3)ArC(2)), 129.5 (NSO2ArC(2)), 134.1 (NSO2ArC(4)), 135.3 (4C(3)ArC(1)), 136.7 
(C(6)ArC(1)), 138.4 (C(3)ArC(3)), 139.2 (NSO2ArC(1)), 141.3 (C(6)), 170.8 (C(4)CO), 
172.0 (C(2)); HRMS (ESI+): C27H26NO5S [M+H]
+






Following general procedure D, the reaction of o-tolylacetic acid (60.1 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
followed by (−)-tetramisole ·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 190 (68.7 mg, 0.2 
mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 92 : 
8 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 226 (63.9 mg, 0.13 
mmol, 67%, 93 : 7 dr) as a white solid. 
mp. 78-80 C; 
20
D][  +45.8 (c 0.55, CH2Cl2); Chiral HPLC (Chiralpak IA, 10:90 IPA : 
hexane, flow rate 1.0 mL min
-1
, 254 nm, 30 C) tR (3S, 4S): 16.3 min, tR (3R, 4R): 56.5 min, 
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99% ee; max (film, cm-1): 2922, 1726, 1516, 1359, 1155, 887; 
1
H NMR (400 MHz, CDCl3) 
major diastereomer δH 1.00 (1H, t, J 7.1, -CH2CH3), 2.25 (3H, s, -CH3), 3.85 (1H, dd, J 10.9, 
4.3, C(4)H), 4.00 (2H, q, J 7.1, -CH2CH3), 4.31 (1H, d, J 10.9, C(3)H), 5.90 (1H, d, J 4.3, 
C(5)H), 6.80 (1H, d, J 7.8, C(3)ArC(3)H ), 7.09 (1H, td, J 7.8, C(3)ArC(4)H ), 7.12- 7.20(2H, 
m, C(3)ArC(5)H and C(3)ArC(6)H), 7.37-7.48 (5H, m, C(6)ArH), 7.51 (2H, td, J 7.6, 1.7, 
NSO2ArC(3)H), 7.67 (1H, t, J 7.1, 1.2, NSO2ArC(4)H), 7.97 (2H, d, J 8.6, NSO2ArC(2)H); 
minor diastereomer (selected) δH 1.09 (1H, t, J 7.1, -CH2CH3), 2.43 (3H, s, -CH3), 4.58 (1H, d, 




H} NMR (101 MHz, CDCl3) C 13.9 
(-CH2CH3), 19.8 (-CH3), 44.4(C(4)), 51.3 (C(3)), 61.7 (-CH2CH3), 116.5 (C(5)), 126.2 
(C(6)ArC)), 126.6 (C(3)ArC(4)), 128.2 (C(3)ArC(5)), 128.5 (C(3)ArC(3)), 128.6 (C(6)ArC), 
128.7 (C(6)ArC), 128.9 (C(3)ArC(4)), 129.0 (NSO2ArC(3)), 129.5 (NSO2ArC(2)), 130.9 
(C(3)ArC(6)), 133.0 (C(3)ArC(1)), 134.2 (NSO2ArC(4)), 136.6 (C(6)ArC(1)), 137.0 
(C(3)ArC(3)), 139.2 (NSO2ArC(1)), 141.3 (C(6)), 170.1 (C(4)CO), 172.2 (C(2)); HRMS 
(ESI+): C27H26NO5S [M+H]
+





Following general procedure D, the reaction of 2-naphthaleneacetic acid (74.5 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 190 (68.7 mg, 0.2 
mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 91 : 
9 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 227 (63.7 mg, 0.12 
mmol, 62%, 92 : 8 dr) as a white solid. 
mp. 178-180 ˚C; 
22
D][  ＋17.3 (c 0.55, CH2Cl2); Chiral HPLC (Chiralpak AD-H, 30:70 IPA: 
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hexane, flow rate 1.0 mL min
-1
, 254 nm, 30 ˚C) tR (3S, 4S): 18.6 min, tR (3R, 4R): 30.8 min, 
97% ee; max (ATR): 2978, 1774, 1446, 1359, 1166, 1124, 1097, 1012; 
1
H NMR (400 MHz, 
CDCl3) major diastereomer δH 0.95 (1H, t, J 7.1, -CH2CH3), 3.86 (1H, dd, J 9.9, 4.7, C(4)H), 
3.96 (2H, qq, J 10.8, 7.1-CH2CH3), 4.26 (1H, dd, J 9.9, C(3)H), 5.84 (1H, d, J 5.2, C(5)H), 
7.05 (1H,dd, J 8.5, 1.9, C(3)ArC(3)H), 7.34-7.57 (10H, m, ArH), 7.62-7.83 (4H, m, ArH), 
7.97 (2H, dd, J 6.8, 1.2, NSO2ArC(1)H); minor diastereomer (selected) δH 1.14 (1H, t, J 7.1, 





H} NMR (101 MHz, CDCl3) major diastereomer δC 14.0 (-CH2CH3), 45.2 
(C(4)), 54.3 (C(3)), 61.7 (-CH2CH3), 116.0 (C(5)), 126.0 (ArC), 126.2 (ArC), 126.4 
(C(3)ArC), 127.8 (ArC), 128.2 (ArC), 128.7 (ArC), 128.8 (ArC), 129.0 (ArC), 129.6 (ArC), 
132.8 (C(3)ArC(2)), 133.0 (C(3)ArC), 133.3 (C(3)ArC), 134.2 (NSO2ArC(4)), 136.7 










Following general procedure D, the reaction of 1-naphthaleneacetic acid (74.5 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 190 (68.7 mg, 0.2 
mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 91 : 
9 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave lactam 228 (70.8 mg, 
0.14 mmol, 69%, 92 : 8 dr) as a white solid. 
mp. 176-178 ˚C; 
22
D][  －14.7 (c 0.58, CH2Cl2); Chiral HPLC (Chiralpak IA, 10:90 IPA: 
 
168 
hexane, flow rate 1.0 mL min
-1
, 211 nm, 30 ˚C) tR (3S, 4S): 30.7 min, tR (3R, 4R): 98.1 min, 
97% ee; max (film, cm-1): 2978, 1721, 1446, 1166, 931; 
1
H NMR (400 MHz, CDCl3) major 
diastereomer δH 0.95 (1H, t, J 7.1, -CH2CH3), 3.89-4.06 (3H, m, C(4)H and -CH2CH3), 4.91 
(1H, d, J 8.6, C(3)H), 5.84 (1H, d, J 5.2, C(5)H), 7.12-7.20 (1H, m, C(3)ArH), 7.33-7.36 (1H, 
m, C(3)ArH), 7.39- 7.50 (5H, m, C(6)ArH), 7.50-7.56 (2H, t, J 7.4, NSO2ArC(2)H), 
7.66-7.72 (1H, m, NSO2ArC(3)H), 7.72-7.76 (1H, m, C(3)ArH),7.80 (1H, d, J 8.3, C(3)ArH), 
7.87 (1H, dd, J 6.8, 2.7, C(3)ArH), 7.99 (2H, dd, J 6.8, 1.2, NSO2ArC(1)H); minor 





NMR (126 MHz, CDCl3) major diastereomer δC 13.8 (-CH2CH3), 44.6 (C(4)), 531.3 (C(3)), 
61.7 (-CH2CH3), 115.8 (C(5)),  
123.2 (C(3)ArC), 125.2 (C(3)ArC), 125.9 (C(6)ArC), 126.2 (C(6)ArC), 126.7 (C(3)ArC), 
126.8 (C(3)ArC(7)), 128.6 (C(6)ArC), 128.6 (C(6)ArC), 128.9 (C(3)ArC), 129.1 (C(3)ArC), 
129.3 (C(3)ArC), 129.6 (Ar), 131.0 (C(3)ArC(2)), 131.7 (C(3)ArC(1)), 134.2 (NSO2ArC(4)), 










Following general procedure D, the reaction of 4-biphenylacetic acid (84.8 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 190 (68.7 mg, 0.2 
mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 92 : 
8 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 229 (82.2 mg, 0.15 
mmol, 76%, 92 : 8 dr) as a white solid. 
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mp. 72-74 C; 
22
D][  ＋16.2 (c 0.73, CH2Cl2); Chiral HPLC, (Chiralpak IA, 10:90 IPA: 
hexane, flow rate 1.0 mL min
-1
, 254 nm, 30 ˚C) tR (3S, 4S): 59.4 min, tR (3R, 4R): 77.6 min, 
97% ee; max (ATR): 2978, 1730, 1489, 1448, 1369, 1170, 1112, 1087, 916; 
1
H NMR (400 
MHz CDCl3) major diastereomer δH 1.06 (3H, t, J 7.1, -CH2CH3), 3.79 (1H, dd, J 9.9, 4.7, 
C(4)H), 4.03 (2H, q, J 7.1, -CH2CH3), 4.13 (1H, d, J 9.9, C(3)H), 5.89 (1H, d, J 4.7, C(5)H ), 
7.08 (2H, d, J 8.2, C(3)ArC(3)H), 7.27-7.57 (14H, m, ArH), 7.66 (1H, t, J 15.0, 1.1, 
NSO2ArC(4)H), 7.96 (2H, dd, J 8.5, 1.0, NSO2ArC(2)H); minor diastereomer (selected) δH 
1.18 (3H, t, J 7.1, -CH2CH3), 3.97 (1H, t, J 5.3, C(4)H), 4.33 (1H, d, J 5.4, C(3)H), 6.02-6.35 




H} NMR (101 MHz, CDCl3) major diastereomer C 14.0 (-CH2CH3), 
45.3(C(4)), 53.9 (C(3)), 61.8 (-CH2CH3), 116.1 (C(5)), 126.2 (ArC), 127.2  (ArC), 127.6  
(ArC), 128.6 (ArC), 128.7 (ArC), 128.9 (ArC), 129.0 (ArC), 129.1 (C(3)ArC(3)), 129.5 
(NSO2ArC(2)), 134.2 (NSO2ArC(4)), 134.4 (C(3)ArC(1)), 136.6 (C(6)ArC(1)), 139.2 
(NSO2ArC(1)), 140.6 (C(3)C), 141.1 (C(3)C), 141.4 (C(6)), 170.9 (C(4)CO, 172.1 (C(2)); 
HRMS (ESI+) C32H28NO5S ([M+H]
+





Following general procedure D the reaction of 4-methoxyphenylacetic acid (66.4 mg, 0.4 
mmol), (
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 
mL), followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 190 (68.7 mg, 
0.2 mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 
92 : 8 dr. Purification by flash chromatography (Et2O–pet. ether, 2 : 3) gave 230 (75.5 mg, 
0.15 mmol, 74%, 92 : 8 dr) as a white solid. 
mp. 152-154 ˚C; 
22
D][  ＋28.9 (c 0.54, CH2Cl2); Chiral HPLC, (Chiralpak AD-H, 20:80 IPA: 
 
170 
Chexane, flow rate 1.0 mL min
-1
, 254 nm, 30 ˚C) tR (3S, 4S): 25.5 min, tR (3R, 4R): 42.8 min, 
98% ee; max (ATR): 2960, 1732, 1716, 1514, 1165, 920; 
1
H NMR (500 MHz, CDCl3) major 
diastereomer δH 1.06 (3H, t, J 7.1, -CH2CH3), 3.71 (1H, dd, J 10.0, 4.6, C(4)H), 3.76 (3H, s, 
-OCH3), 3.97-4.06 (3H, m, C(3)H and -CH2CH3), 5.86 (1H, d, J 4.6, C(5)H), 6.76-6.84 (2H, 
m, C(3)ArC(3)H ), 6.88-6.96 (2H, m, C(3)ArC(2)H), 7.31-7.43 (5H, m, C(6)ArH), 7.46-7.54 
(2H, m, NSO2ArC(3)H), 7.65 (1H, m, NSO2ArC(4)H), 7.90-7.97(2H, m, NSO2ArC(2)H); 
minor diastereomer (selected) δH 1.17 (3H, t, J 7.1, -CH2CH3), 3.91 (1H, dd, J 5.2, C(4)H), 
3.76 (3H, s, -OCH3), 4.11 (2H,dtt, J 10.8, 7.2, 3.7, -CH2CH3), 4.23 (1H, d, J 5.6, C(3)H), 6.19 




H} NMR (126 MHz, CDCl3) major diastereomer δC 14.1 (-CH2CH3), 45.4 (C(4)), 53.6 
(C(3)), 53.5 (C(5)), 61.7 (-CH2CH3), 114.2 (C(3)ArC(3)), 116.2 (C(5)), 126.2 (C(6)ArC), 
127.3 (C(3)ArC(1)), 128.6 (C(6)ArC), 128.6 (C(6)ArC), 128.9 (NSO2ArC(3)), 129.5 
(NSO2ArC(2)), 134.1 (NSO2ArC(4)), 136.7 (C(6)ArC(1)), 139.2 (NSO2ArC(1)), 141.2 (C(6)), 
159.4 (C(3)ArC(4)), 171.0 (C(4)CO) 172.3 (C(2)); HRMS (ESI+) C27H26NO6S ([M+H]
+
), 





Following general procedure D, the reaction of 3,4-dimethoxyphenylacetic acid (78.4 mg, 0.4 
mmol), (
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 
mL), followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 190 (68.7 mg, 
0.2 mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 
93 : 7 dr. Purification by flash chromatography (Et2O–pet. ether, 2 : 3) gave 231 (81.0 mg, 
0.16 mmol, 78%, 97 : 3 dr) as a white solid. 
 
171 
mp. 126-128 ˚C; 
22
D][  ＋32.6 (c 0.53, CH2Cl2); Chiral HPLC, (Chiralpak IA, 30:70 IPA: 
hexane, flow rate 0.5 mL min
-1
, 254 nm, 30 ˚C) tR (3S, 4S): 38.0 min, tR (3R, 4R): 53.5 min, 
98ee; max (ATR): 2937, 1782, 1593, 1516, 1448, 1367, 1298, 1224, 1143, 1087, 1026, 979; 
1
H NMR (500 MHz, CDCl3) major diastereomer δH 1.08 (3H, t, J 7.1, -CH2CH3), 3.72 (1H, 
dd, J 9.8, 4.8, C(4)H), 3.75 (3H, s, C(3)Ar(3)OCH3), 3.83 (3H, s, C(3)Ar(4)OCH3), 3.94-4.11 
(3H, m, C(3)H and -CH2CH3), 5.86 (1H, d, J 4.7, C(5)H), 6.50 (1H, d, J 1.9, C(3)ArC(2)H), 
6.58 (1H, dd, J 8.2, 2.0, C(3)ArC(6)H), 6.75 (1H, d, J 8.3, C(3)ArC(5)H), 7.35-7.40 (5H, m, 
C(6)ArH), 7.40 (2H, t, J 7.9, NSO2ArC(3)H), 7.64 (1H, t, J 7.5, NSO2ArC(4)H), 7.95 (2H, d, 
J 7.4, NSO2ArC(2)H); minor diastereomer (selected) δH 1.16 (1H, t, J 7.1, -CH2CH3), 3.66 
(3H, s, C(3)Ar(3)OCH3), 3.79 (3H, s, C(3)Ar(4)OCH3), 4.22 (1H, d, J 5.1, C(3)H ), 6.15-6.20 




H} NMR (101 MHz, CDCl3) major diastereomer δC 14.1 (-CH2CH3), 
45.3 (C(4)), 53.7 (C(3)), 56.0 (OCH3), 61.7 (-CH2CH3), 111.2 (C(3)ArC(5)), 111.6 
(C(3)ArC(2)), 116.0 (C(5)), 121.1 (C(3)ArC(6)), 126.1 (C(6)ArC), 127.7 (C(3)ArC(1)), 128.6 
(NSO2ArC(3)), 128.7 (C(6)ArC), 129.0 (C(6)ArC), 129.5 (NSO2ArC(2)), 134.1 
(NSO2ArC(4)), 136.7 (C(6)ArC(1)), 139.3 (NSO2ArC(1)), 141.3 (C(6)), 148.9 (C(3)ArC(4)), 
149.0 (C(3)ArC(3)), 170.9 (C(4)CO), 172.2 (C(2)); HRMS (ESI
+
): C28H31NO7S ([M+ NH4]
+
), 





Following general procedure D, the reaction of 4-(dimethylamino) phenylacetic acid (71.7 mg, 
0.4 mmol), (
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 
(1.0 mL), followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 190 
(68.7 mg, 0.2 mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude 
 
172 
residue of 92 : 8 dr. Purification by flash chromatography (Et2O–pet. ether, 2 : 3) gave 232 
(80.3 mg, 0.16 mmol, 80%, 93 : 7 dr) as a white solid. 
mp. 178-180 ˚C; 
22
D][  ＋30.6 (c 0.51, CH2Cl2); Chiral HPLC, (Chiralpak IA, 10:90 IPA: 
hexane, flow rate 1.0 mL min
-1
, 254 nm, 30 ˚C) tR (3S, 4S): 30.4 min, tR (3R, 4R): 55.2 min, 
99% ee; max (ATR): 2933, 1730, 1516, 1355, 1159, 929; 
1
H NMR (400 MHz, CDCl3) major 
diastereomer δH 1.09 (3H, t, J 7.1, -CH2CH3), 2.90 (6H, s, N(CH3)2), 3.68 (1H, dd, J 9.4, 5.0, 
C(4)H), 3.95-4.08 (3H, m, C(3)H and -CH2CH3), 5.85 (1H, d, J 5.0, C(5)H), 6.59 (2H, d, J 
8.8, C(3)ArC(3)H ), 6.85 (2H, d, J 8.7, C(3)ArC(2)H), 7.36-7.40 (5H, m, C(6)ArH), 7.45-7.53 
(2H, m, NSO2ArC(3)H), 7.64 (1H, tt, J 7.1, 1.2, NSO2ArC(4)H), 7.94 (2H, d, J 8.5, 
1.2,NSO2ArC(2)H); minor diastereomer (selected) δH  1.18 (3H, t, J 7.1, -CH2CH3), 2.86 
(6H, s, N(CH3)2), 3.89-3.93 (1H, m, C(4)H), 4.07-4.16 (2H, m, -CH2CH3), 4.20 (1H, d, J 5.8, 





H} NMR (126 MHz, CDCl3) major diastereomer δC 14.1 (-CH2CH3), 
40.6 (N(CH3)2), 45.4 (C(4)), 53.3 (C(3)), 61.6 (-CH2CH3), 112.7 (C(3)ArC(2)), 116.2 (C(5)), 
122.7 (C(3)ArC(1)), 126.2 (C(6)ArC), 128.6 (C(6)ArC), 128.6 (C(6)ArC), 128.8 
(NSO2ArC(3)), 129.3 (NSO2ArC(2)), 129.5 (C(3)ArC(3)), 134.0 (NSO2ArC(4)), 136.9 
(C(6)ArC(1)), 139.4 (NSO2ArC(1)), 141.2 (C(6)), 150.3 (C(3)ArC(4)), 171.1 (C(4)CO), 










Following general procedure D, the reaction of 4-bromophenylacetic acid (86.0 mg, 0.4 
mmol), (
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 
 
173 
mL), followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 190 (68.7 mg, 
0.2 mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 2 h gave a crude residue of 
92 : 8 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 234 (64.6 mg, 
0.13 mmol, 60%, 94 : 6 dr) as a white solid. 
mp. 140-142 C; 
22
D][  ＋31.1 (c 0.54, CH2Cl2); max (ATR): 2976, 1726, 1710, 1448, 1168, 
925; Chiral HPLC, (Chiralpak IA, 30:70 IPA: hexane, flow rate 0.5 mL min
-1
, 254 nm, 30 ˚C) 
tR (3S, 4S): 30.4 min, tR (3R, 4R): 45.8 min, 95% ee; 
1
H NMR (400 MHz, CDCl3) major 
diastereomer δH 1.07 (1H, t, J 7.1, -CH2CH3), 3.72 (1H, dd, J 10.5, 4.2, C(4)H), 3.94-4.09 
(3H, m, C(3)H and -CH2CH3), 5.85 (1H, d, J 4.5, C(5)H ), 6.87 (2H, d, J 8.4, C(3)ArC(2)H ), 
7.32-7.44 (7H, m, C(3)ArC(3)H and C(6)ArH), 7.46-7.55 (2H, m, NSO2ArC(3)H), 7.66 (1H, 
tt, J 7.1, 1.2, NSO2ArC(4)H), 7.93 (2H, d, J 8.5, NSO2ArC(2)H); minor diastereomer 
(selected) δH 1.17 (1H, t, J 7.1, -CH2CH3), 3.90 (1H, t, J 5.4, C(4)H), 4.13 (2H, qt, J 7.1, 3.7, 




H} NMR (101 
MHz, CDCl3) major diastereomer δC 14.0 (-CH2CH3), 45.1(C(4)), 53.6 (C(3)), 61.9 
(-CH2CH3), 115.9 (C(5)), 122.3 (C(3)ArC(4)), 126.2 (C(6)ArC), 128.7 (C(6)ArC), 128.7 
(C(6)ArC), 129.1 (NSO2ArC(3)), 129.5 (NSO2ArC(2)), 130.5 (C(3)ArC(2)), 132.0 
(C(3)ArC(3)), 134.3 (NSO2ArC(4)), 134.4 (C(3)ArC(1)), 136.4 (C(6)ArC(1)), 139.1 
(NSO2ArC(1)), 141.4 (C(6)), 170.6 (C(4)CO), 171.7 (C(2)); HRMS (ESI+) C26H23NO5S 
([M+H]
+





Following general procedure D, the reaction of 4-chlorophenylacetic acid (68.2 mg, 0.4 
mmol), (
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 
 
174 
mL), followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 190 (68.7 mg, 
0.2 mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 3 h gave a crude residue of 
92 : 8 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 235 (53.5 mg, 
0.11 mmol, 54%, 94 : 6 dr) as a white solid. 
mp. 136-138 C; 
22
D][  ＋33.3 (c 0.55, CH2Cl2); max (ATR): 2978, 1724, 1683, 1448, 1367, 
1168, 1087, 921; Chiral HPLC, (Chiralpak IA, 30:70 IPA: hexane, flow rate 0.5 mL min
-1
, 
254 nm, 30 ˚C) tR (3S, 4S): 26.6 min, tR (3R, 4R): 42.0 min, 95% ee; 
1
H NMR (400 MHz, 
CDCl3) major diastereomer δH 1.06 (1H, t, J 7.1, -CH2CH3), 3.72 (1H, dd, J 10.5, 4.2, C(4)H), 
3.94-4.09 (3H, m, C(3)H and -CH2CH3), 5.86 (1H, d, J 4.5, C(5)H ), 6.93 (2H, d, J 8.4, 
C(3)ArC(2)H), 7.25 (2H, d, J 8.5, C(3)ArC(3)H), 7.35-7.39 (5H, m, C(6)ArH), 7.46-7.54 (2H, 
m, NSO2ArC(3)H), 7.66 (1H, tt, J 7.1, 1.2, NSO2ArC(4)H), 7.93 (2H, dd, J 8.5, 1.2, 
NSO2ArC(2)H); minor diastereomer (selected) δH 1.17 (1H, t, J 7.1, -CH2CH3), 3.90 (1H, t, J 





H} NMR (126 MHz, CDCl3) major diastereomer δC 14.0 (-CH2CH3), 
45.1(C(4)), 53.6 (C(3)), 61.9 (-CH2CH3), 116.0 (C(5)), 126.2 (C(6)ArC), 128.7 (C(6)ArC), 
128.7 (NSO2ArC(3)), 129.1 (C(3)ArC(3)), 129.1 (C(6)ArC), 129.5 (NSO2ArC(2)), 130.2 
(C(3)ArC(2)), 133.9 (C(3)ArC(4)), 134.2 (C(3)ArC(1)), 134.3 (NSO2ArC(4)), 136.4 
(C(6)ArC(1)), 139.1 (NSO2ArC(1)), 141.4 (C(6)), 170.7 (C(4)CO), 171.8 (C(2)); HRMS 
(ESI+) C26H23NClO5S ([M+H]
+





Following general procedure D, the reaction of 3-thiophenylacetic acid (56.9 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
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followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 190 (68.7 mg, 0.2 
mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 85 : 
15 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 236 (59.7 mg, 0.13 
mmol, 64%, 92 : 8 dr) as a white solid. 
mp. 112-114 ˚C; 
22
D][  ＋29.3 (c 0.59, CH2Cl2); Chiral HPLC, (Chiralpak IA, 20:80 IPA: 
hexane, flow rate 0.5 mL min
-1
, 254 nm, 30 ˚C) tR (3S, 4S): 40.3, tR (3R, 4R): 72.1, 97% ee; 
max (ATR): 2924, 1728, 1448, 1357, 1303, 1219, 1165, 1120, 1083, 1056, 1029, 1001, 842; 
1
H NMR (400 MHz, CDCl3) major diastereomer δH 1.14 (3H, t, J 7.1, -CH2CH3), 3.68 (1H, 
dd, J 8.1, 5.5, C(4)H), 4.08 (2H, qq, J 7.4, 3.6, -CH2CH3), 4.24 (1H, dd, J 8.1, C(3)H), 5.85 
(1H, d, J 5.5, C(5)H), 6.77 (1H, dd, J 5.0, 1.3, C(3)ArC(5)H ), 7.03 (1H, ddd, J 2.9, 1.3, 0.6, 
C(3)ArC(2)H), 7.23-7.26 (1H, m, C(3)ArC(4)H), 7.34-7.37 (5H, m, C(6)ArH), 7.43-7.54 (2H, 
m, NSO2ArC(3)H), 7.64 (1H, tt, J 7.4, 1.2, NSO2ArC(4)H), 7.92 (2H, dd, J 8.5, 1.2, 
NSO2ArC(2)H); minor diastereomer (selected) δH 3.90 (1H, dd, J 4.7, C(4)H), 4.40 (1H, dd, J 
4.7, C(3)H), 6.18 (1H, d, J 4.7, 0.8, C(5)H), 6.91 (1H, dd, J 5.0, 1.3, C(3)ArC(5)H ), 7.08 (1H, 





(126 MHz, CDCl3) major diastereomer δC 14.1 (-CH2CH3), 44.6 (C(4)), 49.2 (C(3)), 61.8 
(-CH2CH3), 115.3 (C(5)), 123.6 (C(3)ArC(4)), 126.1 (C(6)ArC), 126.5 (C(3)ArC(5)), 126.9 
(C(3)ArC(2)), 128.6 ((C(9)), 128.6 (C(6)ArC), 128.9 (C(6)ArC), 129.4 (NSO2ArC(2)), 134.1 
(NSO2ArC(4)), 134.9 (C(3)ArC(1)), 136.6 (C(6)ArC(1)), 139.1(NSO2ArC(1)), 141.4 ((C(6)), 
170.7 ((C(4)CO)), 171.0 (C(2)); HRMS (ESI
+
): C24H22NO5S ([M+ H]
+
), found 468.0934, 
requires 468.0933 (－0.2 ppm)). 
 
The racemic reaction was repeated using ketimine 190 (172.0 mg, 0.5 mmol) and 
(±)-tetramisoleHCl (24.0 mg, 0.1 mmol, 10 mol %) under the above conditions, then 
recrystallisation (Et2O) giving 236 (68.7 mg, 0.15 mmol, 29%). Spectral data of 236 identical 






Following general procedure D, the reaction of (E)-pent-3-enoic acid (82 μL, 0.8 mmol), 
(
i
Pr)2NEt (140 μL, 0.8 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (2.0 mL), 
followed by (−)-tetramisole·HCl (19.2 mg, 0.08 mmol, 20 mol%), ketimine 190 (137.2 mg, 
0.4 mmol), (
i
Pr)2NEt (70 μL, 0.4 mmol) and CH2Cl2 (4.0 mL), for 1 h gave a crude residue of 
92 : 8 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 9) gave 237 (89.5 mg, 
0.21 mmol, 53%, 88 : 12 dr) as a white solid. 
mp. 56-58 ˚C; 
22
D][  ＋67.0 (c 0.53, CH2Cl2); Chiral HPLC, (Chiralpak OD-H, 5:95 IPA: 
hexane, flow rate 1.0 mL min
-1
, 211 nm, 30 ˚C) tR (3S, 4R): 15.8 min, tR (3R, 4S): 19.5 min, 
98% ee; max (ATR): 2976, 1732, 1448, 1367, 1170, 1085, 1026, 926; 
1
H NMR (400 MHz, 
CDCl3) major diastereomer δH 1.25 (3H, t, J 7.1, -CH2CH3), 1.66 (3H, dd, J 6.3, 1.4, 
C(3)CHCHCH3), 3.37 (1H, dd, J 8.4, 5.4, C(4)H), 3.47 (1H, t, J 8.2, C(3)H), 4.15 (2H, qd, J 
7.1, 1.4, -CH2CH3), 5.30 (1H, ddq, J 15.1, 8.1, 1.5, C(3)CH), 5.64 (1H, m, C(3)CHCH) , 5.80 
(1H, d, J 5.4, C(5)H), 7.30-7.38 (5H, m, C(6)ArH), 7.44-7.51 (2H, m, NSO2ArC(3)H), 7.62 
(1H, tt, J 7.0, 1.2, NSO2ArC(4)H), 7.90 (2H, dt, J 8.6, 1.5, NSO2ArC(2)H); minor 
diastereomer (selected) δH 1.25 (3H, t, J 7.1, -CH2CH3), 1.61-1.64 (3H, m, C(3)CHCHCH3), 




H} NMR (101 MHz, CDCl3) major diastereomer δC 14.3 (-CH2CH3), 18.2 
(C(3)CHCHCH3), 43.7 (C(4)), 51.5 (C(3)), 61.7 (-CH2CH3), 115.7 (C(5)), 123.8 
(C(3)CHCHCH3) 126.1 (C(6)ArC), 128.5 (C(6)ArC), 128.6 (NSO2ArC(3)), 128.8 (C(6)ArC), 
129.4 (NSO2ArC(2)), 132.1 (C(3)CHCHCH3), 134.1 (NSO2ArC(4)), 136.9 (C(6)ArC(1)), 










Following general procedure D, the reaction of phenylacetic acid (1.36 g, 10.0 mmol), 
(
i
Pr)2NEt (1.73 mL, 10.0 mmol) and pivaloyl chloride (1.23 mL, 10.0 mmol) in CH2Cl2 (25 
mL), followed by (−)-tetramisole·HCl (0.24 g, 1.0 mmol, 20 mol%), ketimine 191 (1.79 g, 5.0 
mmol), (
i
Pr)2NEt (0.87 mL, 5.0 mmol) and CH2Cl2 (50 mL), for 1 h gave a crude residue of 
92 : 8 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 240 (1.47 g, 3.1 
mmol, 62%, 93 : 7 dr) as a white solid. Further recrystallisation (Et2O) gave 240 as a single 
diastereoisomer (0.80 g, 1.68 mmol, 33%) as a white solid. 
mp. 129-130 C; 
20
D][  +50.2 (c 0.49, CH2Cl2); Chiral HPLC (Chiralpak IA, 30:70 IPA : 
hexane, flow rate 0.5 mL min
-1
, 254 nm, 30 C) tR (3S, 4S): 20.0 min, tR (3R, 4R): 40.6 min, 
>99% ee; max (film, cm-1): 2978, 1726, 1363, 1166, 927; 
1
H NMR (500 MHz, CDCl3) major 
diastereomer δH 1.08 (3H, t, J 7.1, -CH2CH3), 2.49 (3H, s, -CH3), 3.79 (1H, dd, J 9.6, 4.8, 
C(4)H), 4.05 (2H, qq, J 7.0, 3.7, -CH2CH3), 4.13 (1H, d, J 9.6, C(3)H), 5.89 (1H, d, J 4.8, 
C(5)H), 7.06 (2H, dd, J 6.9, 2.2, C(3)ArC(3)H), 7.30-7.33 (8H, m, ArH), 7.40-7.45 (2H, d, J 




H} NMR (101 MHz, CDCl3) C 
14.0 (-CH2CH3), 21.9 (-CH3), 45.3 (C(4)), 54.1 (C(3)), 61.7 (-CH2CH3), 115.8 (C(5)), 126.2 
(ArC), 128.1 (ArC), 128.6 (ArC), 128.7 (ArC), 128.8 (ArC), 128.9 (ArC), 129.3 (ArC), 129.6 
(ArC), 135.5, 136.4, 136.8, 141.4, 145.3, 170.9 (C(4)CO), 172.0 (C(2)); HRMS (ESI+): 
C29H26NO5S ([M+H]
+
), found 476.1526, requires 476.1526 (－ 0.0 ppm)). 
 
The racemic reaction was repeated using ketimine 191 (1.79 g, 5 mmol) and 
(±)-tetramisoleHCl (0.24 g, 1.0 mmol, 20 mol %) under the above conditions, then 
recrystallisation (Et2O) giving 240 (0.72 mg, 1.5 mmol, 30%). Spectral data of 240 identical 






Following general procedure D, the reaction of phenylacetic acid (55 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (49 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 209 (77 mg, 0.2 
mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 24 h gave a crude residue of 
90 : 10 dr. Purification by flash chromatography (Et2O–pet. ether, 40 : 60) gave 241 (59 mg, 
0.12 mmol, 58%, 90 : 10 dr) as a white solid. 
mp. 132-134 C; 
20
D][  ＋32.5 (c 0.52, CH2Cl2); Chiral HPLC (Chiralpak IA, 30:70 IPA : 
hexane, flow rate 1.0 mL min
-1
, 254 nm, 30 C) tR (3S, 4S): 14.1 min, tR (3R, 4R): 22.4 min, 
99% ee; max (ATR): 2929, 1718, 1606, 1501, 1361, 1161, 926; 
1
H NMR (500 MHz, CD2Cl2) 
major diastereomer δH 1.02 (3H, t, J 7.1, -CH2CH3), 2.45 (3H, s, NSO2ArC(4)CH3) 3.64 (1H, 
dd, J 9.8, 4.8, C(4)H), 3.82 (3H, s, -OCH3), 3.97 (2H, q, J 7.1, -CH2CH3), 4.02 (1H, d, J 9.9, 
C(3)H), 5.75 (1H, d, J 4.8, C(5)H), 6.88-6.91 (4H, m, C(3)ArC(3)H & C(6)ArC(3)H), 
7.23-7.24 (3H, m, C(3)ArC(2)H & C(3)ArC(4)H), 7.33-7.35 (4H, m, NSO2ArC(2)H & 
C(6)ArC(2)H), 7.76-7.79 (2H, m, NSO2ArC(3)H); minor diastereomer (selected) δH 1.55 (3H, 





H} NMR (101 MHz, CD2Cl2) C 14.2 (-CH2CH3), 22.0 (-NSO2ArC(4)CH3), 
45.4(C(4)), 53.8 (-OCH3), 55.4 (C(3)), 62.0 (-CH2CH3), 114.2 (C(6)ArC(2)), 114.7 (C(5), 
127.7.6 (C(3)ArC(4)), 128.3 (C(6)ArC(1)), 129.0 (C(3)ArC), 129.7 (NSO2ArC), 136.2 
(C(3)ArC(1)), 141.3 (C(6)), 146.1 (NSO2ArC(4)), 154.0 (NSO2ArC(1)), 160.6 (C(6)ArC(4)), 
171.2 (C(4)CO), 172.3 (C(2)) HRMS (ESI+): C28H28NO6S ([M+H]
+
), found 506.1625, 






Following general procedure D, the reaction of 4-(dimethylamino) phenylacetic acid (71.7 mg, 
0.4 mmol), (
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 
(1.0 mL), followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 209 
(77.5 mg, 0.2 mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude 
residue of 95 : 5 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 242 
(52.0 mg, 0.095 mmol, 47%, 88 : 12 dr) as a white solid. 
mp. 144-146 C; 
20
D][  ＋23.8 (c 0.55, CH2Cl2); Chiral HPLC (Chiralpak IA, 30:70 IPA : 
hexane, flow rate 1.0 mL min
-1
, 254 nm, 30 C) tR (3S, 4S): 16.7 min, tR (3R, 4R): 19.9 min, 
91% ee; max (ATR): 2926, 1728, 1610, 1512, 1361, 1247, 1165, 1087, 1027, 812; 
1
H NMR 
(500 MHz, CD2Cl2) major diastereomer δH 1.08 (3H, t, J 7.1, -CH2CH3), 2.47 (3H, s, 
NSO2ArC(4)CH3), 2.89 (6H, s, -N(CH3)2), 3.60 (1H, dd, J 9.5, 5.0, C(4)H), 3.84 (3H, s, 
-OCH3), 3.92 (1H, d, J 9.5, C(3)H), 4.01 (2H, qd, J 7.1, 3.9, -CH2CH3), 5.76 (1H, d, J 5.0, 
C(5)H), 6.57 (2H, d, J 8.8, C(3)ArC(3)H), 6.75 (2H, d, J 8.7, C(3)ArC(2)H), 6.82-6.98 (2H, 
m, C(6)ArC(3)H), 7.25-7.43 (4H, m, NSO2ArC(3)H and C(6)ArC(2)H), 7.79 (2H, d, J 8.4, 





H} NMR (126 MHz, CD2Cl2) C 14.3 (-CH2CH3), 22.0 (-NSO2ArC(4)CH3), 
40.3 (-N(CH3)2), 45.4(C(4)), 53.5 (C(3)), 55.8 (-OCH3), 61.9 (-CH2CH3), 114.2 (C(6)ArC(3)), 
114.9 (C(5), 123.2 (C(3)ArC(1)), 127.7.6 (C(6)ArC(2)), 129.5 (C(3)ArC(2)), 129.6 
(NSO2ArC(2)), 129.7 (NSO2ArC(3)), 130.1 (C(6)ArC(1)), 136.9 (NSO2ArC(1), 141.1 (C(6)), 
145.9 (NSO2ArC(4)), 150.7 (C(3)ArC(4)), 160.5 (C(6)ArC(4)), 171.4 (C(4)CO), 172.9 (C(2)); 
HRMS (ESI+): C30H33N2O6S ([M+H]
+
), found 549.2017, requires 549.1054 (－1.2 ppm). 
 
180 
Ethyl (4S,5S)-6-oxo-4,5-diphenyl-1-tosyl-1,4,5,6-tetrahydropyridine-2-carboxylate, 243 
 
Following general procedure D, the reaction of phenylacetic acid (54.5 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
followed by DHPB (7.6 mg, 0.04 mmol, 20 mol%), ketimine 208 (71.6 mg, 0.2 mmol), 
(
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 59 : 41 dr. 
Purification by flash chromatography (Et2O–petrol, 1 : 4) gave 243 (37.9 mg, 0.08 mmol, 
40%, 54 : 46 dr) as a white solid 
mp. 118–120 °C; νmax (ATR): 2987, 1724, 1597, 1363, 1170, 1085, 1028; 
1
H NMR (300 
MHz, CDCl3,) both diastereoisomers δH: 1.37–1.43 (3H, m, OCH2CH3), 2.44 (3H, s, 
NTsCH3), 3.85 (1H, d, J 10.2, CH), 4.03 (1H, d, J 5.8, CH), 4.08 (2H, q, J 5.3, 4.5, 
OCH2CH3), 4.28–4.52 (3H, m, OCH2CH3 and CH), 6.54–6.63 (1H, m, ArH), 6.65 (1H, d, J 
4.2, ArH), 6.69 (1H, d, J 6.0, ArH), 6.85 (1H, dd, J 7.9, 1.5, ArH), 6.87–6.94 (1H, m, ArH), 
7.00 (1H, dd, J 7.4, 5.8, ArH), 7.04–7.13 (2H, m, ArH), 7.12–7.25 (7H, m, ArH), 7.32 (2H, t, 




H} NMR (101 MHz, 
CD2Cl2) δC: 13.9, 21.5, 44.1, 44.5, 55.9, 57.2, 62.2, 126.9, 127.5, 127.6, 127.7, 127.8, 127.9, 
127.9, 128.5, 128.5, 128.8, 128.8, 128.9, 129.3, 129.3, 129.4, 129.5 129.6, 129.9, 131.9, 132.8, 
133.2, 135.4, 135.7, 138.8, 145.8, 170.2, 170.9; HRMS (ESI+): C27H26NO5S ([M+H]+) found 












Following general procedure D, the reaction of phenylacetic acid (54.5 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 195 (68.7 mg, 0.2 
mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 91 : 
9 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 244 (47.1 mg, 0.12 
mmol, 59%, 92 : 8 dr) as a white solid. 
mp. 131-132 C; 
20
D][  －6.3 (c 0.51, CH2Cl2); Chiral HPLC (Chiralpak IA, 5:95 IPA : 
hexane, flow rate 0.5 mL min
-1
, 254 nm, 30 C) tR (3S, 4S): 41.5 min, tR (3R, 4R): 45.0 min, 
99% ee; max (ATR): 2916, 1708, 1653, 1496, 1446, 1344, 1165, 1151, 1118, 960; 
1
H NMR 
(500 MHz, CDCl3) major diastereomer δH 1.18 (1H, t, J 7.1, -CH2CH3), 3.46 (3H, s, -CH3), 
3.78 (1H, t, J 6.3, C(4)H), 4.14 (2H, q, J 7.1, -CH2CH3), 4.26 (1H, d, J 6.3, C(3)H), 5.76 (1H, 
d, J 6.2, C(5)H), 7.20-7.48 (10H, m, ArC); minor diastereomer (selected) δH 3.50 (3H, s, 




H} NMR (101 MHz, 
CDCl3) C 14.1 (-CH2CH3), 43.9 (-CH3), 44.9 (C(4)), 53.2 (C(3)), 62.0 (-CH2CH3), 114.3 
(C(5)), 125.5 (ArC), 128.2 (ArC), 128.3 (ArC), 128.8 (ArC), 129.9 (ArC),129.1 (ArC), 135.0 
(C(3)ArC(1)), 137.0 (C(6)ArC(1)), 141.2 (C(6)), 171.2 (C(4)CO), 173.0 (C(2)); HRMS 
(ESI+): C21H22NO5S [M+H]
+
 found 400.1216, requires 400.1213 (0.7 ppm). 
 
The racemic reaction was repeated using ketimine 195 (0.141 g, 0.5 mmol) and 
(±)-tetramisoleHCl (0.24 g, 1.0 mmol, 20 mol %) under the above conditions, then 







Following general procedure D, the reaction of phenylacetic acid (54.5 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 193 (68.7 mg, 0.2 
mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 95 : 
5 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 245 (58.2 mg, 0.12 
mmol, 59%, 90 : 10 dr) as a white solid. 
mp. 114-115 C; 
20
D][  +18.1 (c 0.52, CH2Cl2); Chiral HPLC (Chiralpak AD-H, 30:70 IPA : 
hexane, flow rate 1.0 mL min
-1
, 254 nm, 30 C) tR (3S, 4S): 17.5 min, tR (3R, 4R): 55.6 min, 
99% ee; max (ATR): 2976, 1720, 1593, 1531, 1496, 1446, 1365, 1303, 1261, 1161, 1087, 
1024, 979; 
1
H NMR (400 MHz, CDCl3) major diastereomer δH 1.04 (3H, t, J 7.1, -CH2CH3), 
3.74 (1H, dd, J 9.7, 4.8, C(4)H), 3.89 (3H, s, -OCH3), 4.01 (2H, qd, J 7.1, 1.7, -CH2CH3), 
4.08 (1H, d, J 9.7, C(3)H), 5.83 (1H, d, J 4.8, C(5)H), 6.93 (2H, dq, J 9.1, 2.4, 1.9, 
NSO2ArC(3)H), 7.01-7.07 (2H, m, C(3)ArC(2)H), 7.26-7.30 (3H, m, C(3)ArCH), 7.34-7.42 
(5H, m, C(6)ArCH), 7.87 (2H, dq, J 9.1, 2.4, 1.9, NSO2ArC(2)H); minor diastereomer 





H} NMR (126 MHz, CDCl3) C 14.0 (-CH2CH3), 45.2 (C(4)), 54.1 (C(3)), 55.9 
(-OCH3), 61.7 (-CH2CH3), 113.7 (NSO2ArC(3)), 115.7 (C(5)), 126.1 (C(6)ArC)), 128.1 
(C(3)ArC), 128.5 (C(6)ArC), 128.7 (C(3)ArC), 128.9 (C(3)ArC(4)), 129.8 (C(6)ArC), 130.5 
(NSO2ArC(1)), 131.9 (NSO2ArC(2)), 135.5 (C(3)ArC(1)), 136.8 (C(6)ArC(1)), 141.3 (C(6)), 
164.1 (NSO2ArC(4)), 170.9 (C(4)CO), 172.0 (C(2)); HRMS (ESI+): C27H26NO6S [M+H]
+
 




The racemic reaction was repeated using ketimine 193 (0.187 g, 0.5 mmol) and 
(±)-tetramisoleHCl (0.24 g, 1.0 mmol, 20 mol %) under the above conditions, then 
recrystallisation (Et2O) giving 245 (77.6 mg, 0.16 mmol, 32%). Spectral data of 245 identical 





Following general procedure D, the reaction of phenylacetic acid (54.5 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 194 (68.7 mg, 0.2 
mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 95 : 
5 dr. Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 246 (67 mg, 0.13 
mmol, 66%, >95 : 5 dr) as a white solid. 
mp. 178-180 C; 
20
D][  +4.46 (c 0.65, CH2Cl2); Chiral HPLC (Chiralpak IA, 30:70 IPA : 
hexane, flow rate 1.0 mL min
-1
, 254 nm, 30 C) tR (3S, 4S): 14.8 min, tR (3R, 4R): 25.4 min, 
98% ee; max (ATR): 3066, 1728, 1521, 1373, 1348, 1261, 1172, 1147, 1107, 1083, 1026, 931; 
1
H NMR (500 MHz, CDCl3) major diastereomer δH 1.12 (3H, t, J 7.1, -CH2CH3), 3.79 (1H, 
dd, J 7.8, 5.6, C(4)H), 4.07 (2H, qd, J 7.8, 2.8, -CH2CH3), 4.15 (1H, d, J 5.6, C(3)H), 5.84 
(1H, d, J 5.6, C(5)H), 7.13 (1H, dd, J 7.5, 1.8, C(3)ArC(3)H), 7.28-7.44 (8H, m, ArH), 8.10 
(2H, d, J 9.0, NSO2ArC(2)H), 8.30 (2H, d, J 9.0, NSO2ArC(3)H); minor diastereomer 
(selected) δH 1.16 (3H, t, J 7.1, -CH2CH3), 3.91-3.85 (1H, m, C(4)H), 4.27 (1H, d, J 5.5, 




H} NMR (101 MHz, CDCl3) C 14.1 (-CH2CH3), 
44.9 (C(4)), 53.7 (C(3)), 62.0 (-CH2CH3), 116.2 (C(5)), 123.7 (NSO2ArC(3)), 126.3 
(C(3)ArC(2)), 128.4 (C(3)ArC(3)), 128.7 (C(6)ArC)), 129.1 (C(6)ArC)), 129.3 (C(6)ArC)), 
 
184 
131.0 (NSO2ArC(2)), 135.0 (C(3)ArC(1)), 136.2 (C(6)ArC(1)), 141.1 (C(6)), 144.4 
(NSO2ArC(4)), 150.8 (NSO2ArC(4)), 170.7 (C(4)CO), 172.0 (C(2)); HRMS (ESI+): 
C26H23N2O7S [M+H]
+
 found 507.1213, requires 507.1220 (－1.5 ppm). 
 
The racemic reaction was repeated using ketimine 194 (0.194 g, 0.5 mmol) and 
(±)-tetramisoleHCl (0.24 g, 1.0 mmol, 20 mol %) under the above conditions, then 
recrystallisation (Et2O) giving 246 (71.6 mg, 0.14 mmol, 28%). Spectral data of 246 identical 





Following general procedure D, the reaction of phenylacetic acid (54.5 mg, 0.4 mmol), 
(
i
Pr)2NEt (70 μL, 0.4 mmol) and pivaloyl chloride (50 μL, 0.4 mmol) in CH2Cl2 (1.0 mL), 
followed by (−)-tetramisole·HCl (9.6 mg, 0.04 mmol, 20 mol%), ketimine 192 (93.9 mg, 0.2 
mmol), (
i
Pr)2NEt (35 μL, 0.2 mmol) and CH2Cl2 (2.0 mL), for 1 h gave a crude residue of 
>95 : 5 dr. Recrystallisation ( Et2O) gave 247 (15.4 mg, 0.03 mmol, 13%, >95 : 5 dr) as a 
white solid. 
mp. 215-216 C; 
20
D][  +110 (c 0.15, CH2Cl2); Chiral HPLC (Chiralpak AD-H, 5:95 IPA : 
hexane, flow rate 1.5 mL min
-1
, 254 nm, 40 C) tR (3S, 4S): 3.44 min, tR (3R, 4R): 3.66 min, 
93% ee; max (film, cm
-1
) 2960, 1734, 1715, 1599, 1172, 938; 
1
H NMR (500 MHz, CDCl3) 
major diastereomer δH 0.96 (3H, t, J 7.1, -CH2CH3), 1.27 (6H, d, J 6.6, 6.5, -CH(CH3)2), 
1.29-1.37 (12H, m, -CH(CH3)2), 2.96 (1H, hept, J 6.9, NSO2ArC(4)CH(CH3)2), 3.72 (1H, dd, 
J 12.9, 3.4, C(4)H), 3.95 (2H, q, J 7.1, -CH2CH3), 4.04 (1H, d, J 12.9, C(3)H), 4.18 (2H, p, J 
 
185 
6.6, NSO2ArC(2)CH(CH3)2), 5.80 (1H, d, J 3.4, C(5)H), 6.71-6.84 (2H, m, C(3)ArC(2)H), 





NMR (126 MHz, CDCl3) C 13.9 (-CH2CH3), 23.7 (-CH(CH3)2), 23.8 (-CH(CH3)2), 25.0 
(-CH(CH3)2), 25.4 (-CH(CH3)2), 30.0 (NSO2ArC(2)CH(CH3)2), 34.4 (NSO2ArC(4)CH(CH3)2), 
46.0 (C(4)), 53.3 (C(3)), 61.5 (-CH2CH3), 114.8 (C(5)), 123.8 (NSO2ArC(3)), 126.2 
(C(6)ArC(2)), 127.8 (ArC), 128.4 (ArC), 129.0 (ArC), 129.2 (ArC), 133.7 (NSO2ArC(1)), 
135.5 (C(3)ArC(1)), 137.1 (C(6)ArC(1)), 142.1 (C(6)), 152.4 (NSO2ArC(2)), 154.2 
(NSO2ArC(4)), 171.0 (C(2)), 171.2 (C(4)CO)); HRMS (ESI+): C35H41N1O5Na1S1 ([M+ Na]
+
), 




Following general procedure D, the reaction of phenylacetic acid (0.55 g, 4.0 mmol), 
(
i
Pr)2NEt (0.70 mL, 4.0 mmol) and pivaloyl chloride (0.50 mL, 4.0 mmol) in CH2Cl2 (10 mL), 
followed by DHPB (76.1 mg, 0.4 mmol, 20 mol%), ketimine 465 (0.70 mg, 2.0 mmol), 
(
i
Pr)2NEt (0.35 mL, 2.0 mmol) and CH2Cl2 (20 mL) for 1 h. Purification by flash 
chromatography (CH2Cl2) then recrystallisation (Et2O) gave the title compounds 475 as a 
white solid (0.42 g, 0.92 mmol, 46%, 94:6 dr). 
mp. 182-184 ˚C; 
1
H NMR (500 MHz, CDCl3) major diastereomer δH 3.92 (1H, d, J 10.7, 
C(3)H), 4.04 (1H, dd, J 10.7, 4.2, C(4)H), 6.07 (1H, d, J 4.2, C(5)H), 6.80-6.82 (2H, m, 
C(4)ArC(2)H), 7.03-7.05 (2H, m, C(3)ArC(2)H), 7.13-7.19 (6H, m, ArH), 7.35-7.44 (5H, m, 
ArH), 7.49 (2H, td, J 7.9, 1.7, NSO2ArC(3)H), 7.63-7.66 (1H, m, NSO2ArC(4)H), 7.97-7.99 
(2H, m, NSO2ArC(2)H); minor diastereomer (selected) δH 4.11 (1H, d, J 5.9, C(3)H), 4.27 
(1H, t, J 5.6, C(4)H), 6.02 (1H, d, J 4.6, C(5)H), 6.66-6.70 (2H, m, ArH), 6.84-6.87 (2H, m, 




H} NMR (126 MHz, CDCl3) major 
 
186 
diastereomer δC 45.3 (C(4)), 59.1 (C(3)), 123.1 (C(5)), 126.2 (ArC), 127.3 (ArC), 127.5 
(ArC), 127.9 (C(3)ArC(2)), 128.5 (ArC), 128.6 (ArC), 128.7 (NSO2ArC(2)), 128.8 (ArC), 
128.9 (C(4)ArC(2)), 129.5 (NSO2ArC(2)), 134.0 (NSO2ArC(4)), 136.4 (C(3)ArC(1)), 137.1 









Following general procedure D, the reaction of phenylacetic acid (0.55 g, 4.0 mmol), 
(
i
Pr)2NEt (0.70 mL, 4.0 mmol) and pivaloyl chloride (0.50 mL, 4.0 mmol) in CH2Cl2 (10 mL), 
followed by DHPB (76.1 mg, 0.4 mmol, 20 mol%), ketimine 464 (0.72 mg, 2.0 mmol), 
(
i
Pr)2NEt (0.35 mL, 2.0 mmol) and CH2Cl2 (20 mL) for 1 h. Purification by flash 
chromatography (CH2Cl2) then recrystallisation gave the title compound 474 as a white solid 
(0.40 g, 0.83 mmol, 42%, >95:5 dr). 




H NMR (500 MHz, CDCl3) major diastereomer δH 2.46 (3H, 
s, -CH3), 3.90 (1H, d, J 10.6, C(3)H), 4.04 (1H, dd, J 10.6, 4.2, C(4)H), 6.02 (1H, d, J 4.2, 
C(5)H), 6.81-6.83 (2H, m, C(4)ArC(2)H), 7.03-7.05 (2H, m, C(3)ArC(2)H), 7.13-7.19 (6H, m, 
ArH), 7.28 (2H, d, J 8.1, ArH), 7.37-7.39 (3H, m, ArH), 7.42-7.44 (2H, m, ArH), 7.85 (2H, d, 




H} NMR (126 MHz, CDCl3) major diastereomer δC 21.9 (-CH3), 
45.3 (C(4)), 59.1 (C(3)), 122.9 (C(5)), 127.3 (ArC), 127.5 (ArC), 127.9 (C(3)ArC(2)), 128.5 
(ArC), 128.6 (ArC), 128.7 (NSO2ArC(2)), 128.8 (ArC), 128.9 (C(4)ArC(2)), 129.2 (ArC), 
129.6 (NSO2ArC(2)), 136.5 (NSO2ArC(1)), 136.5 (C(3)ArC(1)), 137.2 (C(6)ArC(1)), 140.0 







5-8. Data for Derivatisation of Dihydropyridinone 
5-8-1. Dehydrogenation/Desulfonylation 
Ethyl 2-oxo-3,6-diphenyl-1,2-dihydropyridine-4-carboxylate, 252 
 
A solution of dihydropyridinone 212 (46.2 mg, 0.1 mmol, 1 eq.) and HCOONa (34.0 mg, 0.5 
mmol, 5 eq.) in DMF (0.5 mL) was treated with 10% Pd/C (12 mol%) and stirred at 60 °C for 
24 h. The reaction was allowed to cool to rt, diluted with water (5 mL), filtered through 
Celite® , and extracted with EtOAc (3 × 5 mL). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated in vacuo. The residue was purified by flash column 




 214 °C (EtOAc)}; 
1
H NMR (500 MHz, CDCl3) δH 0.95 (3H, t, J 7.1, 
-CH2CH3), 4.07 (2H, q, J 7.1, -CH2CH3), 6.77 (1H, s, C(5)H ), 7.37-7.41 (7H, m, ArH), 7.46 





NMR (126 MHz, CDCl3) C 13.7 (-CH2CH3), 62.0 (-CH2CH3)), 104.7 (C(5)) 126.7 
(C(6)ArC(2)), 128.1 (ArC), 128.2 (ArC), 129.4 (ArC), 129.6 (ArC), 130.7 (C(6)ArC(4)), 
132.4 (C(6)ArC(1)), 134.4 (C(3)ArC(1)), 143.5 (C(3)), 146.0 (C(4)), 163.9 (C(2)), 165.7 
(C(6)), 167.5 (C(4)CO). Data consistent with literature. 
 
5-8-2. Tosylation 
Ethyl 3,6-diphenyl-2-(tosyloxy)isonicotinate, 253 
 
A stirred solution of pyridone 252 (31.9 mg, 0.1 mmol, 1 eq.) in anhydrous THF (1 mL) at 
−78 °C under an argon atmosphere was treated with NaH (60% wt, 6.0 mg, 0.15 mmol, 1.5 
 
188 
eq.) followed by a solution of tosyl chloride (28.6 mg, 0.15 mmol, 1.5 eq.) in anhydrous THF 
(0.5 mL). After 1 h, the reaction mixture was allowed to warm to rt, then heated to 60 °C for 3 
h. The reaction was poured into ice water (10 mL), neutralised with K2CO3, and extracted 
with CHCl3 (3 × 10 mL). The combined organics were dried over Na2SO4, filtered, and 
concentrated in vacuo. The crude was purified by flash chromatography (Et2O–pet. ether, 3 : 
7) to give pyridine 253 (44.6 mg, 0.094 mmol, 94%) as a white solid. 
mp. 122-124 ˚C; max (film, cm-1): 2924, 1732, 1597, 1539, 1375, 1327, 1247, 1192, 1178, 
1168, 1155, 1024, 968; 
1
H NMR (500 MHz, CDCl3) δH 0.94 (3H, t, J 7.1, -CH2CH3), 2.47 
(3H, s, -CH3), 4.07 (2H, q, J 7.1, -CH2CH3), 7.29 (2H, d, J 8.1, NSO2ArC(3)H), 7.31-7.35 





H} NMR (126 MHz, CDCl3) δC 13.6 (-CH2CH3), 21.9 (-CH3), 62.0 
(-CH2CH3), 118.1 (C(5)), 126.3, 127.1 (ArC), 128.3 (ArC), 128.4 (ArC), 128.7 (ArC), 128.7 
(ArC), 128.9 (ArC), 129.6 (ArC), 129.6 (NSO2ArC(3)), 130.1 (ArC), 133.3 (ArC), 135.1 









(3S,4S)-Ethyl 2-oxo-3,6-diphenyl-1,2,3,4-tetrahydropyridine-4-carboxylate, 259 
 
A solution of dihydropyridinone 212 (92.3 mg, 0.2 mmol, 1 eq.) in anhydrous THF (2 mL) at 
−78 °C under an argon atmosphere was treated dropwise with a pre-formed solution of 
sodium (18.4 mg, 0.8 mmol, 4 eq.) and naphthalene (102.5 mg, 0.8 mmol, 4 eq.) in anhydrous 
THF (2 mL) that had been stirred for 1.5 h at rt. The reaction was monitored by TLC and 
when complete (1 h), quenched with brine (5 mL) and extracted with EtOAc (3 × 5 mL). The 
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combined organics were dried over MgSO4, filtered, and the solvent removed in vacuo to 
obtain the crude product (>99 : 1 dr). Purification by flash chromatography (Et2O–pet. ether, 
1 : 1) to give 259 (29.5 mg, 0.092 mmol, 46%, >99 : 1 dr) as a white solid. 
mp. 100-102 C; 
20
D][  ＋136.5 (c 0.26, CH2Cl2); Chiral HPLC (Chiralpak OD-H, 30:70 
IPA : hexane, flow rate 0.5 mL min
-1
, 270 nm, 30 C) tR (3S, 4S): 36.4 min, tR (3R, 4R): 29.2 
min, 99% ee; max (ATR): 3246, 2964, 1728, 1670, 1651, 1456, 1265, 1155.; 
1
H NMR (400 
MHz, CDCl3) δH 1.18 (3H, J 7.1, -CH2CH3), 3.76 (1H, dd, J 7.5, 4.8, C(4)H), 4.13 (2H, q, J 
7.1, -CH2CH3), 4.19 (1H, d, J 7.5, C(3)H), 5.43 (1H, dd, J 4.8, 1.5, C(5)H), 7.29-7.35 (5H, m, 





(101 MHz, CDCl3) C 14.2 (-CH2CH3), 46.7 (C(4)), 48.5 (C(3)), 61.5 (-CH2CH3)), 99.3 (C(5)), 
125.3 (C(6)ArC(2)), 127.8 (C(3)ArC)), 128.4 (ArC)), 128.9 (ArC), 129.2 (ArC), 129.6 (ArC), 
134.5 (C(6)ArC(1)), 137.3 (C(3)ArC(1)), 138.2 (C(6)), 170.8 (C(2)), 171.9 (C(4)CO); HRMS 
(ESI+): C20H20NO3 ([M+H]
+
), found 322.1438, requires 322.1443 (＋1.6 ppm). 
 




A solution of dihydropyridinone 212 (46.2 mg, 0.1 mmol, 1 eq.) in anhydrous THF (1 mL) at 
0 °C under an argon atmosphere was treated dropwise with 2.0 M LiAlH4 in THF (0.1 mL, 
0.2 mmol, 2 eq.). The reaction was stirred at 0 °C for 1 h and quenched with 0.1 м HCl (5 
mL). The reaction mixture was extracted with Et2O (3 × 5 mL), the combined organic layers 
dried over MgSO4, filtered, and concentrated in vacuo. The crude product was purified by 
flash chromatography (Et2O–pet. ether, 1 : 19) to give 260 (27.6 mg, 0.065 mmol, 65%, >99 : 
1 dr) as a white solid. 
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mp. 80-82 C; 
20
D][  ＋79.7 (c 0.47 in CH2Cl2); Chiral HPLC (Chiralpak IA, 30:70 
IPA:hexane, flow rate 0.5 mL min
-1
, 254 nm) tR (3S, 4S): 13.6 min, tR (3R, 4R): 16.7 min, 97% 
ee; max (ATR) 2916, 1718, 1681, 1448, 1398, 1336, 1271, 1251, 1153, 1002; 
1
H NMR (500 
MHz, CDCl3)  0.88 (3H, t, J 7.1, C(13)H3), 3.17 (1H, dd, J 17.3, 3.3, C(4)H), 3.58 (1H, dd, J 
17.3, 10.3, C(4’)H), 3.67- 3.77 (4H, m, C(3)H & C(6)H3), 3.85 (2H, m, C(12)H2), 3.92 (1H, d, 
J 9.5, C(2)H), 7.26- 7.34 (4H, m, ArH), 7.45 (2H, dd, J 8.3, 7.2, ArH), 7.52-7.59 (1H, m, 




H} NMR (126 MHz, CDCl3) C 13.8 (C(13)), 38.4 (C(4) 
& (C(14’)), 44.8 (C(3)), 52.5 (C(6)), 53.5 (C(2)), 60.8 (C(12)), 128.2 (Ar), 128.7 (Ar), 133.4 
(Ar), 135.8 (4ry), 136.5 (4ry), 172.6 (4ry), 173.2 (4ry), 197.7 (4ry); HRMS (ESI+): C21H23O5 
([M+H]
+






Following the procedure outlined by Harrity et al.,
180
 a stirred solution of dihydropyridinone 
212 (46.2 mg, 0.1 mmol, 1 eq.) in anhydrous CH2Cl2 (10 mL) at −78 °C under an argon 
atmosphere was treated dropwise with bromine (12.8 μL, 0.25 mmol, 2.5 eq.) dropwise. 
(
i
Pr)2NEt (19.0 μL, 0.11 mmol, 1.1 eq.) was added and the reaction mixture allowed to warm 
to rt. The reaction was monitored by TLC and complete in 2 h. The reaction mixture was 
quenched with saturated aqueous Na2S2O3 (10 mL), the layers separated and the aqueous 
extracted with CH2Cl2 (3 × 10 mL). The combined organic layers were washed with brine (10 
mL), dried over MgSO4, filtered, and concentrated in vacuo. The crude product was purified 
by flash chromatography (Et2O–pet. ether, 1 : 4) to give 261 (46.3 mg, 0.086 mmol, 86%, 
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>99 : 1 dr) as a white solid. 
mp: 130-132 C; 
22
D][  －26.7 (c 0.61, CH2Cl2); Chiral HPLC Chiralpak IA (30% IPA: 
hexane, flow rate 1.0 mL min
-1
, 254 nm) tR (3S, 4S): 10.9 min, tR (3R, 4R): 15.3 min, 97% ee. 
max (ATR): 2924, 1750, 1732, 1446, 1371, 1181, 1066, 885; δH (500 MHz CDCl3) 1.36 (3H, 
t, J 7.1, -CH2CH3), 4.00 (1H, d, J 3.4, C(4)H), 4.33 (2H, ddq, J 47.0, 10.8, 7.1, -CH2CH3), 
4.54 (1H, d, J 3.4, C(3)H), 7.19 (2H, d, J 7.5, C(3)ArC(6)H), 7.23-7.39 (10H, m, ArH), 7.55 
(1H, t, J 7.4, NSO2ArC(4)H), 7.59 (2H, t, J 7.4, NSO2ArC(2)H); C (126 MHz, CDCl3) 14.2 
(-CH2CH3), 53.8 (C(3)), 54.4 (C(4)), 62.8 (-CH2CH3), 110.2 (C(5)), 127.6 (ArC), 127.9 (ArC), 
128.4 (ArC), 128.6 (ArC), 129.0 (ArC), 129.1 (NSO2ArC(2)), 129.3 (ArC), 129.8 
(C(3)ArC(2)), 133.9 (NSO2ArC(4)), 134.2 (C(6)ArC(1)), 134.9 (C(3)ArC(1)), 137.1 (C(6)), 











A solution of dihydropyridinone 212 (46.2 mg, 0.1 mmol, 1 eq.) in CH2Cl2 (1 mL) at 0 °C 
was treated with mCPBA (70% wt, 37.0 mg, 0.15 mmol, 1.5 eq.). The reaction was allowed to 
warm to rt and stirred for 24 h, before being quenched with sat. NaHCO3 (2 mL). The layers 
were separated and the aqueous layer extracted with CH2Cl2 (3 × 5 mL). The combined 
organics were dried over MgSO4, filtered, and the solvent removed in vacuo to obtain the 
crude product (>99 : 1 dr). Purification by flash chromatography (Et2O–pet. ether, 1 : 4) gave 
266 (34.2 mg, 0.072 mmol, 72%, >99 : 1 dr) as a white solid. 
mp. 116-118 C; 
20
D][  －29.8 (c 0.50, CH2Cl2); max (ATR):2976, 2360, 2322, 1726, 1448, 
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1361, 1273, 1174; 
1
H NMR (500MHz, CD2Cl2) δH 0.84 (3H, J 7.1, -CH2CH3), 3.13 (1H, dd, J 
13.1, 3.7, C(4)H), 3.79 (1H, d, J 3.79, C(5)H), 3.85 (2H, q, J 7.1, -CH2CH3), 4.02 (1H, d, J 
13.1, C(3)H), 6.87 (2H, dd, J 7.3, 2.0, C(3)ArC(3)H), 7.24-7.28 (3H, m, C(3)ArH and 





H} NMR (126 MHz, CDCl3) C 13.9, 49.9, 51.1, 62.24, 64.6, 70.0, 
125.9, 128.8, 129.0, 129.2, 129.4, 129.6, 129.9, 134.2, 134.8, 136.5, 138.7, 169.9, 170.8; 






A solution of dihydropyridinone 212 (46.2 mg, 0.1 mmol, 1 eq.) in anhydrous THF (1 mL) at 
0 °C under an argon atmosphere was treated dropwise with 2.0 M LiAlH4 in THF (0.1 mL, 
0.2 mmol, 2 eq.). The reaction was stirred at 0 °C for 1 h and quenched with 0.1 м HCl (5 
mL). The reaction mixture was extracted with Et2O (3 × 5 mL), the combined organic layers 
dried over MgSO4, filtered, and concentrated in vacuo. The crude product was purified by 
flash chromatography (Et2O–pet. ether, 1 : 19) to give 267 (27.6 mg, 0.065 mmol, 65%, >99 : 
1 dr) as a white solid. 
mp. 74-76 C; 
20
D][  －1.1 (c 0.45, CH2Cl2); Chiral HPLC (Chiralpak AD-H, 30:70 IPA : 
hexane, flow rate 1.0 mL min
-1
, 254 nm, 30 C) tR (3S, 4S): 9.2 min, tR (3R, 4R): 11.1 min, 
97% ee; max (ATR): 2920, 2358, 2320, 1446, 1328, 1165, 1112, 1091, 1049, 1026; 
1
H NMR 
(400 MHz, CDCl3) δH 2.65 (1H, ddd, J 11.7, 4.9, 3.1, C(4)H), 1.67-1.81 (1H, m, C(3)H), 3.18 
(2H, d, J 5.2, C(3)CH2), 3.60 (1H, dd, J 11.5, 4.7, C(5)H2), 3.65-3.73 (1H, m, C(5)H2), 5.59 
 
193 
(1H, dd, J 9.6, C(2)H), 7.09-7.19 (2H, m, C(4)ArC(3)H), 7.20-7.42 (6H, m, C(1)ArCH and 
C(4)ArCH), 7.41-7.50 (4H, m, C(1)ArCH and NSO2ArC(3)H), 7.50-7.59 (1H, m, 





NMR (126 MHz, CDCl3) C 41.5 (C(3)), 48.6 (C(4)), 65.0 (C(3)CH2), 65.8 (C(5)CH2), 125.6, 
126.5, 127.4, 127.4, 127.5, 128.2, 128.3, 128.6, 129.0, 129.1, 129.3, 132.8, 137.5, 138.2, 
140.3, 140.6; HRMS (ESI+): C24H25NO4SNa [M+Na]
+





To a solution of the corresponding racemic dihydropyridinone 212 (46.2 mg, 0.1 mmol, 1 eq) 
in dry THF, was dropwise 2.0 M LiAlH4 in THF (2 eq) at 0 C, under N2. The reaction 
mixture was left stirring in the same temperature and monitored by TLC and complete in 1 h. 
Excess 0.1 м HCl was then added into the reaction mixture then stirred for further 2 h, then 
extracted with CH2Cl2. The combined organic layer then dried over MgSO4 and concentrated 
in vacuo. The residue was purified by column chromatography to afford product 268 as white 
solid (9.8 mg, 0.037 mmol, 37 %, >99:1 dr). 
mp. 74-76 C; Chiral HPLC (Chiralpak OD-H, 10:90 IPA : hexane, flow rate 1.0 mL min
-1
, 
254 nm, 30 C) tR (3S, 4S): 18.9 min, tR (3R, 4R): 21.4 min, 57% ee; max (ATR): 2953, 1887, 
1490, 1448, 1330, 1170, 1112, 1039, 1010, 950; 
1
H NMR (300 MHz, CDCl3) δH 1.72 (1H, dd, 
J 11.7, 5.0, C(8)H2), 2.28 (1H, d, J 11.7, C(8)H2), 2.78 (1H, q, J 4.0, C(5)H), 2.99 (1H, t, J 4.4, 
C(4)H), 4.21-4.35 (2H, m, C(3)H2 and C(6)H2), 4.35- 4.50 4.26 (2H, m, C(3)H2 and C(6)H2), 





NMR (126 MHz, CDCl3) C 38.1 (C(8)), 42.2 (C(5)), 43.1 (C(4)), 64.4 (C(3)), 74.1 (C(6)), 
106.6 (C(1)), 125.6 (ArC), 128.1 (ArC), 128.3 (ArC), 128.4 (ArC), 128.6 (ArC), 140.9 
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(C(1)C(1)), 143.3 (C(4)ArC(1)); HRMS (ESI+): C18H19O2 [M+H]
+
 found 267.1381, requires 
267.1380 (＋0.5 ppm). 
 
Data for Trifluoromethyl enones 
The synthesis of (E)-4-(4-Bromophenyl)-1,1,1-trifluorobut-3-en-2-one, (E)-1,1,1-trifluoro-4- 
(4-nitrophenyl)but-3-en-2-one and (E)-1,1,1-trifluoro-4-(4-methoxyphenyl)but-3-en-2-one 




General procedure E: preparation of trifluoromethyl enones  
 
Following the procedure outlined by Zhang et al.,
108
 to a solution of diisopropylamine (2 eq.) 
in THF was added nBuLi (2.5 M in hexanes, 2 eq.) at −78 °C and the solution was allowed to 
stir for 20 minutes. Diethyl methylphosphonate (1 eq) was added at −78 °C followed by a 
further 30 minutes of stirring. (Z)-2,2,2-trifluoro-N-phenylacetimidoyl chloride (1 eq.) was 
then added slowly followed by stirring at −78 °C for 1 h. The required aldehyde (1 eq.) was 
then added dropwise at −78 °C. The reaction mixture was then warmed slowly to rt and then 
stirred for 16 h. 2M HCl (4 eq.) was added and the reaction mixture was stirred for further 4 h 
before being extracted with Et2O three times. The combined organic extracts were washed 
with sat. aq. NaHCO3, brine, dried over MgSO4, filtered and concentrated in vacuo to give the 











Following general procedure E, diisopropylamine (8.16 mL, 60 mmol) and nBuLi (2.5 M in 
hexanes, 24 mL, 60 mmol) in THF (150 mL), diethyl methylphosphonate (4.44 mL, 30 mmol), 
imidoyl chloride (6.23 mL, 30 mmol) and benzaldehyde (3.06 mL, 30 mmol) followed by 2 м 
HCl (60 mL, 120 mmol), gave enone 323 (5.80 g, 97%) as light yellow oil after purification 
(CH2Cl2 : petrol, 5 : 95). 
1
H NMR (500 MHz, CDCl3) δH: 7.02 (1H, dq, J 16.0, 0.9, C(3)H), 7.43-7.48 (2H, m, ArH), 













Following general procedure E, diisopropylamine (0.70 mL, 5.0 mmol) and nBuLi (2.5 M in 
hexanes, 2.0 mL, 5.0 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 2.5 
mmol), imidoyl chloride (0.52 g, 2.5 mmol) and m-bromobenzaldehyde (0.29 mL, 2.5 mmol) 
followed by 2 м HCl (5.0 mL, 20 mmol), gave enone 324 (438 mg, 63%) as an orange solid 
after purification (CH2Cl2 : petrol, 3:97). 
mp. < 30 °C; 
1
H NMR (500 MHz, CDCl3) δH: 7.00 (1H, dq, J 16.0, 0.7, C(3)H), 7.34 (2H, t, 
J 7.9, ArH), 7.52-7.65 (2H, m, ArH), 7.79 (1H, d, J 1.9, ArH), 7.88 (1H, d, J 16.0, C(4)H). 












Following general procedure E, diisopropylamine (0.70 mL, 5.0 mmol) and nBuLi (2.5 M in 
hexanes, 2.0 mL, 5.0 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 2.5 
mmol), imidoyl chloride (0.52 g, 2.5 mmol) and o-bromobenzaldehyde (0.29 mL, 2.5 mmol) 
followed by 2 M HCl (5.0 mL, 20 mmol), gave enone 325 (540 mg, 77%) as solid after 
purification (CH2Cl2 : petrol, 5:95).  
mp. < 30 °C; 
1
H NMR (400 MHz, CDCl3) δH: 6.96 (1H, dq, J 16.0, 0.9, C(3)H), 7.33 (1H, td, 
J 7.7, 1.8, ArH), 7.39 (1H, tdd, J 7.8, 1.4, 0.6, ArH), 7.64-7.70 (1H, m, ArH), 7.70-7.76 (1H, 








Following general procedure E, diisopropylamine (0.70 mL, 5.0 mmol) and nBuLi (2.5 M in 
hexanes, 2.0 mL, 5.0 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 2.5 
mmol), imidoyl chloride (0.52 g, 2.5 mmol) and p-tolualdehyde (0.3 mL, 2.5 mmol) followed 
by 2 M HCl (5.0 mL, 20 mmol), gave enone 326 (373 mg, 70%) as yellow solid after 
purification (CH2Cl2 : petrol 5:95). 
mp 29-30 °C {Lit.
181
 30-32 °C}; 
1
H NMR (500 MHz, CDCl3) δH: 2.42 (3H, s, Me), 6.98 (1H, 
dq, J 15.9, 1.1, C(3)H), 7.21-7.29 (3H, m, ArH), 7.57-7.50 (2H, m, ArH), 7.95 (1H, d, J 15.9, 











Following general procedure E, diisopropylamine (0.70 mL, 5.0 mmol) and nBuLi (2.5 M in 
hexanes, 2.0 mL, 5.0 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 2.5 
mmol), imidoyl chloride (0.52 g, 2.5 mmol) and furfural (0.21 mL, 2.5 mmol) followed by 2 
M HCl (5.0 mL, 20 mmol), gave enone 327 (113.2 mg, 24%) as light yellow oil after 
purification (CH2Cl2 : petrol 10 : 90). 
1
H NMR (500 MHz, CDCl3) δH: 6.58 (1H, dd, J 3.5, 1.8, ArH), 6.85-6.93 (2H, m, C(3)H and 




H} NMR (471 MHz, CDCl3) 








Following general procedure A, diisopropylamine (0.70 mL, 5.0 mmol) and nBuLi (2.5 M in 
hexanes, 2.0 mL, 5.0 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 2.5 
mmol), imidoyl chloride (0.52 g, 2.5 mmol) and 2-thiophenecarboxaldehyde (0.24 mL, 2.5 
mmol) followed by 2 M HCl (5.0 mL, 20 mmol), gave enone S6 (386 mg, 75%) as light 
yellow solid after purification (CH2Cl2 : petrol 10 : 90). 
mp 37-38 °C;
 1
H NMR (300 MHz, CDCl3) δH: 6.79 (1H, d, J 15.9, C(3)H), 7.15 (2H, dd, J 
5.0, 3.7, ArH), 7.45-7.50 (1H, m, ArH), 7.58 (1H, d, J 5.1, 1.0, ArH) , 8.07 (1H, d, J 15.5, 












Following general procedure E, diisopropylamine (0.70 mL, 5.0 mmol) and nBuLi (2.5 M in 
hexanes, 2.0 mL, 5.0 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 2.5 
mmol), imidoyl chloride (0.52 g, 2.5 mmol) and 2-naphthaldehyde (0.39 g, 2.5 mmol) 
followed by 2 M HCl (5.0 mL, 20 mmol), gave enone 328 (448 mg, 72%) as light yellow 
solid after purification (CH2Cl2 : petrol 5:95). 
mp 62-64 °C {Lit.
1
 65-67 °C}; 
1
H NMR (500 MHz, CDCl3) δH: 7.13 (1H, dq, J 15.9, 1.1, 
C(3)H), 7.52-7.63 (2H, m, ArH), 7.75 (1H, dd, J 8.6, 1.8, ArH), 7.83-7.95 (3H, m, ArH) , 8.08 




(E)- 1,1,1-trifluoro-4-(4-(methylsulfonyl)phenyl)but-3-en-2-one, 367 
 
Following general procedure A, diisopropylamine (0.7 mL, 5.0 mmol) and nBuLi (2.5 M in 
hexanes, 2.0 mL, 5.0 mmol) in THF (10 mL), diethyl methylphosphonate (0.37 mL, 2.5 
mmol), imidoyl chloride (0.52 g, 2.5 mmol) and 4-(methylsulfonyl)benzaldehyde (0.46 g, 2.5 
mmol) followed by 2 м HCl (5.0 mL, 20 mmol), gave enone 367 (481 mg, 69%) as light 
yellow solid after purification (CH2Cl2). 
mp. 102-104 °C; max (ATR): 2993, 1722, 1692, 1612, 1588, 1401, 1294, 1203, 1139, 1122, 
1089, 1053, 950, 831; 
1
H NMR (400 MHz, CDCl3) δH: 3.09 (3H, s, Me), 7.11 (1H, dq, J 16.1, 





H} NMR (101 MHz, CDCl3) C: 44.4 (Me), 116.2 (q, 
1
JCF 290.5, 
C(2)CF), 120.5, 128.3, 129.8, 138.2, 143.2, 147.2, 179.7 (q, 
2









), found 277.0152, requires 
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277.0152 (+0.1 ppm)). 
 




Following the procedure outlined by Webb et al.,
105 
to a solution of sodium hydroxide (1.54 g, 
51.3 mmol, 1.7 eq) and (phenythio)acetic acid (5.08 g, 30.2 mmol, 1 eq) in deionised water 
(30 mL) was stirred at rt for 10 minutes followed by the addition of sodium bicarbonate (20.0 
g) and acetone (25 mL), and the solution cooled down to 0 °C. A solution of Oxone
®
 (12.13 g 
in 50 mL of 4 x 10
-4
 м aq. EDTA) was added dropwise over 10 minutes, keeping the internal 
temperature below 5 °C. The suspension was stirred for 5 minutes then quenched immediately 
with a solution of sodium bisulfite (7.5 g in 15 mL water). EtOAc (200 mL) was added and 
the reaction mixture was acidified with 6 м HCl (45 mL). The layers were separated, and the 
aqueous layer treated with NaCl (37.5 g) and extracted with EtOAc (200 mL). The combined 
organic layers were washed with deionised water (40 mL) and brine (40 mL), dried over 
MgSO4, filtered and concentrated in vacuo to give the product 321 as a white solid which was 
dried in vacuo overnight (4.73 g, 85%). 
mp. 112-114 °C {Lit.
4
 112-113 °C}; 
1









), 7.54-7.57 (3H, m, ArH), 7.69-7.73 (2H, m, 













Following the procedure outlined by Gualtieri et al.,
106
 to a solution of NaOH (0.80 g, 20 
mmol, 2 eq) in absolute EtOH (30 mL) was added thiophenol (1.10 mL, 10 mmol, 1 eq) and 
2-bromopropionic acid (0.90 mL, 10 mmol, 1 eq), and the reaction refluxed overnight. The 
solvent was removed in vacuo, the residue dissolved in water (10 mL), acidified with 6 M 
HCl and extracted with Et2O (3 x 20 mL). The combined organic layers were extracted with 
sat. aq. Na2CO3 (3 x 20 mL). The combined aqueous layers were acidified with 6 M HCl, 
extracted with Et2O (3 x 20 mL) and the combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo to give the title compound 320 as a yellow oil (2.09 g, 
99%). 
1
H NMR (300 MHz, CDCl3) δH: 1.51 (3H, d, J 7.2, Me), 3.78 (1H, q, J 7.2, C(2)H), 7.27-7.35 







Following the procedure of Kenney et al.,
107
 2-(phenylsulfinyl)acetic acid 321 (4.65 g, 25.2 
mmol, 2.0 eq) was refluxed overnight in glacial acetic acid (100 mL). The acetic acid was 
removed in vacuo, and the residue washed with water (3 x 20 mL). The resulting solid was 
recrystallised from AcOH : H2O (19 : 1), filtered and the solid dried in vacuo to leave acid 
322 (2.20 g, 63%) as a white solid. 
mp. 100-101 °C {Lit.
107
 101-103 °C}; νmax (ATR): 3059, 2798, 2671, 2563, 1697, 1468, 1439, 
1416, 1298, 1163, 1152, 1069, 1024, 908; 
1
H NMR (500 MHz, CDCl3) δH: 4.82 (1H, s, 




H} NMR (125 MHz, 
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found 299.0166, requires 299.0171 (−1.6 ppm). 
 
Data for 2-Pyrones 
General Procedure F-2-pyrone synthesis 
To a flame dried vial under N2 was added (phenylthio)acetic acid (2 eq), (
i
Pr)2NEt (3 eq) and 
anhydrous MeCN (2.5 mL / 1.0 mmol acid) and cooled to 0 °C. Pivaloyl chloride (2 eq) was 
then added, and the reaction stirred for 30 minutes. DHPB 214 (indicated mol %) was added 
followed by the addition of α,β-unsaturated trifluoromethyl ketone (1 eq), additional (
i
Pr)2NEt 
(2.5 eq) and anhydrous MeCN (2.5 mL / 1.0 mmol acid). The reaction mixture was stirred at 
rt for 24 h unless otherwise stated, then quenched with 0.1 M HCl, extracted with CH2Cl2 (x 3) 
and dried over MgSO4. The solvent was removed in vacuo to obtain the crude product which 





Following general procedure F, (phenylthio)acetic acid (2.02 g, 12.0 mmol), (
i
Pr)2NEt (3.10 
mL, 18.0 mmol) and pivaloyl chloride (2.20 mL, 18.0 mmol) in MeCN (30.0 mL), followed 
by DHPB (228 mg, 1.2 mmol, 20 mol %), 323 (1.20 g, 6.0 mmol), (
i
Pr)2NEt (2.60 mL, 15.0 
mmol) and MeCN (30.0 mL), gave the title compound 285 as an orange solid (1.30 g, 90%) 
after purification by flash chromatography on silica gel (Et2O : petrol, 5 : 95). 




H NMR (300 MHz, CDCl3) δH: 6.59-6.69 (1H, m, C(3)H), 




The reaction was repeated using 323 (40.0 mg, 0.2 mmol) and DHPB (0.38 mg, 0.002 mmol, 
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1 mol %) under the above conditions, giving 323 (36.8 mg, 77%). Spectral data 




Following general procedure F, (phenylthio)acetic acid (67.3 mg, 0.4 mmol), (
i
Pr)2NEt (104 
μL, 0.6 mmol) and pivaloyl chloride (74 μL, 0.6 mmol) in MeCN (1.0 mL), followed by 
DHPB (7.6 mg, 0.04 mmol, 20 mol %), (E)-4-(4-bromophenyl)-1,1,1-trifluorobut- 3-en-2-one 
(55.8 mg, 0.2 mmol), (
i
Pr)2NEt (87 μL, 0.5 mmol) and MeCN (1.0 mL) gave the title 
compound 337 as an orange solid (60.5 mg, 95%) after purification by flash chromatography 
on silica gel (Et2O : petrol, 5 : 95). 
mp. 114-116°C; max (ATR): 3118, 1739, 1688, 1587, 1490, 1348, 1139, 1097, 827; 
1
H NMR 
(300 MHz, CDCl3) δH: 6.64 (1H, d, J 1.6, C(3)H), 6.91 (1H, d, J 1.6, C(5)H), 7.47 (2H, dt, J 




H} NMR (75 MHz, 
CDCl3) C: 104.5 ( q, 
3
JCF 3.8, C(5)), 114.0 (C(3)), 118.9 (q, 
1
JCF 273.0, C(4)CF3), 126.4 
(C(4)ArC(1’)), 128.2 (C(4)ArC(3’)), 132.9 (C(4)ArC(2’)), 133.1 (4ry, C(4)), 148.9 (q, 
2
JCF 




H} NMR (471 MHz, CDCl3) δF: 




 found 318.9578, requires 318.9576 (+0.6 
ppm). 
 
The reaction was repeated using (E)-4-(4-bromophenyl)-1,1,1-trifluorobut-3-en-2-one (55.8 
mg, 0.2 mmol) and DHPB (0.38 mg, 0.002 mmol, 1 mol %) under the above conditions, 






Following general procedure F, (phenylthio)acetic acid (67.3 mg, 0.4 mmol), (
i
Pr)2NEt (104 
μL, 0.6 mmol) and pivaloyl chloride (74 μL, 0.6 mmol) in MeCN (1.0 mL), followed by 
DHPB (7.6 mg, 0.04 mmol, 20 mol %), 324 (55.8 mg, 0.2 mmol), (
i
Pr)2NEt (87 μL, 0.5 mmol) 
and MeCN (1.0 mL), gave the title compound as an orange solid 338 (60.5 mg, 95%) after 
purification by flash chromatography on silica gel (Et2O : petrol, 5 : 90). 
mp. 65-66 °C; max (ATR): 2924, 1741, 1664, 1556, 1342, 1197, 1145, 1095, 1028, 850; 
1
H 
NMR (500 MHz, CDCl3) δH: 6.64 (1H, d, J 1.6, C(3)H), 6.91 (1H, d, J 1.6, C(5)H), 7.41 (1H, 
t, J 7.9, C(4)ArC(5’)H ), 7.53 (1H, ddd, J 7.9, 1.9, 1.0, C(4)ArC(4’)H ), 7.67 (1H, ddt, J 8.0, 




H} NMR (126 MHz, CDCl3) 
C: 104.5 (q, 
3
JCF 3.8, C(5)), 114.7 (C(3)), 118.0 (q, 
1
JCF 272.9, C(4)CF3), 123.8 
(C(4)ArC(1’)), 125.4 (C(4)ArC(4’)), 129.8 (C(4)ArC(2’)), 131.1 (C(4)ArC(5’)), 134.5 
(C(4)ArC(6’)), 136.3 (C(4)), 148.9 (q, 
2











318.9582, requires 318.9576 (+1.9 ppm). 
 
The reaction was repeated using 324 (55.8 mg, 0.2 mmol) and DHPB (0.38 mg, 0.002 mmol, 
1 mol %) under the above conditions, giving 338 (46.9 mg, 73%). Spectral data 









Following general procedure F, (phenylthio)acetic acid (67.3 mg, 0.4 mmol), (
i
Pr)2NEt (104 
μL, 0.6 mmol) and pivaloyl chloride (74 μL, 0.6 mmol) in MeCN (1.0 mL), followed by 
DHPB (7.6 mg, 0.04 mmol, 20 mol %), 325 (55.8 mg, 0.2 mmol), (
i
Pr)2NEt (87 μL, 0.5 mmol) 
and MeCN (1.0 mL), gave the title compound 339 as a yellow solid (52.2 mg, 82%) after 
purification by flash chromatography on silica gel (Et2O : petrol, 5 : 95). 
mp. 68-69 °C; max (ATR): 2926, 1747, 1666, 1568, 1343, 1276, 1195, 1145, 1095, 827, 758; 
1
H NMR (500 MHz, CDCl3) δH: 6.50 (1H, s, C(3)H), 6.83 (1H, d, J 1.6, C(5)H), 7.31 (1H, dd, 
J 7.6, 1.7, C(4)ArC(6’)H ), 7.36 (1H, td, J 7.8, 1.8, C(4)ArC(4’)H ), 7.45 (1H, td, J 7.5, 1.2, 




H} NMR (126 MHz, CDCl3) 
C: 107.4 (q, 
3
JCF 3.9, C(5)), 118.1 (q, 
1
JCF 273.7, C(4)CF3), 119.2 (C(3)), 121.0, 125.4, 129.8, 
131.1, 134.5, 136.5 (C(4)), 147.8 (q, 
2











318.9576, requires 318.9576 (+0.0 ppm). 
 
The reaction was repeated using 325 (55.8 mg, 0.2 mmol) and DHPB (0.38 mg, 0.002 mmol, 
1 mol %) under the above conditions, giving 339 (39.9 mg, 63%). Spectral data 











Following general procedure F, (phenylthio)acetic acid (67.3 mg, 0.4 mmol), (
i
Pr)2NEt (104 
μL, 0.6 mmol) and pivaloyl chloride (74 μL, 0.6 mmol) in MeCN (1.0 mL), followed by 
DHPB (7.6 mg, 0.04 mmol, 20 mol %), (E)-4-(4-nitrophenyl)-1,1,1-trifluorobut-3-en-2-one 
(49.0 mg, 0.2 mmol), (
i
Pr)2NEt (87 μL, 0.5 mmol) and MeCN (1.0 mL) gave the title 
compound 340 as an orange solid (48.7 mg, 85%) after purification by flash chromatography 
on silica gel (Et2O : petrol, 10 : 90). 
mp. 170-172 °C {Lit.
104
 178-180 °C}; max (ATR): 3115, 1745, 1521, 1350, 1227, 1139, 1097, 
846; 
1
H NMR (300 MHz, CDCl3) δH: 6.73 (1H, d, J 1.0, C(3)H ), 6.94 (1H, d, J 0.9, C(5)H), 




H} NMR (75 MHz, 
CDCl3) C: 104.2 (q, 
3
JCF J 3.6, C(5)), 116.2 (C(3)), 117.9 (q, 
1
JCF 269.1, C(4)CF3), 124.8, 
128.0, 140.3, 149.4 (q, 
2









 found 286.0326, requires 286.0322 (+1.5 ppm). 
 
The reaction was repeated using (E)-4-(4-nitrophenyl)-1,1,1-trifluorobut-3-en-2-one (49.0 mg, 
0.2 mmol) and DHPB (0.38 mg, 0.002 mmol, 1 mol %) under the above conditions, giving 










μL, 0.6 mmol) and pivaloyl chloride (74 μL, 0.6 mmol) in MeCN (1.0 mL), followed by 
DHPB (7.6 mg, 0.04 mmol, 20 mol %), 326 (42.8 mg, 0.2 mmol), (
i
Pr)2NEt (87 μL, 0.5 mmol) 
and MeCN (1.0 mL) gave the title compound 341 as an orange solid (44.7 mg, 88%) after 
purification by flash chromatography on silica gel (Et2O : petrol, 5 : 95). 
mp. 108-110 °C {Lit.
104
 114-115 °C}; max (ATR): 3101, 1724, 1664, 1558, 1355, 1207, 1138, 
1101, 808; 
1
H NMR (300 MHz, CDCl3) δH: 2.43 (1H, s, -Me), 6.64 (1H, d, J 0.9, C(3)H), 





H} NMR (75 MHz, CDCl3) C: 21.5 (Me), 104.8 (q, 
3
JCF 3.7, C(5)), 
113.0 (C(3)), 118.23 (q, 
1
JCF 272.9, C(4)CF3), 126.7 (C(4)ArC(2’)), 130.3 (C(4)ArC(3’)), 
131.3 (4ry, C(4)ArC(1’)), 142.4 (4ry,C(4)), 148.52 (q, 
2
JCF 39.0, C(6)), 153.2 (4ry, 




H} NMR (282 MHz, CDCl3) δF: −71.70; HRMS (ESI+) 
C13H10O2F3 [M+H]
+
 found 255.0629, requires 255.0627 (+0.6 ppm). 
 
The reaction was repeated using 326 (42.8 mg, 0.2 mmol) and DHPB (0.38 mg, 0.002 mmol) 





Following general procedure F, (phenylthio)acetic acid (67.3 mg, 0.4 mmol), (
i
Pr)2NEt (104 
μL, 0.6 mmol) and pivaloyl chloride (74 μL, 0.6 mmol) in MeCN (1.0 mL), followed by 
DHPB 1 (7.6 mg, 0.04 mmol, 20 mol %), (E)-4-(4-methoxyphenyl)-1,1,1-trifluorobut- 
3-en-2-one (46.0 mg, 0.2 mmol), (
i
Pr)2NEt (87 μL, 0.5 mmol) and MeCN (1.0 mL), with 
stirring for 72 h, gave the title compound 342 as a orange solid (32.9 mg, 61%) after 
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purification by flash chromatography on silica gel (Et2O : petrol, 10 : 90). 
mp. 84-86 °C; max (ATR): 2926, 1735, 1664, 1604, 1577, 1556, 1516, 1429, 1352, 1307, 
1274, 1247, 1197, 1184, 1145, 1095, 1031, 829; 
1
H NMR (500 MHz, CDCl3) δH: 3.88 (3H, s, 
OMe), 6.60 (1H, dt, J 1.6, 0.7, C(3)H), 6.96 (1H,dt, J 1.6, 0.7, C(5)H), 6.98-7.06 (2H, m, 




H} NMR (101 MHz, CDCl3) C: 
55.6 (OMe), 104.5 (q, 
3
JCF 3.6, C(5)), 111.7 (C(3)), 115.1 (ArC), 118.3 (q, 
1
JCF 272.9, 
C(4)CF3), 126.2 (ArC), 128.4 (ArC), 148.4 (q, 
2









 requires 271.0579, found 




Following general procedure F, (phenylthio)acetic acid (67.3 mg, 0.4 mmol), (
i
Pr)2NEt (104 
μL, 0.6 mmol) and pivaloyl chloride (74 μL, 0.6 mmol) in MeCN (1.0 mL), followed by 
DHPB (7.6 mg, 0.04 mmol, 20 mol %), 367 (55.7 mg, 0.2 mmol), (
i
Pr)2NEt (87 μL, 0.5 mmol) 
and MeCN (1.0 mL) gave the title compound 343 as a white solid (60.2 mg, 95%) after 
purification by flash chromatography on silica gel (Et2O : CH2Cl2, 2 : 98). 
mp. 201-202 °C; max (ATR): 2916, 1749, 1668, 1558, 1394, 1294, 1149, 1091, 950, 829; 
1
H 
NMR (500 MHz, CD3CN) δH: 3.11 (3H, s, Me), 6.85 (1H, s, C(3)H), 7.23 (1H, s, C(5)H), 




H} NMR (126 
MHz, CD3CN) C: 44.3 (Me), 106.3 (q, 
3
JCF 3.6, C(5)), 116.1 (C(3)), 119.3 (q, 
1
JCF 271.6, 
C(4)CF3), 128.9 (ArC), 140.0 (ArC), 143.9 (ArC), 148.4 (q, 
2









319.0246, requires 319.0246 (−0.1 ppm). 
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The reaction was repeated using 367 (55.7 mg, 0.2 mmol) and DHPB (0.38 mg, 0.002 mmol, 
1 mol %) under the above conditions, giving 343 (36.4 mg, 57%). Spectral data of 343 





Following general procedure F, (phenylthio)acetic acid (67.3 mg, 0.4 mmol), (
i
Pr)2NEt (104 
μL, 0.6 mmol) and pivaloyl chloride (74 μL, 0.6 mmol) in MeCN (1.0 mL), followed by 
DHPB (7.6 mg, 0.04 mmol, 20 mol %), S6 (41.2 mg, 0.2 mmol), (
i
Pr)2NEt (87 μL, 0.5 mmol) 
and MeCN (1.0 mL), gave the title compound 344 as a red solid (41.0 mg, 83%) after 
purification by flash chromatography on silica gel (Et2O : petrol, 5 : 95). 
mp. 136-137 °C {Lit.
104
 141-143 °C}; max (ATR): 2922, 1741, 1688, 1564, 1352, 1192, 1136, 
839; 
1
H NMR (500 MHz, CDCl3) δH: 6.59 (1H, s, C(3)H ), 6.93 (1H, s, C(5)H), 7.21 (1H, dd, 





H} NMR (126 MHz, CDCl3) C: 103.8 (q, 
3
JCF 3.6, C(5)), 110.2 (C(3)), 
118.0 (q, 
1
JCF 273.0, C(4)CF3), 129.2 (C(4)ArC(5’)), 129.2 (C(4)ArC(4’)), 131.3 
(C(4)ArC(3’)), 137.4 (C(4)), 146.1 (C(4)ArC(1’)), 148.5 (q, 
2
JCF 39.3, C(6)), 159.5 (C(2)); 
19
F 




 found 247.0035, 
requires 247.0035 (+0.0 ppm). 
 
The reaction was repeated using S6 (41.2 mg, 0.2 mmol) and DHPB (0.38 mg, 0.002 mmol, 1 
mol %) under the above conditions, giving 344 (22.0 mg, 45%). Spectral data of 21 identical 






Following general procedure F, (phenylthio)acetic acid (67.3 mg, 0.4 mmol), (
i
Pr)2NEt (104 
μL, 0.6 mmol) and pivaloyl chloride (74 μL, 0.6 mmol) in MeCN (1.0 mL), followed by 
DHPB (7.6 mg, 0.04 mmol, 20 mol %), 327 (38.0 mg, 0.2 mmol), (
i
Pr)2NEt (87 μL, 0.5 mmol) 
and MeCN (1.0 mL), gave the title compound 345 as an orange solid (31.3 mg, 68%) after 
purification by flash chromatography on silica gel (Et2O : petrol, 5 : 95). 
mp. 123-124 °C; max (ATR): 2922, 1718, 1670, 1593, 1359, 1286, 1197, 1095, 862; 
1
H 
NMR (300 MHz, CDCl3) δH: 6.62 (1H, dd, J 3.6, 1.8, 1H, C(4)ArC(4’)H), 6.64-65 (1H, m, 





H} NMR (126 MHz, CDCl3) C: 102.08 (q, 
3
JCF 3.6, C(5)), 108.2 (C(3)), 
113.3 (C(4)ArC(4’)), 114.5 (C(4)ArC(5’)), 118.0 (q, 
1
JCF 272.9, CF3), 141.1 (C(4)ArC(1’)), 
146.9 (C(4)ArC(3’)), 148.1(C(4)), 148.8 (q, 
2









 found 231.0263, requires 





Following general procedure F, (phenylthio)acetic acid (67.3 mg, 0.4 mmol), (
i
Pr)2NEt (104 
μL, 0.6 mmol) and pivaloyl chloride (74 μL, 0.6 mmol) in MeCN (1.0 mL), followed by 
DHPB (7.6 mg, 0.04 mmol, 20 mol %), 328 (50.0 mg, 0.2 mmol), (
i
Pr)2NEt (87 μL, 0.5 mmol) 
and MeCN (1.0 mL), gave the title compound 346 as an orange solid (58.7 mg, 99%) after 
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purification by flash chromatography on silica gel (Et2O : petrol, 5 : 95). 
mp. 138-139 °C {Lit.
8
 147-148 °C}; max (ATR): 2922, 1743, 1766, 1624, 1558, 1351, 1272, 
1199, 1132, 850; 
1
H NMR (500 MHz, CDCl3) δH: 6.77 (1H, s, C(3)H ), 7.11 (1H, s, C(5)H), 
7.57-7.63 (2H, m, ArH), 7.65 (1H, dd, J 8.6, 1.8, ArH), 7.88-7.96 (3H, m, ArH), 7.97 (1H, d, J 




H} NMR (126 MHz, CDCl3) C: 104.8 (q, 
3
JCF 3.4, 
C(5)), 113.9 (C(3)), 118.2 (q, 
1
JCF 273.0, C(4)CF3), 123.0 (ArC), 127.3 (ArC), 127.5 (ArC), 
127.9 (ArC), 128.3 (ArC), 128.9 (ArC), 131.3 (4ry, ArC), 133.3 (4ry, ArC), 134.5 (4ry, ArC), 
148.5 (q, 
2









 found 291.0630, requires 291.0627 (+0.9 ppm). 
 
The reaction was repeated using 328 (50.0 mg, 0.2 mmol) and DHPB (0.38 mg, 0.002 mmol, 
1 mol %) under the above conditions, giving 346 (51.9 mg, 89%). Spectral data of 3463 
identical to the above. 
 
5-12. Data for α-substituted pyrones 
General procedure G: α-substituted pyrone synthesis 
To a flame dried vial under N2 was added (phenylthio)acetic acid (2 eq), (
i
Pr)2NEt (3 eq) and 
anhydrous MeCN (2.5 mL / 1.0 mmol acid) and cooled to 0 °C. Pivaloyl chloride (3 eq) was 
then added, and the reaction stirred for 30 minutes. DHPB 1 (indicated mol%) was added 
followed by the addition of α,β-unsaturated trifluoromethyl ketone (1 eq) and additional 
(
i
Pr)2NEt (2.5 eq) and anhydrous MeCN (2.5 mL / 1.0 mmol acid). The vial was sealed and 
the reaction mixture was stirred and heated to 95 °C for 24 h, then cooled and quenched with 
0.1 M HCl (10 mL), extracted with CH2Cl2 (x 3) and dried over MgSO4. The solvent was 
removed in vacuo to obtain the crude product which was purified by flash chromatography on 





and 3-methyl-4-phenyl-6-(trifluoromethyl)-2H-pyran-2-one, 359 
 
Following general procedure G, 320 (72.9 mg, 0.4 mmol), (
i
Pr)2NEt (104.0 μL, 0.6 mmol) 
and pivaloyl chloride (74 μL, 0.6 mmol ) in MeCN (1.0 mL), following by DHPB (7.6 mg, 
0.04 mmol, 20 mol %), 323 (40.0 mg, 0.2 mmol), (
i
Pr)2NEt (87.0 μL, 0.5 mmol) and MeCN 
(1.0 mL), gave 360 as a white solid (21.9 mg, 30%) after purification by flash 
chromatography on silica gel (Et2O : petrol 3 : 97). 
mp. 127-128°C; max (ATR): 2927, 1774, 1703, 1454, 1438, 1361, 1290, 1192, 1139, 1085, 
956; 
1
H NMR (500 MHz, CDCl3) δH: 1.10 (3H, s, Me), 3.73 (1H, dd, J 6.3, 1.6, C(4)H), 6.16 
(1H, dd, J 6.5, C(5)H), 7.05-7.11 (2H, m, ArH), 7.30-7.39 (5H, m, ArH), 7.45 (1H, t, J 67.4, 




H} NMR (126 MHz, CDCl3) C: 21.4 (Me), 48.8 (C(4)), 
55.3, 109.2 (q, 
3
JCF 3.3, C(5)), 118.6 (q, 
1
JCF 271.2, C(4)CF3), 125.7, 128.2, 128.6, 128.8, 
129.4, 129.6, 130.7, 135.7, 137.5, 139.9 (q, 
2




H} NMR (471 MHz, 




 found 387.0634, requires 
387.0636 (−0.3 ppm). 
 
Purification also gave 359 as a white solid (26.3 mg, 52%); mp. 62-63 °C; max (ATR): 2926, 
1732, 1363, 1263, 1197, 1145, 1087, 1043;
 1
H NMR (500 MHz, CDCl3) δH: 2.15 (3H, s, Me), 




H} NMR (126 
MHz, CDCl3) C: 14.8 (Me), 108.1 (q, 
3
JCF 3.5, C(5)), 118.3 (q, 
1
JCF 272.2, C(4)CF3), 125.7, 
128.0, 129.0, 129.7, 136.3, 144.88 (q, 
2




H} NMR (376 




 found 255.0628, requires 
255.0627 (+0.2 ppm). 
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Formation of 359 from the Oxidation of 360
9
 
A solution of 360 (14.1 mg, 0.039 mmol, 1 eq) and Na2CO3(160.0 mg, 1.510 mmol, 39 eq) in 
CH2Cl2 (2 mL) at 0 °C was treated with a solution of m-CPBA (70%, 28.6 mg, 0.116 mmol, 3 
eq) in CH2Cl2 (2 mL), allowed to warm to rt and stirred for 30 minutes. The mixture was 
filtered though a plug of silica gel (Et2O eluent). The solvent was removed in vacuo and the 
crude product purified by flash chromatography on silica gel (Et2O : petrol, 5 : 95), to give 
359 as a white solid (9.0 mg, 91%). Spectral data of 359 identical to the above. 
 
One-Pot Procedure for the formation of 359 from 323 and 320 
Following general procedure C, 320 (72.9 mg, 0.4 mmol, 2 eq), (
i
Pr)2NEt (104 μL, 0.6 mmol, 
3 eq) in MeCN (1.0 mL), pivaloylchloride (74 μL, 0.6 mmol, 2 eq), followed by DHPB 1 (7.6 
mg, 0.04 mmol, 20 mol %), 323 (40.0 mg, 0.2 mmol), (
i
Pr)2NEt (87.0 μL, 0.5 mmol, 2.5 eq) 
and MeCN (1.0 mL). After work-up and extraction, the crude product was re-dissolved in 
CH2Cl2 (5 mL) then treated with m-CPBA (70% pure, 148 mg, 0.6 mmol, 3 eq) in CH2Cl2 (2 
mL) at 0 °C, and warmed to rt for 30 minutes. The mixture was filtered though a plug of silica 
gel (Et2O eluent). The solvent was removed in vacuo was purified by flash chromatography 
on silica gel (Et2O : petrol, 5 : 95), to give 359 as a white solid (32.4 mg, 64%). Spectral data 
of 359 identical to the above. 
 
3,4-Diphenyl-6-(trifluoromethyl)-2H-pyran-2-one, 364 and 3-methyl-4-phenyl-6- (trifluoro 
methyl)-5,6-dihydro-2H-pyran-2-one, 365 
 
Following general procedure G, α-(phenylthio)phenylacetic acid (97.7 mg, 0.4 mmol),  
(
i
Pr)2NEt (104.0 μL, 0.6 mmol) and pivaloyl chloride (74 μL, 0.6 mmol) in MeCN (1.0 mL), 
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following by DHPB (7.6 mg, 0.04 mmol, 20 mol %), 323 (40.0 mg, 0.2 mmol), (
i
Pr)2NEt 
(87.0 μL, 0.5 mmol) and in MeCN (1.0 mL), gave pyrone 364 as a white solid (29.4 mg, 
46%), after flash chromatography on silica gel (Et2O : petrol 2 : 98). 
mp. 94-96°C; max (ATR): 2926, 1739, 1365, 1271, 1199, 1145, 1105, 1053, 985; 
1
H NMR 
(500 MHz, CDCl3) δH: 6.84 (1H, s, C(5)H), 7.08-7.13 (2H, m, ArH), 7.14-7.20 (2H, m, ArH), 




H} NMR (126 MHz, CDCl3) C: 108.6 (q, 
3
JCF 3.5, C(5)), 118.2 
(q, 
1
JCF 272.6, C(4)CF3), 128.3, 128.6, 128.7, 129.5, 130.6, 132.6, 136.2, 146.4 (q, 
2
JCF 39.4, 









) found 317.0782, requires 317.0784 (−0.6 ppm). 
 
Dihydropyranone 365 was also isolated from the above reaction as a white solid (21.3 mg, 
33%). 
mp. 102-104 °C; max (ATR): 2924, 1730, 1444, 1363, 1282, 1188, 1143, 948; 
1
H NMR (500 














(126 MHz, CDCl3) C: 29.1 (C(5)), 73.1 (q, 
2
JCF 33.9, C(6)), 122.8 (q, 
1
JCF 280.2, C(6)CF3), 




H} NMR (471 MHz, 















5-13. COX-2 inhibitor Synthesis 
4-(4-Methanesulfonylphenyl)-3-(phenylsulfanyl)-6-(trifluoromethyl)-2H-pyran-2-one, 366 
 
Following general procedure F, 322 (110.5 mg, 0.4 mmol, 2 eq), (
i
Pr)2NEt (104 μL, 0.6 mmol, 
3 eq) and pivaloylchloride (74 μL, 0.6 mmol, 2 eq) in MeCN (1.0 mL), following by DHPB 
(7.6 mg, 0.04 mmol, 0.2 eq), 367 (55.7 mg, 0.2 mmol, 1 eq), (
i
Pr)2NEt (87 μL, 0.5 mmol, 2.5 
eq) and MeCN (1.0 mL), with stirring for 2 h, gave the title compound 366 as yellow solid 
(39.6 mg, 46%) after flash chromatography on silica gel (CH2Cl2). 
mp. 151-152 °C; max (ATR): 2927, 1741, 1683, 1506, 1313, 1197, 1149, 954; 
1
H NMR (400 
MHz, CDCl3) δH: 3.08 (3H, s, Me), 6.68 (1H, s, C(5)H), 7.13-7.24 (5H, m, ArH), 7.56 (2H, d, 




H} NMR (101 MHz, CDCl3) 
C: 44.5 (Me), 107.4 (q, 
3
JCF 3.5, C(5)), 118.0 (q, 
1
JCF 273.1, C(4)CF3), 126.7, 127.9, 128.1, 
129.2, 129.4, 132.4, 141.3, 141.8 147.0 (q, 
2




H} NMR (376 




 found 449.0098, requires 
449.0100 (−0.3 ppm). 
 
Pyrone 14 was also isolated from this reaction (29.5 mg, 46%). Spectral data of 14 identical to 
the above. 
 
The reaction was repeated using 367 (55.7 mg, 0.2 mmol) and DHPB (0.38 mg, 0.002 mmol) 
under the above conditions, giving 366 (26.3 mg, 31%). Spectral data of 366 are identical to 
the above. 
Pyrone 343 was also isolated from this reaction (29.6 mg, 47%). Spectral data of 343 identical 
to the above. 
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5-14. Data for derivatisation of 2-pyrone 





Following the conditions of Usachev et al.,
104
 a solution of 285 (120 mg, 0.50 mmol, 1 eq) 
and NH4OAc (77.1 mg, 1.0 mmol, 2 eq) in 80% aq. DMF (5 mL) was stirred and heated to 
170 °C for 2 h. The reaction mixture was poured into water (25 mL), and the white precipitate 
filtered and washed with cold petrol to obtain the title compound 384 as a white solid (87.9 
mg, 74%). 
mp. 198-200 °C {Lit.
8
 213-214 °C}; 
1
H NMR (300 MHz, DMSO-d6) δH: 7.21 (1H, d, J 1.3, 
C(3)H), 7.46-7.58 (3H, m, ArH), 7.62 (1H, d, J 1.3, C(5)H), 7.78-7.89 (2H, m, ArH), 11.81 








Following the conditions of Fujita et al.,
114
 a solution of tosyl chloride (14.3 mg, 0.075 mmol, 
1.5 eq) in THF (0.25 mL) was added to a stirred suspension of 384 (12.0 mg, 0.050 mmol, 1 
eq) and NaH (60% in mineral oil, 3.0 mg, 0.075 mmol, 1.5 eq) in THF (0.5 mL) at −78 °C. 
The reaction mixture was stirred at −78 °C for 1 h then heated to 60 °C for further 5 h. The 
mixture was poured into ice water (5 mL), neutralised with K2CO3, and then extracted with 
CHCl3 (3 x 2 mL). The combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo to give the crude product which was purified by flash chromatography 




mp. 128-130 °C {Lit.
149
 130-132 °C}; 
1
H NMR (500 MHz, CDCl3) δH: 2.47 (3H, s, Me), 7.37 
(2H, d, J 8.2, ArH), 7.48 (1H, d, J 1.3, ArH), 7.51-7.53 (3H, m, ArH), 7.61-7.63 (2H, m, ArH), 




5-14-3. 2-Amino Pyridine Synthesis 
4-Phenyl-6-(trifluoromethyl)pyridin-2-amine, 386 
 
The conditions of Ram et al. were modified for this procedure.
112
 A solution of 285 (48.0 mg, 
0.2 mmol, 1 eq), cyanamide (42.0 mg, 1.0 mmol, 5 eq) and anhydrous KOH powder (56.1 mg, 
1.0 mmol, 5 eq) in anhydrous DMF (2.0 mL) was stirred at rt for 72 h. The reaction mixture 
was poured into ice water then acidified to pH 4 with 0.1 M HCl. The mixture was extracted 
with CH2Cl2 (5 mL x 3), the combined organic layers washed with water (10 mL) and brine 
(10 mL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo to 
obtain the crude product which was purified by flash chromatography on silica gel (Et2O : 
petrol, 30 : 70) to give the title compound 386 as a white solid (25.8 mg, 54%). 
mp. 110-112 °C; max (ATR): 3321, 3201, 1637, 1558, 1558, 1282, 1205, 1122, 767; 
1
H NMR 
(500 MHz, CDCl3) δH: 4.78 (2H, s, NH2), 6.83 (1H, s, C(3)H), 7.25 (1H, d, J 1.3, C(5)H), 




H} NMR (126 MHz, CDCl3) C: 109.3, 
121.9 (q, 
1
JCF 274.2, C(6)CF3), 127.0, 129.2, 129.5, 137.7, 147.1 (q, 
2
















5-14-4. Naphthalene Synthesis 
3-Phenyl-1-(trifluoromethyl)naphthalene, 375 
 
The conditions of Bronner et al. were modified for this procedure.
184
 A solution of 285 (24.0 
mg, 0.10 mmol, 1 eq), 2-(trimethylsilyl)phenyl trifluoromethanesulfonate (149 mg, 0.50 
mmol, 5 eq) and CsF (76.0 mg, 0.50 mmol, 5 eq) in anhydrous MeCN (1.0 mL) was heated at 
100 °C for 18 h. The reaction mixture was cooled rt and the solvent removed in vacuo to 
obtain the crude product that was purified by flash chromatography on silica gel (petrol) to 
give the title compound 375 as a colourless oil (14.8 mg, 54%). 
max (ATR): 2922, 1521, 1323, 1267, 1128, 1118, 979, 893; 
1
H NMR (500 MHz, CDCl3) δH: 
7.40-7.47 (1H, m, ArH), 7.49-7.56 (2H, m, ArH), 7.58-7.68 (1H, m, ArH), 7.69-7.76 (1H, m, 




H} NMR (126 MHz, CDCl3) C: 124.3 (q, 
3
JCF 2.0, C(6)), 124.7 (q, 
3
JCF 6.0, C(2)), 
124.8 (q, 
1
JCF 274.6, C(1)CF3), 126.7 (q, 
2
JCF 30.0, C(1)), 127.1, 127.4, 127.7, 128.1, 128.2, 









 found 273.0887, requires 273.0886 (+0.5 ppm). 
 
5-14-5. Diels-Alder Reaction 
1,2-dimethyl 5-phenyl-3-(trifluoromethyl)benzene-1,2-dicarboxylate, 374 
 
The conditions of Ziegler et al. were modified for this procedure.
185
 A stirred solution of 285 
(48.0 mg, 0.2 mmol, 1 eq) and dimethylacetylene dicarboxylate (0.13 mL, 1.0 mmol, 5 eq) in 
xylene (0.2 mL) in a sealed tube was heated to 200 °C for 72 h. The reaction mixture was 
cooled to rt and the solvent removed in vacuo to obtain the crude product which was purified 
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by flash chromatography on silica gel (Et2O : petrol, 10 : 90) to give 374 as a white solid 
(64.3 mg, 95%). 
mp. 82-84 °C; max (ART): 2954, 1743, 1734, 1456, 1435, 1355, 1280, 1231, 1138, 1062; 
1
H 
NMR (500 MHz, CDCl3) δH: 3.95 (3H, s, OMe), 3.99 (3H, s, OMe), 7.46 (1H, t, J 7.5, 
C(5)ArC(4’)H), 7.51 (2H, t, J 7.5, C(5)ArC(3’)H), 7.62 (2H, t, J 7.5, C(5)ArC(4’)H), 8.07 




H} NMR (126 MHz, CDCl3) C: 53.1 
(Me), 53.3 (Me), 123.2 (q, 
1
JCF 274.5, C(3)CF3), 127.3 (ArC), 128.7 (q, 
3
JCF 4.6, C(4)), 129.1 
(q, 
2
JCF 32.3, C(3)), 129.2 (ArC), 129.4 (ArC), 130.0 (ArC), 132.0 (ArC), 132.1 (q, 
3
JCF 1.8, 









 found 339.0838, requires 339.0839 (−0.2 ppm). 
 
Ethyl 3-phenyl-5-(trifluoromethyl)benzoate, 377 and Ethyl 4-phenyl-2- (trifluoromethyl) 
benzoate, 376 
 
The conditions of Ziegler et al. were modified for this procedure.
14
 A solution of 285 (24.0 
mg, 0.1 mmol, 1 eq) and ethyl propiolate (51.0 μL, 0.5 mmol, 5 eq) in xylene (0.2 mL) in a 
sealed tube was refluxed for 72 h. The reaction mixture was cooled to rt and the solvent 
removed in vacuo to obtain the crude product, which was purified by flash chromatography 
on silica gel (Et2O : petrol, 2 : 98) to give the ester 377 as a colourless oil (17.1 mg, 58%). 
max (ATR): 2927, 1724, 1440, 1373, 1355, 1263, 1244, 1170, 1128, 1068, 1020, 900; 
1
H 
NMR (500MHz, CDCl3) δH: 1.45 (3H, t, J 7.1, Me), 4.45 (2H, q, J 7.1, CH2), 7.43 (1H, t, J 
7.3, ArH), 7.50 (2H, t, J 7.5, ArH), 7.60-7.68 (2H, m, ArH), 8.01 (1H, s, C(4)H), 8.28 (1H, s, 




H} NMR (126 MHz, CDCl3) C: 14.1 (Me), 61.8 (CH2), 
123.9 (q, 
1
JCF 272.7, C(5)CF3), 125.2 (q, 
3
JCF 3.8, C(6)), 127.3 (ArC), 128.0 (q, 
3
JCF 3.6, C(4)), 
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128.6, 129.2, 131.5, 131.7 (q, 
2









295.0942, requires 295.0940 (+0.5 ppm). 
 
Ester 376 was also isolated from the above reaction as a colourless oil (6.8 mg, 23%). 
max (ATR): 2927, 1724, 1614, 1452, 1367, 1323, 1294, 1257, 1170, 1136, 1047, 902; 
1
H 
NMR (500 MHz, CDCl3) δH: 1.41 (3H, t, J 7.2, Me), 4.42 (2H, q, J 7.2, CH2), 7.47-7.53 (1H, 
m, ArH), 7.57-7.65 (2H, m, ArH), 7.81 (1H, dd, J 8.0, 1.6, C(5)H), 7.89 (1H, d J 8.0, C(6)H), 




H} NMR (126 MHz, CDCl3) C: 14.1 (Me), 62.9 (CH2), 123.5 
(q, 
1
JCF 273.6, C(2)CF3), 125.6 (q, 
3
JCF 5.4, C(3)), 127.4 (ArC), 128.9 (ArC), 129.5 (q, 
2
JCF 
32.4, C(2)), 130.0 (q, 
3









 found 295.0943, 
requires 295.0940 (+0.9 ppm). 
 
5-15. Data for Tri-Substituted Pyridine 
Ethyl 2-phenyl-6-((phenylsulfonyl)oxy)isonicotinate,400 
 
A flask containing a stirrer bar was charged with CH2Cl2 (to give 0.4 м acid), 
(phenylthio)acetic acid (33.6 mg, 0.2 mmol, 2 eq.), (
i
Pr)2NEt (35 μL, 0.2, 1 eq.) and cooled to 
0 °C. Pivaloyl chloride (25 μL, 0.2, 1 eq.) was added and the reaction stirred for 30 minutes. 
(−)-Tetramisole·HCl (7.6 mg, 0.04 mmol, 20 mol%) was added followed by the ketimine xx 
(68.7 mg, 0.2 mmol, 1 eq.) and additional (
i
Pr)2NEt (35 μL, 0.2, 1 eq.) in CH2Cl2 (to give 0.4 
м of ketimine). The reaction was allowed to warm to rt and stirred until complete by TLC. 
The reaction was quenched with 0.1 м HCl (～20 mL/mmol acid), the layers separated and 
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the aqueous layer extracted with CH2Cl2 (2 × eq. vol.). The combined organics were dried 
over MgSO4, the solvent removed in vacuo and the residue purified by flash chromatography 
giving the title compound 400 as white solid (31.7 mg, 0.08 mmol, 41%); 
1
H NMR (500 MHz, CDCl3) δH 1.43 (3H, t, J 7.1, CH2CH3), 4.45 (2H, q, J 7.1, CH2CH3), 
7.36-7.45 (3H, m, ArH), 7.54-7.61 (3H, m, ArH), 7.68-7.72 (1H, m, ArH), 7.73-7.76 (2H, m, 




H} NMR (126 MHz, CDCl3) δC 14.3 (CH2CH3), 62.4 
(CH2CH3), 113.56, 118.3, 127.1, 128.9, 129.2, 130.2, 134.2, 136.8, 137.5, 143.1, 157.3, 157.7, 
164.1 
 
5-16. Data for α-Aroyloxyaldehydes 
General procedure H: Preparation of α-Aroyloxyaldehydes 
On the basis of a literature procedure,
168
 tert-butyl hydroperoxide (5−6 M in decane) was 
added to a solution of the appropriate aldehyde (1.5 equiv), p-nitrobenzoic acid (1 equiv), 
tetrabutylammonium iodide (20 mol %), and piperidine (10 mol %) in ethyl acetate (to make 
0.2 M solution of acid). The resulting solution was heated at 50 °C for 5 h before being 
cooled to room temperature and quenched with Na2S2O3 and NaHCO3. The phases were 
separated, the aqueous phase was extracted with ethyl acetate (×2), and the combined 
organics were washed with brine before being dried over MgSO4, filtered, and concentrated. 
The crude product was purified by flash chromatography. 
 
1-oxopropan-2-yl 4-nitrobenzoate, 476 
 
Following general procedure H, propionaldehyde (2.71 mL, 37.5 mmol), p-nitrobenzoic acid 
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(4.18 g, 25 mmol), tetrabutylammonium iodide (1.85 g, 5.00 mmol) and piperidine (0.25 mL, 
2.50 mmol) in EtOAc (125 mL), and tert-butyl hydroperoxide (5.00 mL, 27.5 mmol) resulted 
the crude mixture, which purified by column chromatography on silica (70:30 petrol:EtOAc) 





H NMR (500 MHz, CDCl3) δH: 1.59 (3H, d, J 7.2, CH3), 5.39 
(1H, q, J 7.2, CH3CH), 8.27 (2H, d, J 8.9, ArC(2)H2), 8.33 (2H, d, J 8.9, ArC(3)H2), 9.60 (1H, 




1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate, S7 
 
Following general procedure H, 3-phenylpropionaldehyde (4.93 mL, 37.5 mmol), 
p-nitrobenzoic acid (4.18 g, 25 mmol), tetrabutylammonium iodide (1.85 g, 5.00 mmol) and 
piperidine (0.25 mL, 2.50 mmol) in EtOAc (125 mL), and tert-butyl hydroperoxide (5.00 mL, 
27.5 mmol) resulted the crude mixture, which purified by column chromatography on silica 
(70:30 petrol:EtOAc) the recrystallistion (Et2O) to give the title compound S7 as a pale 
yellow powder (1.15 g, 15%). 
mp. 91-92 {Lit.
168
 85−86 °C}; 
1
H NMR (500 MHz, CDCl3) δH: 3.22 (1H, dd, J 8.4, 14.6, 
ArCHaHb), 3.35 (1H, dd, J 4.8, 14.5, ArCHaHb), 5.52 (1H, dd, J 4.9, 8.4, CHCHO), 7.28 (2H, 
d, ArH), 7.30-7.38 (2H, m, ArH), 8.19 (2H, d, J 8.6, ArH), 8.30 (2H, d, J 8.6, ArH), 9.68 (1H, 








5-17. Data for aryl ketimines 
N-((1Z,2E)-1,3-diphenylallylidene)-4-methylbenzenesulfonamide, 464 
 
Following general procedure C (see page 156), the reaction of (E)-chalcone (4.16 g, 20 mmol), 
p-toluenesulfonamide (3.42 g, 20 mmol), NEt3 (5.6 mL, 40 mmol) and TiCl4 (2.2 mL, 20 
mmol) in CH2Cl2 (40 mL) gave the title compound 464 after trituration (Et2O) (6.54 g, 18.1 
mmol, 90%) as yellow solid. 
mp. 146-148 C {Lit.
68
 116-120C }; νmax (ATR): 3120, 1610, 1545, 1495, 1304, 1157, 1094; 
1
H NMR (500 MHz, CDCl3) δH 2.45 (3H, s, -Me), 7.10 (1H, d, J 16.0, C(3)H), 7.34 (2H, d, J 
8.0, ArH), 7.39-7.53 (5H, m, ArH), 7.53-7.72 (5H, m, ArH), 7.89-8.02 (2H, m, ArH), 8.12 






Following general procedure C (see page 156), the reaction of (E)-chalcone (4.16 g, 20 mmol), 
benzeenesulfonamide (3.14 g, 20 mmol), NEt3 (5.6 mL, 40 mmol) and TiCl4 (2.2 mL, 20 
mmol) in CH2Cl2 (40 mL) gave the title compound 465 after trituration (Et2O) (5.46 g, 15.7 
mmol, 79%) as white solid. 
mp. 123-125 C; νmax (ATR): 3062, 1612, 1527, 1442, 1296, 1149, 1080; 
1
H NMR (500 
MHz, CDCl3) δH 7.09 (1H, d, J 16.2, C(3)H), 7.38-7.49 (5H, m, ArH), 7.48-7.75 (8H, m, 




), found 348.1055, 








Following general procedure C (see page 156), the reaction of (E)-chalcone (2.08 g, 10 mmol), 
p-nitrobenzenesulfonamide (2.02 g, 10 mmol), NEt3 (2.8 mL, 20 mmol) and TiCl4 (1.1 mL, 
10 mmol) in CH2Cl2 (20 mL) gave the title compound 466 after trituration (Et2O) (3.06 g, 7.9 
mmol, 79%) as yellow solid. 
mp. 154-156 C; νmax (ATR): 1614, 1517, 1440, 1298, 1145, 1082; 
1
H NMR (500 MHz, 
CDCl3) δH 7.17 (1H, d, J 15.9, C(3)H), 7.38-7.54 (5H, m, ArH), 7.54-7.75 (5H, m, ArH), 8.00 




H} NMR (101 MHz, 
CDCl3) δC 124.2, 128.6 128.7, 129.1, 129.3, 130.4, 131.7, 132.6, 134.4, 136.7, 147.3, 150.1, 









Following general procedure C (see page 156), the reaction of (E)-chalcone (417 mg, 2.0 
mmol), N,N-dimethylsulfamide (250 mg, 2.0 mmol), NEt3 (558 μL, 4.0 mmol) and TiCl4 (220 
μL, 2.0 mmol) in CH2Cl2 (25 mL) gave the title compound 467 after flash column 
chramgraphy (Et2O: petrol, 1:4) (0.19 g, 0.6 mmol, 30%) as yellow solid. 
mp. 56-58 C {Lit.
187
 58-10 C }; 
1
H NMR (400 MHz, CDCl3) δH 2.94 (6H, s, NMe2), 7.06 
(1H, d, J 16.2, C(3)H), 7.40-7.41 (3H, m, ArH), 7.44-7.52 (2H, m, ArH), 7.53-7.62 (3H, m, 




H} NMR (101 MHz, CDCl3) 







5-18. Data for aldimines 
General procedure I: Preparation of aldimines 
A Dean-Stark containing a stirrer bar was charged with the requisite sulfonamide (1 eq.), 
trans-cinnamaldehyde (1 eq.) and toluene (ca. 0.1 M). The resulting solution was heated at 
reflux overnight. The solid product precipitated with Et2O and the suspension filtered. The 




Following general procedure I, the reaction of tosylamide (0.66 g, 5.0 mmol), 
trans-cinnamaldehyde (0.68 g, 5.0 mmol) in CH2Cl2 (5 mL), gave the title compound 469 as a 
white solid (1.26 g, 4.4 mmol, 88%). 
mp. 115-116 °C; 
1
H NMR (500 MHz, CDCl3) δH 2.44 (3H, s, SO2ArC(4)CH3), 6.99 (1H, dd, 
J 9.5, 15.8, C(2)H),7.31-7.37 (2H, m, ArH), 7.41-7.46 (2H, m, ArH), 7.49 (1H, dd, J 15.8, 





NMR (126 MHz, CDCl3) δC 12.8 (CH3), 124.9, 128.1, 128.8, 129.3, 130, 131.8, 134.3, 135.5, 




Following general procedure I, the reaction of 4-methoxylsulfonamide (0.94 g, 5.0 mmol), 
trans-cinnamaldehyde (0.68 g, 5.0 mmol) in CH2Cl2 (5 mL), gave the title compound 470 as a 
solid crystal (1.25 g, 4.1 mmol, 83%). 
mp. 121-122 °C{Lit.
188
 125-190 ˚C}; 
1
H NMR (500 MHz, CDCl3) δH 3.88 (3H, s, OCH3), 
6.94-7.04 (2H, m, ArH and C(2)H), 7.42-7.43 (2H, m, ArH)7.48 (1H, d, J 6.9, C(3)H), 7.55 
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H} NMR (126 
MHz, CDCl3) δC 55.8 (OCH3), 114.6, 124.9, 128.7 129.3, 129.9, 130.3, 131.7, 134.3, 153.7, 




5-19. Data for dihydropyridinones 
(3R,4S)-3-methyl-4,6-diphenyl-1-tosyl-3,4-dihydropyridin-2(1H)-one, 478 
 
Following the procedure outlined by Smith et al.,
168
 The appropriate α-aroyloxyaldehyde 476 
(134.0 mg, 0.6 mmol, 1.5 equiv), ketimine 467 (144.6 mg, 0.4 mol, 1.0 equiv), and NHC 
precatalyst 477 (14.7 mg, 10 mol %) were dissolved in anhydrous THF (8 ml) in a sealed vial 
containing 4 Å  molecular sieves. Et3N (84 μl, 60.7 mg, 1.5 equiv) was added and the reaction 
mixture was stirred at rt until complete by TLC analysis. The mixture was diluted with EtOAc 
and washed successively with 1 м HCl, saturated NaHCO3 and brine. The organic layer was 
dried with MgSO4, filtered, and concentrated in vacuo to give the crude product that was 
purified by flash silica column chromatography (Et2O: Petrol, 5:95), gave the title compound 
478 as a white solid (145.5 mg, 0.35 mmol, 87%, 74:26 dr). 
mp. 148-150 ˚C; 
1
H NMR (400 MHz, CDCl3) major diastereomer (selected) δH 0.94 (3H, d, 
J 6.9, -CH3), 2.45 (3H, s, SO2ArCH3), 2.66 (1H, dq, J 6.9, 12.1, C(3)H), 3.45 (1H, dd, J 3.7, 
12.0, C(4)H), 5.91 (1H, J 3.7, C(5)H); minor diastereomer (selected) δH 1.03 (3H, d, J 7.1, 
-CH3), 2.45 (3H, s, SO2ArCH3), 2.86-2.98 (1H, m, C(3)H), 3.89 (1H, t, J 5.8, C(4)H), 5.99 
(1H, J 5.7, C(5)H); both diastereoisomers δH 7.18 (2H, m, ArH), 7.23-7.43 (11H, m, ArH), 




), found 440.1282, requires 








Following the procedure outlined by Bode et al.,
65
 The ethyl trans-4-oxo-2-butenoate (66 μl, 
0.55 mmol, 1.1 equiv), ketimine 470 (150.7 mg, 0.5 mol, 1.0 equiv), and NHC precatalyst 480 
(16.6 mg, 10 mol %) were dissolved in toluene/THF (10:1 V/V, 10 ml) in a sealed vial 
containing 4 Å  molecular sieves. i-Pr2NEt (8.6 μl, 0.05 mmol, 10 mol%) was added and the 
reaction mixture was stirred at rt until complete by TLC analysis. The mixture was diluted 
with EtOAc and washed successively with 1 м HCl, saturated NaHCO3 and brine. The 
organic layer was dried with MgSO4, filtered, and concentrated in vacuo to give the crude 
product that was purified by flash silica column chromatography (Et2O: Petrol, 5:95), gave 
the title compound 481 as a white solid (49.9 mg, 0.13 mmol, 25%, 85:15 dr). 
 
5-20. Data for C-sulfonyl Dihydropyridinones 
General procedure J: preparation of C-sulfonyl dihydropyridinone  
A solution of dihydropyridinone (1 eq.) in CH2Cl2 (0.1 м) in RBF, which was thoroughly 
cleaned in a KOH bath and washed with water before used, under UV light at 365 nm at rt for 
16 hours. The solvent removed in vacuo on a rotary evaporator and the crude mixture was 





Following general procedure J, the reaction of dihydropyridinone 212 (185.0 mg, 0.4 mmol) 
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in degased CH2Cl2 (4.0 mL) for 18 h gave the crude mixture. Purification by flash 
chromatography (Et2O : CH2Cl2, 3 : 97) gave the title compound 482 as a white solid (174.6 
mg, 0.34 mmol, 95%). 
mp. 144-145 ˚C; max (ATR): 3267, 2962, 2926, 1730, 1627, 1446, 1261, 1143, 1089, 1022, 
802 ; 
1
H NMR (500 MHz, CDCl3) δH 1.38 (3H, t, J 7.1, -CH2CH3), 4.28-4.39(3H, m, C(3)H 
and -CH2CH3), 4.52 (1H, d, J 1.0, C(4)H), 6.82 (2H, d, J 7.7, ArH), 6.99-7.03 (3H, m, ArH), 




H} NMR (101 
MHz, CDCl3) δC 14.3 (-CH2CH3), 47.3 (C(3)), 48.0 (C(4)), 62.5 (-CH2CH3), 114.8 (C(5)), 
127.1 (ArC), 127.6 (ArC), 128.3 (ArC), 128.8 (ArC), 129.4 (ArC), 130.7 (ArC), 131.9 
(C(3)ArC(1)), 132.5 (ArC), 135.6 (NSO2ArC(1)), 141.1 (C(6)ArC(1)), 147.1 (C(6)), 168.4 




, found 462.1372 requires 
472.1370 (＋0.5 ppm).  
 
(3S,4S)-Ethyl 2-oxo-3,6-diphenyl-5-tosyl-1,2,3,4-tetrahydropyridine-4-carboxylate, 484 
 
Following general procedure J, the reaction of dihydropyridinone 241 (47.6 mg, 0.1 mmol) in 
degaseded CH2Cl2 (1.0 mL) for 18 h gave the crude mixture. Purification by flash 
chromatography (Et2O : CH2Cl2, 3 : 97) gave the title compound 484 as a white solid (41.9 
mg, 0.088 mmol, 88%). 
mp. 169-170 ˚C; max (film, cm-1): 3240, 2924, 1726, 1691, 1631, 1452, 1348, 1145, 1087, 
1014, 813; 
1
H NMR (500 MHz, CDCl3) δH 1.38 (3H, t, J 7.1, -CH2CH3), 2.30 (3H, s, -CH3), 
4.23-4.40 (3H, m, C(3)H and -CH2CH3), 4.47 (1H, d, J 1.5, C(4)H), 6.76 (2H, d, J 8.2 
SO2Ar(3)H), 6.83 (2H, d, J 8.2 SO2Ar(2)H), 7.17 (2H, m, ArH), 7.26-7.34 (5H, m, ArH), 7.36 




H} NMR (101 MHz, CDCl3) δC 14.3 (-CH2CH3), 
21.6 (SO2Ar(4)CH3), 47.3 (C(3)), 49.2 (C(4)), 62.4 (-CH2CH3), 115.6 (C(5)), 127.1 (ArC), 
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Following general procedure J, the reaction of dihydropyridinone 245 (77.6 mg, 0.158 mmol) 
in degased CH2Cl2 (1.6 mL) for 18 h gave the crude mixture. Purification by flash 
chromatography (Et2O : CH2Cl2, 5 : 95) gave the title compound 485 as a white solid (70.8 
mg, 0.44 mmol, 91%). 
mp. 196-198 ˚C; max (film, cm-1): 3232, 2978, 1722, 1703, 1633, 1593, 1496, 1454, 1267, 
1141, 1091, 1016; 
1
H NMR (400 MHz, CDCl3) δH 1.37 (3H, t, J 7.1, -CH2CH3), 3.76 (3H, s, 
-OCH3), 4.24-4.38 (3H, m, C(3)H and -CH2CH3), 4.46 (1H, d, J 1.7, C(4)H), 6.48 (2H, d, J 
9.0, NSO2ArC(3)H), 6.79 (2H, d, J 8.9, NSO2ArC(2)H), 7.14-7.18 (3H, m, ArH), 7.28-7.42 




H} NMR (101 MHz, CDCl3) δC 14.2 (-CH2CH3), 47.3 (C(4)), 48.1 (C(3)), 
55.7 (-OCH3), 62.4 (-CH2CH3), 113.5 (NSO2ArC(3)), 115.2 (C(5)), 127.1 (ArC), 128.1 (ArC), 
128.5 (ArC), 129.1 (ArC), 129.3 (ArC), 129.7 (ArC), 130.6 (ArC), 132.1 (C(6)ArC(1)), 132.7 
















Following general procedure J, the reaction of dihydropyridinone 246 (50.7 mg, 0.1 mmol) in 
degased CH2Cl2 (1.0 mL) for 18 h gave the crude mixture. Purification by flash 
chromatography (Et2O : CH2Cl2, 3 : 97) gave the title compound 486 as a white solid (43.1 
mg, 0.085 mmol, 85%). 
mp. 220-221 ˚C; max (film, cm-1): 3255, 2981, 1728, 1624, 15.27, 1448, 1348, 1303, 1145, 
1089, 854; 
1
H NMR (400 MHz, CDCl3) δH 1.40 (3H, t, J 7.1, -CH2CH3), 4.28-4.43 (3H, m, 
C(3)H and -CH2CH3), 4.52 (1H, d, J 1.8, C(4)H), 6.87 (2H, d, J 9.0, NSO2ArC(2)H), 7.13 
(2H, m, NH and ArH), 7.28-7.31 (4H, m, ArH), 7.37-7.42 (3H, m, ArH), .37-7.42 (3H, m, 




H} NMR (101 
MHz, CDCl3) δC 14.2 (-CH2CH3), 47.3 (C(4)), 47.6 (C(3)), 62.6 (-CH2CH3), 113.7 (C(5)), 
123.1 (NSO2ArC(3)), 126.9 (ArC), 128.3 (C(6)ArC(1)), 128.6 (NSO2ArC(2)), 128.7 (ArC), 
129.4 (ArC), 131.1 (ArC), 135.3 (C(3)ArC(1)), 146.6 (NSO2ArC(1)), 148.3 (C(6)), 149.5 










Following general procedure J, the reaction of dihydropyridinone 244 (62.7 mg, 0.157 mmol) 
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in degased CH2Cl2 (1.6 mL) for 18 h gave the crude mixture. Purification by flash 
chromatography (Et2O : CH2Cl2, 3 : 97) gave the title compound 487 as a white solid (42.3 
mg, 0.11 mmol, 67%) and recovered starting material 244 dihydropyridinone (16.4 mg, 0.041 
mmol, 26%).  
mp. 86-87 ˚C; max (film, cm-1): 3250, 2926, 1726, 1701, 1629, 1448, 1300, 1132, 954; 
1
H 
NMR (400 MHz, CDCl3) δH 1.35 (3H, t, J 7.1, -CH2CH3), 2.5 (3H, s, -CH2), 4.24-4.38 (2H, 





H} NMR (101 MHz, CDCl3) δC 14.3 (-CH2CH3), 44.0 (-CH3), 46.4 (C(4)), 47.7 
(C(3)), 62.5 (-CH2CH3), 113.8 (C(5)), 127.0 (ArC), 128.4 (ArC), 128.8 (ArC), 128.9 (ArC), 
129.3 (ArC), 131.1 (ArC), 132.0 (C(6)ArC(1)), 135.2 (C(3)ArC(1)), 147.6 (C(6)), 169.0 




, found 400.1218, requires 





Following general procedure J, the reaction of dihydropyridinone 236 (68.7 mg, 0.147 mmol) 
in degased CH2Cl2 (1.5 mL) for 18 h gave the crude mixture. Purification by flash 
chromatography (Et2O : CH2Cl2, 3 : 97) gave the title compound 488 as a white solid (54.2 
mg, 0.115 mmol, 79%). 
mp. 152-153 ˚C; max (film, cm-1): 3265, 2980, 2360, 1730, 1701, 1627, 1446, 1301, 1145, 
1089, 756; 
1
H NMR (400 MHz, CDCl3) δH 1.35 (3H, t, J 7.1, -CH2CH3), 4.14-4.39(3H, m, 
C(3)H and -CH2CH3), 4.58 (1H, d, J 1.7, C(4)H), 6.98-7.04 (2H, m, ArH), 7.05-7.17 (6H, m, 




H} NMR (101 MHz, 
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CDCl3) δC 14.3 (-CH2CH3), 44.5 (C(3)), 46.0 (C(4)), 62.4 (-CH2CH3), 114.7 (C(5)), 122.3 
(C(3)ArC), 126.9 (ArC), 127.1 (ArC), 127.6 (ArC), 128.4 (ArC), 128.6 (ArC), 128.9 (ArC), 
130.5 (ArC), 131.9 (C(3)ArC(1)), 132.6 (ArC), 135.2 (NSO2ArC(1)), 141.1 (C(6)ArC(1)), 










Following general procedure J, the reaction of dihydropyridinone 237 (60.0 mg, 0.141 mmol) 
in degased CH2Cl2 (1.5 mL) for 18 h gave the crude mixture (92:8 dr). Purification by flash 
chromatography (Et2O : CH2Cl2, 3 : 97) gave the title compound 489 as a white solid (48.0 
mg, 0.113 mmol, 80%, 96:4 dr). 
mp. 155-156 ˚C; max (film, cm-1): 3265, 2978, 1728, 1701, 1629, 1446, 1303, 1226, 1178, 
1145, 1091, 1031, 964; 
1
H NMR (400 MHz, CDCl3) major diastereomer δH 1.23 (3H, t, J 7.1, 
-CH2CH3), 1.61 (3H, t, J 7.1, -C(3)CHCHCH3), 3.49-3.58 (1H, m, C(3)H), 4.03 (1H, d, J 1.8, 
C(4)H), 4.07-4.24 (1H, m, -CH2CH3), 5.26 (1H, ddq, J 15.3, 6.3, 1.6, -C(3)CHCHCH3), 5.72 
(1H, dqd, J 14.5, 6.5, 1.5, -C(3)CHCHCH3), 6.80 (1H, s, NH), 7.11 (2H, J 7.3, ArH), 
7.17-7.29 (4H, m, ArH), 7.30-7.42 (4H, m, ArH); minor diastereomer (selected) δH 1.18 (3H, t, 
J 7.1, -CH2CH3), 1.73 (3H, ddd, J 17.4, 6.7, 1.4, -C(3)CHCHCH3), 3.45 (1H, t, J 7.0, C(3)H), 





(101 MHz, CDCl3) major diastereomer δC 14.0 (-CH2CH3), 21.2 (-CH3), 45.2 (C(4)), 53.7 
(C(3)), 61.7 (-CH2CH3), 116.0 (C(5)), 126.2 (C(6)ArC), 128.5 (C(6)ArC), 128.7 (C(3)ArC(2)), 
128.9 (NSO2ArC(3)), 129.5 (NSO2ArC(2)), 129.5 (C(3)ArC(3)), 132.3 (C(3)ArC(1)), 134.1 
 
232 
(NSO2ArC(4)), 136.7 (C(6)ArC(1)), 137.9 (C(3)ArC(4)), 139.2 (NSO2ArC(1)), 141.3 (C(6)), 




), found 426.1370, 




Following general procedure J, the reaction of dihydropyridinone 474 (48.0 mg, 0.1 mmol) in 
degaseded CH2Cl2 (1.0 mL) for 18 h gave the crude mixture. Recrystalisation (Et2O) gave the 
title compound 490 as a white solid (42.4 mg, 0.088 mmol, 88%). 
mp. 232-234 ˚C {Lit.
68
 238-240˚C }; 
1
H NMR (500 MHz, CDCl3) δH 2.29 (3H, s, -CH3), 
4.10(1H, s, C(3)H), 4.82 (1H, s, C(4)H), 6.63 (2H, d, J 8.3, SNO2ArC(3)H), 6.77 (2H, d, J 8.0, 







Following general procedure J, the reaction of dihydropyridinone 475 (46.7 mg, 0.1 mmol) in 
degased CH2Cl2 (1.0 mL) for 18 h gave the crude mixture. Recrystallisation gave the title 
compound 491 as a white solid (40.2 mg, 0.087 mmol, 87%). 
mp. 249-250 ˚C; max (film, cm-1): 3209, 2897, 1695, 1672, 1494, 1315, 1145, 1089, 800; 
1
H 
NMR (400 MHz, CDCl3) δH 4.11 (1H, s, C(3)H), 4.87 (1H, s, C(4)H), 6.72 (2H, d, J 7.4, 




H} NMR (101 MHz, CDCl3) 
δC 47.3 (C(4)), 53.9 (C(3)), 119.2 (C(5)), 127.1 (ArC), 127.3 (ArC), 127.5  (ArC), 127.9  
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(ArC), 128.1 (ArC), 128.2 (ArC), 128.6 (ArC), 129.4  (ArC), 129.5  (ArC), 130.5 (ArC), 
132.3 (NSO2ArC(1)), 132.4 (ArC), 137.2 (C(3)ArC(1)), 139.7 (C(4)ArC(1)), 141.3 





466.1468, requires 466.1471 (－0.7 ppm).  
 
Ethyl 3-methyl-2-oxo-6-phenyl-5-tosyl-1,2,3,4-tetrahydropyridine-4-carboxylate, 492 
 
Following general procedure J, the reaction of dihydropyridinone 478 (47.6 mg, 0.114 mmol, 
74:26 dr) in degaseded CH2Cl2 (1.2 mL) for 18 h gave the crude mixture. Purification by flash 
chromatography (Et2O : CH2Cl2, 3 : 95) gave the title compound 492 as a white solid (31.6 
mg, 0.076 mmol, 66%, 69:31 dr). 
mp. 182-184 ˚C; max (film, cm-1): 3244, 2972, 1697, 1629, 1597, 1456, 1288, 1145, 1089, 
813; 
1
H NMR (500Hz, CDCl3) major diastereomer (selected) δH  1.39 (3H, d, J 7.3, -CH3), 
2.31 (3H, s, SO2ArCH3), 2.83 (1H, q, J 7.4, C(3)H), 4.24 (1H, d, J 1.0, C(4)H), 6.96 (2H, d, J 
8.1, NSO2ArC(3)H), 7.03 (2H, d, J 8.3, NSO2ArC(2)H); minor diastereomer (selected) δH 
1.06 (3H, d, J 6.9, -CH3), 2.27 (3H, s, SO2ArCH3), 3.22 (1H, q, J 6.8, C(3)H), 4.43 (1H, d, J 
7.4, C(4)H), 6.75 (2H, d, J 8.3, NSO2ArC(3)H), 6.84 (2H, d, J 8.0, NSO2ArC(2)H); both 
diastereoisomers δH 7.21 (1H, dd, J 2.9, 6.6, ArH), 7.24-7.32 (7H, m, ArH), 7.34 (1H, t, J 7.6, 





NMR (101 MHz, CDCl3) major diastereomer (selected) δC 17.9 (-CH3), 21.6 (SO2Ar(4)CH3), 
43.8 (C(3)), 46.8 (C(4)), 118.4 (C(5)), 127.7 (NSO2ArC(2)), 129.0 (NSO2ArC(3)), 132.7 
(C(6)Ar C(1), 138.6 (SO2Ar C(1)), 140.1 (C(4)ArC(1)), 143.5 (SO2Ar C(4)), 145.7 (C(6)), 
172.2 (C=O); minor diastereomer (selected) δC 12.3 (-CH3), 21.4 (SO2Ar(4)CH3), 40.5 (C(3)), 
45.2 (C(4)), 118.1(C(5)),127.6 (NSO2ArC(3)), 128.7 (NSO2ArC(2)); both diastereoisomers δC 
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127.1 (ArC), 127.5 (ArC), 127.5 (ArC), 127.8 (ArC), 127.9 (ArC), 128.5 (ArC), 128.7 (ArC), 
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Appendix I. Selected HPLC Trace 
(3S,4S)-Ethyl-2-oxo-3,6-diphenyl-1-(phenylsulfonyl)-1,2,3,4-tetrahydropyridine-4-carbo
xylate, 212 
Chiral HPLC, (Chiralpak IA, 20:80 IPA: hexane, flow rate 0.5 mL min
-1
, 254 nm, 30 ˚C) tR 








Chiral HPLC Chiralpak IA (10% IPA:hexane, flow rate 1.0 mL min
-1
, 254 nm, 30 ˚C) tR (3S, 








Chiral HPLC, (Chiralpak AD-H, 20:80 IPA: Chexane, flow rate 1.0 mL min
-1
, 254 nm, 30 ˚C) 









Chiral HPLC Chiralpak IA (30% IPA:hexane, flow rate 1.0 mL min
-1
, 254 nm) tR (3S, 4S): 








Ethyl (3S,4S)-2-oxo-3,6-diphenyl-1,2,3,4-tetrahydropyridine-4-carboxylate, 259 
Chiral HPLC (Chiralpak OD-H, 30:70 IPA : hexane, flow rate 0.5 mL min
-1
, 270 nm, 30 C) 











Chiral HPLC, (Chiralpak IA, 30:70 IPA: hexane, flow rate 1.0 mL min
-1
, 254 nm, 30 ˚C) tR 








Appendix II. Selected NMR Spectra 
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